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JURISDICTION 
The Court has jurisdiction over this appeal under Utah Code section 78-2a-3(2)(j). 
STATEMENT OF THE ISSUES AND STANDARDS OF REVIEW 
This appeal involves a breach of contract claim filed by Sonja Jensen against her 
former husband, Mr. William A. Jensen, and Summit Dialysis L.L.C.,1 a company that 
owns two kidney dialysis centers in the Salt Lake valley. Sonja contends that William, 
either individually or on behalf of their family business entities—Focus Enterprise, 
L.L.C. and William A. Jensen Family Limited Partnership (collectively "Focus")— 
entered into a contract to obtain an ownership interest in Summit. Summit and William 
not only deny they entered into a contract, but Summit's operating agreement identifying 
all owners does not list William or Focus, and Sonja has never explained the details of 
the alleged contract or ownership interest, except that it is secret and hidden. After Sonja 
failed to produce a signed written agreement or admissible evidence of an oral agreement, 
the district court entered summary judgment in favor of William and Summit. 
Issue 1: Whether a third party can prove the existence of a contract where the 
alleged parties to the contract deny its existence and only an unsigned draft agreement is 
produced. 
Standard of Review: The court reviews for correctness an order granting 
summary judgment. Berry v. Greater Park City Co., 2007 UT 87, f 8, 171 P.3d 442. In 
1
 Sonja has also sued various entities that own or are related to Summit, which will 
collectively be referred to as Summit unless otherwise specified: James B. Stinson, 
M.D., Elisabeth Thor, M.D., Melinda J. McAnulty, M.D., Richard Cline, M.D., Richard 
Lambert, M.D., David Tien, M.D., Jeff A. Barklow, M.D., Nephrology Associates, 
L.L.C, Oquirrh Artificial Kidney Center, L.L.C, West Valley Associates, L.L.C, East 
Valley Associates, L.L.C, Robert Santelli, Mark Caputo, Summit Dialysis II, Inc., 
Mercer Utah L.L.C, and Wasatch Artificial Kidney Center, L.L.C 
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addition, whether a contract exists presents a question of law. Herm Hughes & Son, Inc. 
v. Quintek, 834 P.2d 582, 583 (Utah Ct. App. 1992). 
Issue 2: Whether a district court abuses its discretion by denying a motion to 
intervene where summary judgment of all claims would have been appropriate even if 
intervention had been permitted. 
Standard of Review: Intervention involves the discretion of the trial court, and 
an appellate court "will not overturn [the trial court's] ruling absent a clear abuse of 
discretion." State v. Sucec, 924 P.2d 882, 887 (Utah 1996). 
DETERMINATIVE PROVISIONS 
Utah Rule of Civil Procedure 19 states: 
(a) Persons to be joined if feasible. 
A person who is subject to service of process and whose joinder will not deprive 
the court of jurisdiction over the subject matter of action shall be joined as a party 
in the action if (1) in his absence complete relief cannot be accorded among those 
already parties, or (2) he claims an interest relating to the subject of the action and 
is so situated that the disposition of the action in his absence may (i) as a practical 
matter impair or impede his ability to protect that interest or (ii) leave any of the 
persons already parties subject to a substantial risk of incurring double, multiple, 
or otherwise inconsistent obligations by reason of his claimed interest. If he has 
not been so joined, the court shall order that he be made a party. If he should join 
as a plaintiff but refuses to do so, he may be made a defendant, or, in a proper 
case, an involuntary plaintiff. If the joined party objects to venue and his joinder 
would render the venue of the action improper, he shall be dismissed from the 
action. 
(b) Determination by court whenever joinder not feasible. 
If a person as described in Subdivision (a)(l)-(2) hereof cannot be made a party, 
the court shall determine whether in equity and good conscience the action should 
proceed among the parties before it, or should be dismissed, the absent person 
being thus regarded as indispensable. The factors to be considered by the court 
include: first, to what extent a judgment rendered in the person's absence might be 
prejudicial to him or those already parties; second, the extent to which, by 
protective provisions in the judgment, by the shaping of relief, or other measure, 
the prejudice can be lessened or avoided; third, whether a judgment rendered in 
the person's absence will be adequate; fourth, whether the plaintiff will have an 
adequate remedy if the action is dismissed for nonjoinder. 
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STATEMENT OF THE CASE 
I. Nature of the Case and Course of Proceedings 
On February 11, 2005, Sonja Jensen, on behalf of herself and Focus, filed a 
complaint against Summit and William Jensen alleging claims for (i) breach of contract, 
(ii) third-party beneficiary, (iii) fraud, (iv) conspiracy, and (v) intentional interference 
with contractual relations. (R. 1, 12-18.) Summit filed a motion to dismiss all claims. 
(R. 151.) The district court granted this motion in part, dismissing all claims except 
breach of contract and intentional interference. (R. 342.) 
William filed his own motion to dismiss Focus, arguing Sonja had no authority to 
bring claims on behalf of Focus. (R. 103.) The district court granted this motion, and 
Sonja thereafter repeatedly moved to have Focus joined as an intervening party. (R. 475, 
478, 792.) The district court denied each of these motions, the final denial the district 
court described as being implicit in the court's grant of summary judgment from which 
Sonja appeals. (R. 769, 1109, 1117.) 
On November 14, 2006, after Summit had taken Sonja's deposition, Summit filed 
a motion for summary judgment on Sonja's remaining breach of contract and intentional 
interference claims. In support of the motion, Summit argued that there was no 
enforceable contract conveying any interest in Summit to either William or Focus (or 
Sonja), and therefore, there is no contract to be the subject of a breach of contract claim. 
(R. 567-83.) Summit then argued that either there is no contract to be intentionally 
interfered with or, assuming there is a contract, then, as parties to that contract, William 
and the individual owners of Summit cannot be liable for intentional interference under 
Utah law. (R. 563, 567, 941.) 
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In response, Sonja, presumably because there is no written contract, asserted that 
the contract to convey an interest in Summit was an oral contract. (R. 780.) Sonja's new 
assertion concerning an oral contract contradicted her earlier testimony under oath to the 
demonstrating any oral agreement. Therefore, on May 29, 2007, the district court granted 
,.n , . . .-.:.: ------ -- .iiig agreement, 
written, oral, or otherwise, to convey to William Jensen or any plaintiff an interest in 
Summit Dialysis LIA . • ;*'- i'>.-. i he district court also dismissed the intentional 
interference claims because parties to a contract cannot be • Hat le foi it ltentioi ia'1 
interference with that contract. In its ruling, the district court also implicitly denied 
S n ! ? i : » * * ! » ^ t - » t l ^ : i . ^ ' •
 lUlL , , c i i l , , : . . . . , : : i l , 
because the court ruled that the undisputed evidence demonstrated that neither William 
!i.;,.. „;v ....crest in Summit, no interest COU.J he*,,. been conveyed to Sonja 
when she acquired the right to act on behalf of Focus. (R. 1117.) A copy of the district 
court's order granting summary judgment at attached at Addendum 1. 
"i )() 7 Soi I ja filed a it. l :»tlce of appeal. 
9 
Sonja has not appealed the court's grant of summary judgment on her intentional 
interference claims. 
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II. Statement of Facts 
As background to help the court understand who all the named defendants are, 
Summit will explain the history leading to Sonja's complaint. Ultimately, the 
relationship among the various defendants is largely irrelevant to resolving this appeal 
because Summit—the entity Sonja claims an interest in—was not formed until 2002, well 
after many of the events involving the other defendants. 
A. Sunrise Healthcare Initiates the Development of Dialysis Centers in the 
Salt Lake Valley 
Nephrology Associates, L.L.C. is an association of doctors specializing in the non-
surgical treatment of kidney diseases. As part of this treatment, the Nephrology 
Associates doctors send their patients for treatment in dialysis centers. (R. 586-87.) 
William has worked for various companies that own and operate kidney dialysis centers, 
and became acquainted with Nephrology Associates through its work in the industry. 
(R. 587-88, 594-95.) 
In 2001, Sunrise Healthcare Corporation, a company unrelated to Summit, laid the 
groundwork to establish, through a series of subsidiary companies, two new dialysis 
centers in the Salt Lake valley—one on the west side and another on the east side. 
(R. 605-09, 613-14, 619.) Nephrology Associates obtained a 49% ownership position in 
the entity developing the east side facility. (R. 613-14.) Robert Santelli, another named 
3
 Sunrise Healthcare owned the facility on the west side through two subsidiaries. The 
first subsidiary was called West Valley Associates, L.L.C. and the second subsidiary, 
which was wholly-owned by West Valley Associates, was called Oquirrh Artificial 
Kidney Center, L.L.C. Sunrise Healthcare similarly owned the facility on the east side 
through two subsidiaries. The first subsidiary was called East Valley Associates, L.L.C. 
and the second subsidiary, which was majority-owned by Sunrise Healthcare, and 
minority-owned by Nephrology Associates, was ultimately named Wasatch Artificial 
Kidney Center, L.L.C. (R. 613-14, 619.) 
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d e l c ^ i . •> - , . MI) ' ~ ; ! h • I K ' t l l i i h •• 'IL'bC ML II IUCS 
throughout most of 2001. (R. 606, 608-09, 613.) 
B. Summit Purchases Sunrise Healthcare's Interests in the Dialysis 
Centers 
In late 2001 or early 2002, concerns over covenants not to compete that may have 
limited trie acu\ uies o: iNepinoiogy Associates caused Sunrise Healthcare to back ou, ,-.: 
the project. In March 2002, Sunrise Healthcare sold all of its interests in the dialysis 
facilities to Summit, a company owned by Mark Caputo and Robert Santelli. (R. 610, 
615 620 ) 
In an effort to avoid any problems with the covenants not to compete, Mr. Caputo 
i n s i s t ^ i M l h : -' : . • : i ; b l i > !- , . . l C s , A C p i i i O I O g N 
Associates relinquish its interests in the east side facility so that *cthe slate was wiped 
completely clean. , u, XOV-TW., arch 2u02, Nephrology Associates gave up its 49% 
interest in the east side facilit" ** ^ fh^se tw ^ ; 
Summit came to own 100% of all the interests associated with both the east side and west 
L. wm*w.. discusses, But Does Not Obtain, an Ownership Interest 
lit 




" " - i t i u ' , * . ! i g a 
To assist anyone reviewing the record in detail, Summit n mai ^ie east side facility's 
name was changed to Wasatch Artificial Kidney Center. (R. 647.) Thus, Nephrology 
Associates owned, and released, a minority position in Wasatch. The east side facility 
that came to be known as Wasatch should not be confused with its parent company, East 
Valley Associates L.L.C. 
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covenant not to compete was resolved, Summit hired William and opened discussions 
about the possibility of William obtaining an ownership interest in Summit. (R. 596-98, 
640-41.) 
Summit drafted an amended membership agreement for Summit, dated June 19, 
2003, which listed Focus (the family partnership) as an 8% member of Summit. This 
document was "a draft or copy for discussion purposes." (R. 600, 643-44.) The draft 
was never signed. (R. 667-68, 655-673.) 
On or about June 23, 2003, the Jensens separated. Because of the instability in 
William's life caused by this situation, and the fact that he might be moving from Utah, it 
was not clear whether William would remain involved with Summit. (R. 596, 641.) As a 
result, discussions about the possibility of William obtaining an ownership interest in 
Summit ceased. (R. 596, 600, 641.) For this reason, the draft agreement never became a 
signed contract. 
A week later on July 1, 2003, the Second Amended and Restated Limited Liability 
Company Agreement of Summit Dialysis L.L.C. was executed. (R. 675-715.) Through 
it, Nephrology Associates obtained an ownership interest in Summit, after making a 
capital contribution and agreeing to guarantee certain debts owed by Summit. Neither 
William nor Focus was a party to or signed this agreement. (R. 676-77, 707-09.) 
Confirming this, Santelli, Caputo, and Stinson (representing Nephrology Associates), as 
well as William himself, each testified that neither William nor Focus has any ownership 
interest in Summit. (R. 615-16; 641-42; 596, 599-600; 589-90.) 
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D. Sonja's Claims in this Case 
Sonja nonetheless contends that she is entitled to an ownership interest in Summit. 
She seeks half of whatever interest her ex-husband has. (R. 732.) Her claims regarding 
this interest vary and are based on a variety of alleged agreements—all with different 
subject matters, parties, terms, and dates. 
First, she claims she is entitled to an ownership interest in Summit through three 
separate written contracts: (i) the East Valley Artificial Kidney Center L.L.C. Operating 
Agreement ("East Valley agreement"); (ii) the West Valley Artificial Kidney Center 
L.L.C. Operating Agreement ("West Valley agreement"); and (iii) a June 19, 2003 draft 
agreement. (R. 720-21, 724, 735-66.) The East Valley agreement, on its face, mentions 
neither William nor Focus, let alone indicates they are parties to that agreement; the 
alleged West Valley agreement has never been produced; and the unsigned draft 
agreement was just that, a draft agreement. As stated above, there was a later (signed and 
fully integrated) agreement concerning the various ownership interests in Summit 
Dialysis, but neither William nor Focus (nor Sonja) is a party to that agreement. (R. 675-
715.) Before the district court, Sonja's theory concerning these alleged agreements was 
that William has had an ownership in Summit "since May of '01;" however, Sonja 
explained, everyone, including "my husband . . . they're hiding it." (R. 725.) However, 
the East Valley agreement and alleged West Valley agreement—the only agreements 
Sonja lists relevant to that time frame—could not have involved Summit, the entity in 
which Sonja claims an interest, because Summit was not formed until 2002, well after 
these agreements were made. (R. 639.) In addition, any such agreement would have 
been superseded by Summit's July 1, 2006 operating agreement. (R. 675-715.) 
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After Summit had filed for summary judgment, Sonja came up with another 
theory—the ownership interest is via oral agreement. However, this theory directly 
contradicts her deposition testimony that her lawsuit is not based upon any oral contracts: 
Q: Tell me what unwritten agreements that you're suing for in this lawsuit. 
A: Well, I've already said Pasadena and Austin, and we've decided that they're 
not as part of this lawsuit, so that would be the end of the answer. 
Q: So there are no unwritten agreements that you're suing for— 
A: No. 
Q: —In this lawsuit. 
(R. 723.) 
Sonja's new theory was that the three written agreements are not themselves 
contracts, but are evidence of an oral contract that she is aware of from having overheard 
conversations between William and Summit in which the possibility of William 
becoming an owner was discussed. (R. 809-814.) From this, Sonja speculates that an 
agreement must have been consummated. Yet every person who actually participated in 
these discussions has uniformly testified that, although there were discussions about 
William obtaining an ownership interest in Summit, no agreement was ever reached. 
(R. 676-77, 707-09; 615-16; 641-42; 596, 599-600; 589-90.) In fact, beginning 
approximately one week after the draft agreement was sent to William, Summit has been 
governed by a fully executed and integrated agreement that makes no provision for 
ownership by William, Focus, or Sonja. (R. 675-715.) 
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E. Focus Was Not Permitted to Intervene Because Sonja Lacked 
Authority to Act on Behalf of Focus 
Originally, this suit was brought by Sonja and Focus. After concluding that Sonja 
had no authority to act on behalf of Focus, the district court granted William's motion to 
dismiss. (R. 478.) Thereafter, the district court denied each of Sonja's repeated attempts 
for Focus to intervene. (R. 769, 1117.) As part of William and Sonja's divorce, William 
agreed to transfer ownership of Focus to Sonja because it was worthless; however, the 
divorce decree granting Sonja ownership of Focus was not entered until April 2, 2007, 
and William did not convey his interest to Sonja until May 21, 2007, more than two 
months after the district court had granted Summit's motion for summary judgment.5 
(R. 1056, 1089-93, 1097.) 
Even if Sonja had obtained the right to act on behalf of Focus prior to the district 
court having ruled on the summary judgment motion, the summary judgment ruling 
itself—that no contract exists transferring to "William Jensen or any plaintiff an interest 
in Summit Dialysis"—would eliminate any claim Focus might have brought. (R. 1009-
10.) 
SUMMARY OF THE ARGUMENT 
William and Focus do not own any portion of Summit or the dialysis centers, and 
therefore, there is no contract conveying such an interest that could provide a basis for 
Sonja's breach of contract claims. Sonja references three different documents as 
providing William or Focus an ownership interest in Summit: (i) an East Valley 
agreement; (ii) a West Valley agreement; and (iii) an unsigned draft agreement between 
5
 Summit's motion for summary judgment was granted on March 12, 2007 (well before 
any final divorce decree or transfer of Focus), although the order was not entered until 
May 29, 2007. (R. 1056, 1075.) 
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William and Focus. These documents cannot provide a basis for Sonja's claims. The 
East Valley agreement does not mention William or Focus, was created before Summit 
existed, and was superseded by Summit's subsequent operating agreement, which sets 
forth ownership interests in Summit and also does not mention William or Focus. There 
is no evidence the West Valley agreement exists. And the unsigned draft agreement is 
just that, an unsigned draft of an agreement that was never signed. While Summit does 
have a fully integrated operating agreement, it does not list William or Focus (or Sonja) 
as having any ownership interest. These documents demonstrate as a matter of law the 
opposite of what Sonja claims. William and Focus have no ownership interest in 
Summit. 
With no evidence of a written agreement, Sonja argues that these same documents 
are evidence of an oral agreement between William and Summit. This claim also fails as 
a matter of law. First, these documents (or the lack thereof) provide better evidence of no 
oral agreement, as they demonstrate that if there were such a contract, it would have been 
set forth in writing. Second, Sonja repeatedly testified under oath that her claims were 
based only on an alleged written contract, not an oral contract. Only after Summit filed 
its summary judgment motion demonstrating the lack of any evidence of written contract 
did Sonja file a self-serving affidavit contradicting her earlier testimony and in which 
Sonja speculates that there is an oral contract. Sonja's speculation, which contradicts her 
earlier statements under oath, is not sufficient to preclude summary judgment. 
Sonja also claims the district court abused its discretion by failing to allow Focus 
to intervene. This claim also fails. First, summary judgment would be appropriate 
regardless of whether Focus were a party, and therefore, any error was harmless. Second, 
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for the same reason, Focus was not a necessary party under Rule 19. Third, the district 
court did not err because Sonja did not have authority to act on behalf of Focus until after 
the district court ruled on Summit's motion for summary judgment. The court should 
affirm. 
ARGUMENT 
The district court did not err by entering summary judgment in favor of Summit, 
as there is no evidence a contract exists upon which Sonja could base her breach of 
contract claim. Sonja suspects that her ex-husband, William, and Summit entered into a 
contract giving William an ownership interest in Summit because Sonja saw a draft 
agreement in which William and Summit contemplate exactly that. However, the 
agreement was never signed because Sonja and William decided to end their marriage 
just after the draft agreement was drafted. It is irrelevant whether, as Summit contends, 
Summit refused to sign the agreement due to Summit's apprehension over William's 
future or, as Sonja contends, William refused to sign the agreement so Sonja could not 
claim an interest in Summit through their divorce proceedings. The fact remains that the 
agreement was never signed and there was never a meeting of the minds, leaving William 
and Focus without an ownership interest in Summit, and leaving Sonja with no basis for 
her breach of contract claim. 
Because there is no contract, it is of no consequence that Focus was not a party to 
this lawsuit. The result would have been the same. The court should affirm. 
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I. Summary Judgment was Appropriate Because There is No Contract—Either 
Written or Oral—Conveying an Interest In Summit to William, Focus, or 
Sonja 
The undisputed facts demonstrate that there is no contract conveying any interest 
in Summit to William or Focus (or Sonja). Sonja claims there are three written contracts 
that convey an interest in Summit to William, one of which does not mention William or 
Summit, one of which has never been produced, and one of which was never signed. As 
a result, Sonja claims the contract must have been oral; however, this position contradicts 
(i) Sonja's earlier testimony under oath that she was not claiming there was an oral 
contract; (ii) the testimony of all of the alleged parties to the alleged oral contract, all of 
which say no such contract exists; and (iii) a fully executed and integrated agreement 
which does govern Summit and which does not mention William, Focus, or Sonja. 
Sonja's claims fail as a matter of law. 
A. There is No Enforceable Written Agreement to Provide William or 
Focus an Ownership Interest in Summit 
Sonja's breach of contract claim is premised on the existence of a contract to 
convey an ownership interest in Summit to William, Focus, or Sonja. To succeed on her 
claims, Sonja must prove the existence of a contract. Kelly v. Richards, 83 P.2d 731, 734 
(Utah 1938) ("It is elementary that where one seeks to recover under a contract, he must 
allege the making of the contract either with him or with someone under whom he 
claims."). Under Utah law, whether a contract exists is a question of law. Herm Hughes 
& Son, Inc. v. Ouintek, 834 P.2d 582, 583 (Utah Ct. App. 1992). The undisputed facts 
demonstrate that no such contract exists. 
Sonja first claims that William or Focus obtained an ownership interest in Summit 
via written contract. The three documents Sonja alleges constitute such a contract are: 
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(i) the East Valley agreement; (ii) the West Valley agreement; and (iii) a June 19, 2003 
draft agreement. (R. 720-21, 724.) None of these documents constitute a contract. 
Summit will address each in turn. 
1. The East Valley Agreement 
The East Valley agreement does not constitute a contract to convey an ownership 
interest in Summit to William or Focus because, as Sonja admits, the document does not 
mention William or Focus. (R. 719, 726.) A copy of the East Valley agreement is 
attached at Addendum 2. Instead, the parties to the agreement are the Nephrology 
Associates doctors. (R. 735.) The fact that William and Focus are not mentioned in the 
document is sufficient to demonstrate that it does not pertain to them. In addition, 
because Sonja is not a party to the East Valley agreement, she has no rights under that 
agreement. Wagner v. Clifton, 62 P.3d 440, 442 (Utah 2002) ("One of the most basic 
principles of contract law is that, as a general rule, only parties to the contract may 
enforce the rights and obligations created by the contract."). 
Moreover, the document itself does not relate to Summit either, as Summit was 
not established until 2002—approximately one year after this document was executed. 
(R. 735.) William or Focus could not have obtained an ownership interest in Summit via 
the East Valley agreement, and therefore, the East Valley agreement cannot provide 
Sonja an ownership interest in Summit, which is what she ultimately claims. 
In an attempt to overcome this problem, Sonja contends that William's ownership 
interest was secretly held for him by the Nephrology Associates doctors. However, even 
if there were any evidence to support this claim, it is irrelevant as a matter of law. The 
ownership interest that Nephrology Associates at one time held in the east side facility— 
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including any secret interest it may have held for William—was relinquished in 2002 in 
connection with the Summit purchase, after which Summit was the sole owner of the 
clinics. (R. 9, 614-15; 647.) Therefore, Sonja's claim of a secret agreement based on the 
East Valley agreement could not preclude summary judgment even if there were evidence 
to support it. 
2. The West Valley Agreement 
The alleged West Valley agreement also cannot constitute an enforceable contract 
because it does not exist. The purported parties to the agreement have testified that it 
does not exist, and no party—including Sonja—has ever seen such an agreement. 
(R. 727.) There is simply no evidence of a West Valley agreement for the court to 
enforce. Cf Valarce v. Bitters, 362 P.2d 427, 428-29 (Utah 1961) ("the court cannot 
fabricate the kind of contract the parties ought to have made and enforce it."). 
Even if such an agreement did exist, however, it would suffer from the same 
defects as the East Valley agreement. It is undisputed that Sunrise Healthcare owned 
100% of the west side facility, all of which it transferred to Summit in 2002. (R. 619-20.) 
Accordingly, the undisputed evidence demonstrates that Summit—not William or 
Focus—owned the west side facility as of 2002. The alleged West Valley agreement 
therefore would be irrelevant as a matter of law, even if there were some evidence of its 
existence. 
3. The June 19, 2003 Draft Agreement 
Finally, Sonja contends that a June 19, 2003 draft agreement is a contract by 
which William received an ownership interest in Summit. A copy of the draft agreement 
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is attached at Addendum 3. This document cannot constitute an enforceable contract for 
at least three reasons. 
First, the draft agreement expressly contemplates that it must be signed to be 
enforceable. It was never signed. Under Utah law, "if the parties make it clear that they 
do not intend that there should be legal consequences unless and until a formal writing is 
executed, there is no contract until that time." Engineering Assocs. Inc. v. Irving Place 
Assocs., Inc., 622 P.2d 784, 787 (Utah 1980); see also R.J. Daum Constr. v. Child, 247 
P.2d 817, 820 (Utah 1952) ("[I]f an intention is manifested in any way that legal 
obligations between the parties shall be deferred until the writing is made, the preliminary 
negotiations and agreements do not constitute a contract." (citation omitted)). The draft 
agreement had blanks for all the potential owners to sign before the agreement would be 
enforceable. (R. 665, 667-68.) Accordingly, the June 19, 2003 draft cannot, as a matter 
of law, constitute an enforceable contract because it was never signed.6 
In addition, the draft agreement itself states that it represents nothing more than a 
"draft for discussion purposes." (R. 643-44.) To prove the formation of a valid contract, 
Sonja must prove that there was a "meeting of the minds" between William and Summit 
as to the terms of the contract. Prince, Yeates & Geldzahler v. Young, 94 P.3d 179, 183 
(Utah 2004) ("a meeting of the minds on the integral features of an agreement is essential 
6
 Indeed, Sonja recognized that the unsigned draft was not enforceable in her briefing in 
opposition to Summit's motion to dismiss. In that briefing, she conceded that "the terms 
of said agreement are not binding on any of the parties since it was not signed." (R. 210, 
213.) These statements in her brief constitute judicial admissions. Kempter v. Hurd, 713 
P.2d 1274, 1279 (Colo. 1986) (judicial admissions are deliberate declarations made by a 
party or his attorney during the course of judicial proceedings for the purpose of 
dispensing with proof of facts about which there is no real dispute, and they are 
conclusive on the party making them). 
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to the formation of a contract." (citation omitted)); Valcarce v. Bitters, 362 P.2d 427, 
428-29 (Utah 1961) ("A condition precedent to the enforcement of any contract is that 
there must be a meeting of the minds of the parties, which must be spelled out, either 
expressly or impliedly, with sufficient definiteness to be enforced.") Here, there was no 
meeting of the minds. 
Discussions, drafts, signed letters of intent, and other evidence of preliminary 
negotiations are insufficient to show that the parties came to a meeting of the minds. If 
drafts could be used in this manner, parties could never exchange draft agreements 
without becoming bound by each one. The Utah Supreme Court recognized this 
common-sense principle in Harmon v. Greenwood, 596 P.2d 636, 637-38 (Utah 1979). 
In Harmon, a plaintiff sued the defendant for breach of an alleged agreement to convey 
an ownership interest in an auto dealership. The parties had a lawyer draft a letter of 
intent, which they both signed, outlining the general terms under which the plaintiff 
would purchase a 50% ownership interest in the dealership. Id. The parties never 
executed formal paperwork to effect the sale. Id at 638. The court held that no contract 
existed because a letter of intent and oral discussions demonstrated only that "the parties 
simply committed themselves to the intention of entering into an agreement at a later 
time." Id. at 639. The "parties intended to create some form of jointly-owned entity, but 
they never actually accomplished that goal." Id. 
The same reasoning applies here. The undisputed evidence shows that there were 
discussions and negotiations concerning William potentially obtaining an ownership 
interest in Summit. (R. 616; 640-41; 597-98.) A draft agreement was prepared, but it 
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was never signed. The parties discussed an ownership interest for William, "but they 
never actually accomplished that goal." 
Finally, William and the owners of Summit have all testified that neither William 
nor Focus has an ownership interest in Summit by any agreement. (R. 615-16; 641-42; 
596, 599-600; 589-90.) This is confirmed by the fact that the draft agreement required 
William to pay for his ownership interest, something he did not do, thereby leaving those 
funds in his marital estate. It is also confirmed by a membership agreement governing 
Summit, which was signed a week after Summit sent William the draft agreement. A 
copy of that agreement at attached at Addendum 4. The signed agreement identifies the 
members in Summit, their percentage ownership, their respective contributions, and the 
amount of debt each has guaranteed. (R. 677, 707-09.) Neither William nor Focus (nor 
Sonja) is identified as having any ownership interest in the signed agreement. Because 
the later signed agreement governs, the draft agreement is irrelevant. 
In short, the draft agreement is just that, a draft. None of the three alleged 
documents identified by Sonja can provide the basis for concluding a contract between 
William and Summit exists, much less that a contract was breached. The court should 
affirm. 
B. There Is No Enforceable Oral Agreement to Provide William Jensen or 
Focus an Ownership Interest in Summit 
Perhaps recognizing that none of the documents Sonja identifies constitute a 
contract, in response to Summit's motion for summary judgment Sonja asserted that there 
was an oral agreement to convey an interest in Summit to William or Focus.7 (R. 784.) 
7
 Sonja's affidavit states that she "misunderstood" the deposition questions and that 
"there are unwritten agreements in regard to the dialysis centers involved with [Summit 
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In an attempt to manufacture a disputed issue of fact, Sonja submitted an affidavit 
asserting an oral agreement. A copy of the affidavit is attached at Addendum 5. 
However, not only does Sonja's affidavit contradict her deposition testimony and 
previous answers to interrogatories and amount to mere speculation, but she also 
presented no evidence of an oral agreement. The district court correctly rejected Sonja's 
self-serving affidavit as a basis to continue this litigation and recognized that there is no 
evidence of an oral agreement conveying any interest in Summit to William, Focus or 
Sonja. 
1. Sonja Has Twice Stated, Under Oath, hat Her Claims Are Not 
Based Upon an Oral Agreement 
Sonja's answer to interrogatories and testimony in her deposition preclude her 
affidavit from creating a question of fact to prevent summary judgment. "[W]hen a party 
takes a clear position in a deposition, that is not modified on cross-examination, he may 
not thereafter raise an issue of fact by his own affidavit which contradicts his deposition, 
unless he can provide an explanation of the discrepancy." Webster v. Sill, 675 P.2d 
1170, 1172-73 (Utah 1983). "A contrary rule would undermine the utility of summary 
judgment as a means for screening out sham issues of fact." Id. at 1173. Only where 
there is some "substantial likelihood" that the deposition testimony was in error can the 
contradictory affidavit be considered. Id; see also Brinton v. IHC Hosps., Inc., 973 P.2d 
and William]." As evidence of an oral agreement, Sonja stated "[T]here were numerous 
conversations after 2001 wherein [Summit and William] specifically agreed that Mr. 
Jensen would be given his 8% interest in Summit Dialysis after the DaVita lawsuit was 
settled. . . . [Sonja] had various conversations with [William] . . . wherein [William] 
indicated that in his conversations with [Summit] that his 8% interest in Summit Dialysis 
would be finalized and completed after the DaVita lawsuit was settled." (R. 809-814.) 
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956, 973 (Utah 1998) (affidavit could not create fact issue because it contradicted 
plaintiffs earlier deposition testimony). 
Here, Sonja did not establish a substantial likelihood that deposition testimony—in 
which she testified that she was not suing to enforce an oral agreement—was an error. 
After Sonja opposed Summit's motion to dismiss on the ground that there was an oral 
contract, Summit conducted discovery to determine what that oral agreement was. 
First, Sonja was given the opportunity to identify the oral agreement in response to 
interrogatories. Specifically, Summit submitted Interrogatory No. 2 asking Sonja to 
identify the terms of any contract to convey an ownership in Summit that Sonja believes 
o 
was breached. In response to this interrogatory (and contrary to her later affidavit), 
Sonja did not describe any oral agreement to convey an interest in Summit. (R. 809-814; 
969-77.) A copy of Sonja's answer is attached at Addendum 6. Instead, Sonja described 
the three written documents discussed above. Sonja then admitted that her claims 
8
 Interrogatory No. 2: Describe in detail the terms of any contract to convey to 
Plaintiffs any ownership interest in Summit Dialysis, L.L.C., or any other 
business entity involved in kidney dialysis, that you claim Summit breached. 
Your answer should include the following information: 
(a) The identity of all parties to the alleged agreement(s); 
(b) When the alleged agreement(s) were made; 
(c) What Plaintiffs promised to do or pay to obtain an ownership interest in 
Summit Dialysis, L.L.C. or any other business entity involved in 
kidney dialysis; 
(d) The percentage of ownership interest Plaintiffs were to receive; 
(e) When Plaintiffs were supposed to have received this interest and what 
rights they were to have in Summit Dialysis, L.L.C. or any other 
business entity involved in kidney dialysis, as a result of this interest; 
(f) All other terms of the alleged agreement(s). 
(R. 969-77.) 
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required a signed contract: "Plaintiffs [including Sonja] were to receive their 8% 
ownership interest by signing the Second Amended and Restated Limited Liability 
Company Agreement of Summit Dialysis LLC, dated 6-19-03" (i.e., the June 19, 2003 
draft agreement). (R. 976 (emphasis added).) Sonja was not referring to an oral 
agreement here, at least not one that did not have to be reduced to writing before 
becoming enforceable. 
Second, Sonja was provided the opportunity to identify the oral contract at her 
deposition (at which she was represented by counsel). During her deposition, Sonja was 
referred to paragraph 51 of her complaint, which says that "Summit, Nephrology 
Associates and Nephrology Members, Santelli, Caputo, Krupka, Mercer, and Summit 
Dialysis II have breached their agreements with the Plaintiffs." (R. 720.) She was then 
asked to identify the agreements that were breached, as referenced in paragraph 51 of the 
complaint. She identified only the same three documents she had identified in her 
interrogatory answer. (R. 720-21.) 
After identifying these three documents, she was asked "[a]re there other 
unwritten agreements that you're referring to in paragraph 51?" (R. 721.) She described 
agreements relating to facilities in Pasadena, California, and Austin, Texas—which are 
not related to this lawsuit—but then acknowledged that these facilities were not 
implicated in this lawsuit. (R. 721-22.) When Sonja was asked to limit her responses to 
written or unwritten agreements that she is suing for in this lawsuit, other than the three 
documents she had already identified, she clearly stated that there were no unwritten 
agreements: 
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Q: Well, the answer to my question might be you don't know, 
but you need to answer my question which is: Are you suing for 
breach of agreements concerning Pasadena and Austin, Texas, in 
this— 
A: Not in this Complaint. 
Q: Okay. I'm only interested in the agreements that you're 
suing for that are referred to in paragraph 51. Other than the 
three written documents that you've told me you believe are 
agreements that Plaintiffs are party to, are there any other 
agreements that you're suing under in this lawsuit? 
A: Can I answer? 
Mr. Nemelka (counsel for Sonja): Oh, you betcha. Go ahead. 
He's talking about whether they're verbal or written agreements; 
is that correct Counsel? Either written or unwritten? 
Mr. Lalli (counsel for Summit): You tell me. 
Sonja: Can you say the question again? 
Mr. Lalli: Yeah. 
Q: I want to know how many agreements you claim that the 
Plaintiffs had with the Summit and that the Summit breached. 
You've already told me about three. 
A: Right. 
Q: I want to know if there are any more, written or unwritten. 
A: I believe there are others that are verbal, like I just told you 
about. 
Q: Okay. That you are suing for in this lawsuit? 
A: Okay. No. 
(R. 722.) And to make sure that the "verbal agreements" Sonja was referring to were 
those in Pasadena and Austin, Summit's counsel repeated the question: 
Q: Tell me what unwritten agreements that you're suing for in 
this lawsuit. 
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A: Well, I've already said Pasadena and Austin, and we've 
decided that they're not as part of this lawsuit, so that would be 
the end of the answer. 
Q: So there are no unwritten agreements that you're suing for— 
A: No. 
Q: —In this lawsuit. 
(R. 723.) The relevant portions of the deposition transcript are attached at 
Addendum 7. 
Sonja's answers to interrogatories and to questions in her deposition demonstrate 
that there is not a substantial likelihood that her answers were mistaken. Her counsel 
assisted her with all of her answers, and no oral contract relevant to this lawsuit was ever 
identified. As a result, Sonja's contradictory assertions in her affidavit about the 
existence of an oral contract should be disregarded. 
2. There is No Evidence of a Purported Oral Agreement 
Apart from her self-serving assertions in her affidavit, Sonja has provided no 
evidence of an oral contract. The existence of a contract is ultimately a question of law. 
Harris v. Albrecht 86 P.3d 728, 730 (Utah Ct. App. 2004). To prove an oral contract, 
Sonja must prove that there was a meeting of the minds between the parties, including 
proof of a valid offer, acceptance, consideration and sufficiently definite terms. Albrecht, 
86 P.3d at 730-31 (holding that trial court properly granted summary judgment in favor 
of defendant on alleged oral contracts to obtain insurance because the alleged oral 
agreement lacked sufficient details to show the essential elements of an insurance 
contract); Clausse v. First Sec. Corp., 261 P.2d 375, 378 (Utah 1953) (requiring evidence 
of offer, acceptance, and consideration to enforce an oral contract). 
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Sonja's affidavit provides no evidence that there was a meeting of the minds on 
definite terms. It is difficult to imagine how it could. Sonja was not a party to the 
alleged oral contract. In her deposition, Sonja testified that she had not entered into a 
contract—oral or written—with Summit, and instead she was simply claiming an interest 
through her husband by virtue of their marriage.9 (R. 810, 726.) And there is no 
evidence anywhere in the record that Summit agreed to compensate Sonja with an 
ownership interest in Summit in exchange for any alleged support she gave her husband 
to set up the dialysis facilities.10 
This leaves only Sonja's speculation about conversations she overheard in which 
the possibility of William obtaining an ownership interest was discussed, which cannot 
provide a basis for precluding summary judgment. "An affidavit which merely reflects 
the affiant's unsubstantiated conclusions and which fails to state evidentiary facts is 
insufficient to create an issue of fact." Williams v. Melbv, 699 P.2d 723, 725 (Utah 
Insofar as Sonja is claiming an interest in Summit through her husband, the court may 
affirm on the basis that she lacks standing to maintain a claim against Summit. One 
spouse does not gain standing to enforce another spouse's contract simply because of the 
marriage. Rodriguez v. United States, 69 Fed. CI. 487 (Fed. CI. 2006) (husband was not 
party to contract for purchase of vehicle between his wife and the U.S. government and 
therefore could not sue the government for breaches of the warranties contained in the 
contract); Pacetti v. United States, 50 Fed. CI. 239 (Fed. CI. 2001) (because husband was 
not party to contract between IRS and his wife, he lacked standing to assert claims based 
on the contract); Serpe v. Williams, 776 F. Supp. 1285, 1289 (N.D. 111. 1991) (wives were 
not parties to or third party beneficiaries of contracts between their husbands and their 
husbands' employers); Hatchwell v. Blue Shield of Cal., 244 Cal. Rptr. 249, 253-54 (Cal. 
Ct. App. 1988) (even though wife was covered as dependent under husband's insurance 
policy, wife was not a party to her husband's insurance contract, and therefore lacked 
standing to pursue contractual claims based on denial of benefits to her husband). 
In the complaint, Sonja alleged that she assisted Summit in the "procurement of real 
estate" for the facilities. (R. 10.) What this amounted to was that Sonja drove her 
husband around the Salt Lake valley, looking for potential locations for the facilities. In 
her deposition, Sonja confirmed that no one agreed to compensate her for such efforts. 
(R. 994.) 
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1985). Sonja's affidavit is insufficient to show that the parties to the alleged oral contract 
had a meeting of the minds on definite terms. Webster v. Sill 675 P.2d at 1172 ("The 
mere assertion that an issue of fact exists without a proper evidentiary foundation to 
support that assertion is insufficient to preclude the granting of a summary judgment 
motion."). 
On appeal, Sonja attempts to overcome the lack of any evidence of the specific 
terms of an oral contract by arguing that the three written agreements she identified in her 
interrogatory responses and in her deposition—particularly the June 19, 2003 draft 
agreement—represent the terms of the oral contract. She also argues that the June 19, 
2003 draft agreement was prepared to "solidify" the parties' earlier oral contract. 
(R. 810.) Insofar as Sonja's claim relies essentially upon the written agreements, her 
claim fails for all the same reasons her direct reliance on the written agreements is 
misplaced. 
Indeed, if the unsigned draft agreement was meant to capture the terms of a prior 
oral contract, then the draft agreement serves as evidence that there is not an enforceable 
oral contract. The draft agreement, like the East Valley agreement, contains an 
integration clause that specifically disavows any prior agreements, including oral 
agreements, and includes a signature block.11 Engineering Assocs. Inc. v. Irving Place 
The East Valley agreement includes this clause "Entire Agreement. This instrument 
contains all of the understandings and agreements of whatsoever kind and nature existing 
between the parties hereto with respect to this Agreement and the rights, interests, 
understandings, agreements and obligations of the respective parties hereto." (R. 735, 
759.) The June 19, 2003 draft includes the clause: "Entire Agreement. This Agreement 
constitutes the entire agreement of the parties thereto relating to the Company and 
supersedes all prior contracts or agreements with respect to the Company, whether oral or 
written." (R. 655, 665.) 
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Assocs., Inc., 622 P.2d 784, 787 (Utah 1980) ("There does not appear to be any doubt 
that if the parties make it clear that they do not intend that there should be legal 
consequences unless and until a formal writing is executed, there is no contract until that 
time."); R J. Daum Constr. v. Child, 247 P.2d 817, 820 (Utah 1952) ("if an intention is 
manifested in any way that legal obligations between the parties shall be deferred until 
the writing is made, the preliminary negotiations and agreements do not constitute a 
contract.") (citation omitted). 
The documents refute, and certainly do not support, Sonja's assertion that there 
was an oral contract. In the end, the only final, signed, integrated contract governing the 
ownership of Summit does not mention William or Focus. This again is dispositive of 
the fact that neither William nor Focus owns part of Summit. (R. 675-715.) 
In short, the undisputed evidence demonstrates that there were discussions and 
negotiations about the possibility for William or Focus to obtain an ownership interest in 
Summit, but those discussions failed to yield a contract. As a result, there is no 
enforceable contract—oral or otherwise. The trial court correctly concluded that, as a 
matter of law, there was no binding contract conveying William or Focus (or Sonja) any 
interest in Summit. Therefore, Sonja's breach of contract claim fails as a matter of law. 
C. Under Sonja's Theory of the Case, Summit Could Not Have Breached 
a Contract to Convey William an Interest in Summit Because She 
Believes William Already Has Such an Interest 
Sonja's breach of contract claim, insofar as it is directed at Summit, fails for an 
additional reason. In her deposition, Sonja testified that William currently holds 
ownership interest in Summit, an ownership he has held since May of 2001. (R. 725.) If 
this is correct—which it is not—then Summit has not breached any contract. The alleged 
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contract, according to Sonja, requires Summit to recognize William's ownership interest 
in Summit, something which, again according to Sonja, Summit has done by allowing 
William currently to hold such an interest. Holmes Dev. LLC v. Cook, 48 P.3d 895, 903 
(Utah 2002) (defendant could not be liable for breach of title insurance contract where it 
fully performed under the contract). 
While Sonja is mistaken on both counts, it is worth noting that, under Sonja's own 
theory, the court should affirm the summary judgment. If, as Sonja contends, there 
actually was a contract that Summit fully performed by conveying an interest to 
William—which, according to Sonja, William currently possesses—then Sonja cannot 
assert a breach of contract claim, but rather the proper forum for her to assert an interest 
in her husband's property is through divorce proceedings. The court should affirm even 
if Sonja's own theory of the case were accurate. 
II. Sonja's Arguments for Intervention Have Not Been Preserved, Have Not 
Been Adequately Briefed, and Fail on the Merits 
The district court did not abuse its discretion when it denied Sonja's numerous 
motions for intervention, including her final "Renewed Motion for Intervention." 
(R. 792, 1117.) The court need not address this issue, however, because summary 
judgment is appropriate for Sonja and Focus, and the result would be the same regardless 
of whether Focus had remained a party from the onset of this litigation or had been added 
as a party along the way. Indeed, Summit drafted its summary judgment papers as if 
Focus were a party for just this purpose. (R. 567-68, 945.) Having Focus as a party 
would not change the evidence in the summary judgment record, which is what makes 
summary judgment appropriate. Thus, assuming there was an error, it was harmless. 
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In any event, the district court did not err in denying the motion to intervene 
because, prior to summary judgment, Sonja did not have authority to act on behalf of 
Focus. Contrary to Sonja's assertions, on December 6, 2006, at the time she filed her 
final motion for intervention, she still did not have the authority to assert claims on behalf 
of Focus,12 authority Sonja did not have until May 21, 2007, when William quit claimed 
his interest in Focus to her. (R. 1056, 1097.) Without an interest in Focus, Sonja could 
not act on its behalf. 
Finally, Summit notes that Sonja has changed theories on appeal, now arguing the 
motion to intervene should have been granted under Rule 24 (permissive intervention), 
whereas, before the district court, she only moved under Rule 19 (joinder of necessary 
parties). (R. 475-76, 792.) This new Rule 24 theory was not presented below and is 
therefore waived on appeal, and the old Rule 19 theory was not been presented in the 
opening brief and is therefore waived on appeal. Associated Gen. Contrs. v. Bd. of Oil 
2001 UT 112, [^27 n.5, 38 P.3d 291 (because issue was not raised before the trial court, it 
is therefore waived on appeal); Smith v. Batchelor, 832 P.2d 467, 470 n.4 (Utah 1992) 
("We have long held that where an appellant fails to brief an issue on appeal, the point is 
waived."). 
In any event, the Rule 19 argument fails. Rule 19 requires joinder of "necessary" 
parties "if feasible." Under Rule 19(a), "a party is necessary if 'in his absence complete 
The unsigned, proposed order from her divorce proceedings that Sonja submitted in 
support of her renewed motion to intervene did not grant Sonja ownership of Focus. 
(R. 802.) Sonja herself, in fact, had objected to the proposed order and had moved for a 
new trial. (R. 1007.) Without a final divorce decree, no interest in Focus could have 
been transferred to Sonja. A final divorce decree was not entered until April 2, 2007, 
well after summary judgment had been granted. (R. 1089-93.) 
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relief cannot be accorded among those already parties.'" Landes v. Capital City Bank, 
795 P.2d 1127, 1130 (Utah 1990) (quoting Utah R. Civ. P. 19(a)(1)). Further, a party is 
necessary "if he claims an interest relating to the subject of the action and is so situated 
that the disposition of the action in his absence may (i) as a practical matter impair or 
impede his ability to protect that interest or (ii) leave any of the persons already parties 
subject to a substantial risk of incurring double, multiple, or otherwise inconsistent 
obligations by reason of his claimed interest." Id. (citing Utah R. Civ. P. 19(a)(2)). 
Sonja has not claimed that any of these requirements apply to Focus, and instead merely 
makes the conclusory statement that Focus is "necessary" and that she has authority to act 
1 O 
on its behalf. (Opening Br. at 27.) In any event, Focus is not a necessary party, as 
complete relief could be afforded to Sonja without Focus, and Sonja makes no claim that 
Focus would have made any arguments Sonja did not make. 
In sum, any error concerning intervention is harmless, as the same arguments 
would have entitled Summit to summary judgment against Focus. In addition, Sonja 
waived any claim under Rule 24 by not raising it before the district court, and has waived 
any claim under Rule 19 by not raising it in her opening brief. Finally, the court did not 
err in denying the motion to intervene because, at the time the motion was made and at 
the time the court ruled on Summit's summary judgment motion, Sonja did not have 
authority to bring any claim on behalf of Focus. The court should affirm. 
Sonja's arguments should fail for inadequate briefing alone, as she does not cite Rule 
19 in her appellate brief. See, e.g., Mackav v. Hardy, 973 P.2d 941, 948 n.9 (Utah 1998) 
(listing cases where briefing which included only conclusory statements was inadequate 
and the court refused to address the issues); Spencer v. Pleasant View City, 2003 UT App 
379,1|21 n.9, 80 P.3d 546. 
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CONCLUSION 
Sonja's speculation that Focus or William, her ex-husband, has an interest in 
Summit is not enough to create an interest in Summit or to preclude summary judgment. 
In the end, the only basis Sonja has for her claims is her suspicion that her ex-husband 
refused to enter into a contract out of spite. If true, then this explains why there is no 
contract; it does not support a theory that there is a contract. William and Focus own no 
interest in Summit, and Sonja has provided no admissible evidence indicating otherwise. 
Therefore, summary judgment was appropriate. The court should affirm the district 
court's entry of summary judgment. 
For the same reason, the court should affirm the district court's denial of the 
motion to intervene. Summary judgment would have been equally appropriate had Focus 
been permitted to intervene. In addition, the arguments Sonja raises on appeal were not 
preserved below. Finally, denial of the motion was not an abuse of discretion because 
Sonja was not authorized to act on behalf of Focus until after she filed her motion and the 
court had ruled on the summary judgment motion. The court should affirm. 
DATED this 4th day of January, 2008. 
Snell & Wilmer L.L.P. 
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"•PWyCltrtT 
IN THE THIRD JUDICIAL DISTRICT COURT IN AND FOR 
SALT LAKE COUNTY, STATE OF UTAH 
SONJA M. JENSEN et al., 
Plaintiffs, 
v. 
JAMES B. STINSON, M.D., et ah, 
Defendants. 
ORDER GRANTING SUMMARY 
JUDGMENT 
Case No. 050902765 
Honorable Denise Lindberg 
On March 12, 2007, the Court heard oral argument on the motion for summary judgment 
filed by Defendants James B. Stinson, M.D., Elisabet Thor, M.D., Melinda J. McAnulty, M.D., 
Richard Cline, M.D., Richard Lambert, M.D., David Tien, M.D., Jeff A. Barklow, M.D., 
Nephrology Associates, L.L.C, Oquirrh Artificial Kidney Center, L.L.C, West Valley 
Associate L.L.C, East Valley Associates, L.L.C, Summit Dialysis, L.L.C Robert Santelli, 
Mark Caputo, Summit Dialysis II, Inc., Mercer Utah L.L.C, and Wasatch Artificial Kidney 
Center, L.L.C's (the "Summit Defendants"5)- Defendant William Jensen joined in the motion. 
The Summit Defendants were represented by Matthew L. Lalli and Tyler L. Murray. Defendant 
William Jensen was represented by Bart Johnsen. Plaintiffs were represented by Richard 
Nemelka. 
Based upon the supporting memoranda, exhibits, affidavits, and the arguments of 
counsel, and for good cause appearing 
IT IS HEREBY ORDERED that 
L The motion for summary judgment on plaintiffs' first cause of action for breach 
of contract is GRANTED. Plaintiffs have failed to raise a material issue of fact regarding this 
claim. Plaintiffs have failed to properly controvert Defendants' statement of undisputed facts in 
accordance with Rule 7(c)(3)(A). In addition, plaintiffs cannot create a genuine issue of material 
fact by offering the affidavit of Sonja Jensen, which contradicts her sworn interrogatory response 
and deposition testimony. Also, the undisputed evidence shows that there is no binding 
agreement, written, oral, or otherwise, to convey to William Jensen or any plaintiff an interest in 
Summit Dialysis LLC Plaintiffs' first cause of action is therefore dismissed with prejudice. 
2. The motion for summary judgment on plaintiffs' fifth and sixth causes of action, 
for intentional interference with contract, and tortious interference with actual and prospective 
economic relations, against defendants James B. Stinson and William Jensen, is GRANTED. 
Plaintiffs contend that Dr. Stinson and Mr. Jensen were parties to the contract(s) that were 
allegedly interfered with. Under Utah law, "it is settled that one party to a contract cannot be 
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liable fo~ the tort of interference with contract for inducing a breach by himself or the other 
contracting party." Leigh Furniture and Carpet Co. v. horn, 657 P.2d 293, 301 (Utah 1982). 
Plaintiffs' fifth and sixth causes of action are therefore dismissed with prejudice. 
On September 21, 2005, the Court dismissed plaintiffs' second, third, and fourth causes 
of action, and also dismissed plaintiffs' fifth and sixth causes of action against defendants Mark 
Caputo and Robert Santelli. On October 7, 2005, the Court dismissed the claims against 
detendant Michael Krupka for lack of personal jurisdiction. As a result of these prior rulings, 
and the Court's ruling on the motion for summary judgment, all claims pending in this case have 
been dismissed. 
IT IS THEREFORE FURTHER ORDERED that 
1. This case is dismissed, with prejudice, and that final judgment should be entered 
in favor of defendants; and 
Defendants are awarded their costs of court. 
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APPROVED AS TO FORM: 
Richard Nemelka 
Attorney for Plaintiffs 








EAST VALLEY ARTIFICIAL KIDNEY CENTER LLC 
M THIS OPERATING AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as'of 
thiyfcy3ay of M^Rf2001 by and among East Valley Associates, Inc., a Delaware corporation ("Managing Member" 
or Associptes"), James B. Stinson, M.D., Richard G. Lambert, M.D., Richard C. Cline, M.D., Elisabet Atkin-Thor, 
M.D., Melmda J. McAnulty, M.D., Gary M. Rabetoy,M.D. and Christy Price-Rabetoy, M.S.N. Managing Member and 
the individuals set forth above are sometimes hereinafter collectively referred to as the "Members," who intending to be 
legally bound, agree as follows: 
Preliminary Statements 
A. The initial Non-Managing Members (hereinafter defined) are licensed nephrologists providing medital 
se^ices m the State of Utah. The initial Non-Managing Members have serious concerns about the quality of care 
provided by the owner and manager of certain of the dialysis facilities in the State of Utah in which such physicians 
cun^ntly provide medical services (the "Existing Facilities") and each of the initial Non-Managing Members desire lo 
ertabJish one Dr more new dialysisJacilities to improve and enhance the overall quality of care provided to dialysis 
patients in the areas served by such new facilities, by, among other things, (i) improving the quality of the dialysis 
facility, (ii) improving the medical equipment used in such facility, (iii) improving the training and experience of thej 
medical staff of such facililty and (iv) improving the overall management of the facility. 
B. In addition, the initial Non-Managing Members have serious concerns about the lack of continuity of the 
management of the manager of the Existing Facilities, including the officers, personnel and staff of such manager, ai^ d 
desire to establish a new dialysis facility which is managed by an experienced, competent, and prudent dialysis facility 
management company. The initial Non-Managing Members have serious concerns about the attempt to dictate clinical 
practice by the corporate senior medical officer of the owner of the Existing Facilities. Finally, the initial Non-Manajging 
Members have other serious concerns with respect to such owner and manager of the Existing Facilities and therefore the 
Non-Managing Members seek to terminate any business relationship with such owner and manager as soon as 
practicable. 
C. Associates is an affiliate of an experienced, knowledgable and prudent medical services company, the 
principals of which have significant experience in the establishment and operation of dialysis clinics throughout the 
United States. 
D. The Members have executed and delivered this Operating Agreement to set forth their mutual agreement 
with respect to the matters set forth herein. 
ARTICLE 1 
ORGANIZATION 
1.1 Formation, Name and Filings. On the day of March, 2001, the Members organized East Valley 
Artificial Kidney Center LLC, a limited liability company (the "Company") pursuant to the Act, as hereinafter defined. 
The Articles of Organization are hereby adopted and ratified by the Members. In the event of a conflict betweert the 
terms of this Agreement and the terms of the Articles of Organization, the terms of this Agreement shall prevail. The 
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business of the Company shall be conducted under the name of East Valley Artificial Kidney Center LLC or such 
other name as the Members may designated in writing. The Members agree to execute such certificates or documents 
and make such filings and recordings and do all other acts, including the filing or recording of alternate name(s) in the 
appropriate offices in the State of Delaware and the State in which the Facility is located as may be required in order to 
comply with all applicable laws. The Managing Member shall prepare and arrange for such filings and pay all 
appropriate filing fees out of Company funds. 
1.2 Offices, Registered Office and Registered Agent. The registered office and the pnncipal dffice of the 
Company shall be The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801. The Company 
may have such substituted and additional offices at such other locations situated in the State in which the Facility is 
located and the State of Florida as the Members may, in their discretion, deem advisable. The Company's initial 
registered agent shall be CT Corporation. The Members may, within their sole and unrestricted discretion, change the 
principal office, registered office or registered agent of the Company, and establish additional offices of the Company. 
1.3 Title to Company Property. Title to property to be acquired by the Company shall be in the name of the 
Company. The Managing Member shall execute such documents as may be necessary to reflect the Company's 
ownership of its property in such public offices in the State in which the Facility is located as may be required^ 
1.4 Commencement; Term. The Company shall commence on the date of the filing of the
 ?Articles of 
Organization and shall terminate in accordance with the Article 16 hereof. 
i.5 Place of Business. The principal place of business of the Company shall be located in Salt Lake County, 
in the State of Utah and such other place or places in the State of Utah as may be decided by the Required Mejmbers. 
1.6 Nature of Interest. The interest of the Members in the Company shall be personal propbrty fpr all 
purposes. 
ARTICLE 2 
CHARACTER OF BUSINESS AND PURPOSES 
The character of the business and the purposes of the Company shall be as follows: 
2.1 General. 
2.1.1 The purpose of the Company shall be, among other things, to develop, to own, aind to 
operate an end stage renal dialysis treatment center to be located east of Interstate 15 in Salt Lake Count}!, Utalji (the 
"Facility"), or such other place or places east of Interstate 15 in Salt Lake County, Utah as may from time| to tiijie be 
chosen It shall further be among the purposes of the Company to provide chronic hemodialysis, continuous kmbuiatory 
peritoneal dialysis ("CAPD"), continuous cyclying peritoneal dialysis ("CCPD"), home hemodialysis, othjer Dialysis 
Services and any other treatment modalities related to the care of renal patients. The Company shall havej all powers 
which are reasonable necessary to fulfill its purpose. The Company shall not engage in any business or activity outside 
the scope of its purposes without the approval of the Required Members. The Center will accept any dialysis-dependent 
patient requiring dialysis maintenance treatment meeting the Center's criteria, including but not limited to stable clinical 
condition, adequate hemodialysis access and insurance. 
2.1.2 Except as specifically provided for in this Agreement, no Member shall be Restricted in 
any manner from engaging in a capacity other than as a Member in the Company, in any business or activityjin which it 
may now or hereafter be engaged. 
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2.1.3 Associates and its Affiliates are or may become also engaged in businesses which will 
provide services to the Company at competitive market rates in which businesses the Members will have no Interest! No 
/lember as such shall have any right by virtue of this Agreement in or to the other Member's or (heir Affiliates separate 
investments, property interests, or independent ventures, or to the income or profits derived therefrom,, except as 
otherwise provided in this Article 2 hereof. This Agreement shall continue in full force and effect throtighoujt the 
exis'cr; e of the Company. 
2.2 Other Acts. The doing of any and all acts and things necessary, appropriate, proper, advisable, 
incidental to or convenient for the furtherance and accomplishment of the business, objectives and purposes set forth in 
Article 2 hereof. 
ARTICLE 3 
DEFINITIONS 
The defined terms used in this Agreement shall, unless the context otherwise requires, have the meaning set forth 
in this Article 3. Certain additional defined terms are set forth elsewhere in this Agreement 
* Act" shall mean the Delaware Limited Liability Company Act, 6 Del. C. Section 18-101 et seq. as now in qnect 
or as hereafter amended or revised. 
* A ffiliate of a Member" or "Affiliate" shall mean any Person, corporation, partnership, trust, association or other 
entity which is controlled by, controls or is under common control with the Company, any Member or other specified 
person, as the case may be, and includes, without limitation, a Person's spouse, parents, lineal descendants arid sibljings, 
and parent companies and subsidiaries. 
"Agreement" shall mean this Operating Agreement as originally executed and as hereinafter amended modified, 
extended or supplemented from time to time. 
"Approved Budget" shall have the meaning set forth in Section 8.8. 
"Available Cash from Operations"shall mean any cash received by the Company in connection with the ordinary 
operations of the Company business, less the sum of: (i) current operating and development expenses,; including, 
without limitation, management and administrative expenses; (ii) Debt Service; and (iii) Reserves. 
"Available Cash from Sale or Financing" shall mean any cash received by the Company in connection with the 
sale, exchange, other disposition, financing or refinancing of the Company property, less the sum of any amounts \fhich 
must be paid as a result of or in connection with such sale, exchange, other disposition, financing or refinanc&ig. 
"Bankrupt" shall mean, with respect to any Member, the occurrence of any one or more of the following: (i) the 
making by the Member of an assignment for the benefit of creditors; (ii) the filing of an involuntary petitionjseekiag an 
adjudication of bankruptcy under Chapter 7 of the Bankruptcy Code, which filing is not dismissed within sixtyi (60) 
days of the filing; (iii) the filing of a voluntary petition by the Member under Chapter 7 of the Bankruptcy|Code£ (iv) 
the filing of a voluntary or involuntary petition under Chapters 11 or 13 of the Bankruptcy Code which is not dismissed 
within sixty (60) days of (he filing, but only if the Member is not the debtor-in-possession of his assets; (v) $ie entry of 
an order, judgment or decree by a court of competent jurisdiction providing for the liquidation of the assets oif the 
Member or appointing a receiver, trustee or other administrator of the Member's assets which continues hi effecjt and 
unstayed for a period of sixty (60) days; (vi) the confirmation of any plan of reorganization under either Chapter 11 or 
13 of the Bankruptcy Code providing for the liquidation of substantially all of the Member's assets. For purposes of 
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(iv) above, a Member shall not be considered a debtor-in-possession of his assets if a trustee, receiver or other person or 
entity is appointed to, or in fact does, control or operate the assets of the Member. 
"Bankruptcy Code" shall mean Title 11 of the United States Code, as now in effect or as hereafter amended. 
"Capital Account" shall mean, as to any Member, such Member's capital account, as provided in Article 4 hereof. 
"Capital Contributions" shall mean the total amount of money and property contributed to the Qompafty as 
provided in Article 4 hereof by the Members or any Member, as is applicable. The value of any property contributed 
to the Company shall be the fair market value on the date it is contributed to the Company. 
"Capital Transaction" shall mean any transaction not in the ordinary course of business which results in the 
Company's receipt of cash or other consideration other than Capital Contributions, including, without limitation, 
proceeds of sales or exchanges or other dispositions of property not in the ordinary course of business/ financing, 
refinancing, condemnations, and insurance proceeds for the destruction of assets used in the trade or business of the 
Company; provided however that the following transactions shall not constitute a "Capital Transaction" (i) a5Significant 
Sale, (ii) a sale under Section 11.6 and (iii) the Transfer by Associates of any Interest of Associates to any Affiliate of 
Associates. 
"Code" shall mean the Internal Revenue Code of 1986, as amended. 
"Company Indebtedness" shall mean the collective reference to (a) all indebtedness of the Company or the' Real 
Property Affiliate for borrowed money or for the deferred purchase price of property or services (other than current 
trade liabilities incurred in the ordinary course of business and payable in accordance with customary practices, which 
are not more than 30 days past due) or which is evidenced by a note, bond, debenture or similar instrument, (b) all 
obligations of the Company or the Real Property Affiliate under financing leases, and (c) all liabilities seciired by any 
lien or security interest on any property owned by the Company even though the Company, the Real Property Affiliate, 
any Member or owner of the Real Property Affiliate has not assumed or otherwise become liable for tfie payment 
"Debt Service" shall mean all costs of obtaining and servicing indebtedness of the Company. 
"Dialysis Services" shall mean all dialysis services and related services provided by the Company at any jtime, 
including, without limitation, hemodialysis, peritoneal dialysis of any type, staff-related services, and any oijtxor service 
or treatment for persons diagnosed as having end stage renal disease ("ESRD") or pre-end stage renal disease, as well 
any any dialysis services provided in an acute hospital. To the extent such regulation is changed or amended, the! term 
"ESRD" shall have the same meaning as set forth in Title 42, Code of Federal Regulations 405.2101 et. seq. or any 
successor thereto. 
"Facility" shall mean the dialysis clinic to be located to the east of Interstate 15 in Salt Lake County,, Utahjto be 
established and operated by the Company and managed by the Manager pursuant to the terms of the Management 
Services- Agreement to provide Dialysis Services as described in Section 2.1.1. 
"Interest" shall mean the economic and membership right to vote and participate in the business affairs, profits 
and losses of the Company for each Member in the percentage set forth opposite his or its name on Schedule I attached 
hereto, which Interest may be revised or adjusted, from time to time in accordance with this Agreement. 
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"Management Services Agreement" shall mean that certain Management Services Agreement by and between 
the Company and Manager, in substantially the form attached hereto as Exhibit B, as such agreement may be amerided, 
modified, supplemented and replaced, from time to time. 
"Manager" shall mean Associates and any replacement to Associates which is an affiliate of Associates. Without 
limiting the foregoing, the Members agree that Associates may subcontract its management obligations to KRU Medical 
Ventures LLC. 
"Managing Member" shall mean East Valley Associates, Inc., a Delaware corporation, and any successrir or 
assignee thereof. 
"Members" shall mean Associates, James B. Stinson, MX)., Richard G. Lambert, M.D., Richard C. Cline, M.D. 
Elisabet Atkin-Thor, M.D., Melinda J. McAnulty, M.D., Gary M. Rabetoy, MX), and Christy Price-Rabetoy, M.S.N.jand 
any person admitted as an additional or substitute Member in accordance with this Agreement in such person's capacity 
as a Member. The costs (including attorney's fees) associated with each Memberfs Interest shall be borne by each 
respective Member. 
"Non-Managing Member" shall mean any Member which is not the Managing Member. 
''Non-Managing Member Group" shall mean the collective reference to the Non-Managing Members. 
"Person" shall mean any individual, partnership, joint venture, corporation, trust, association, or other entity or 
organization. 
"Qualified Party" shall mean an individual approved to be admitted as a Member by the Required Members 
"Real Property Affiliate" shall have the meaning set forth in Section 8.7. 
"Regulations" or any abbreviation thereof shall mean the income tax regulations promulgated under the Code, as 
such regulations may be amended from time to time. 
"Required Members" shall mean a written vote, consent or action of the Members owning at least eighty percent 
(80%) of the Interests. 
"Reserves" shall mean all Company reserves reasonably established for the Company by the Managing Member 
or the Manager for Company purposes, including, but not limited to, accrued or deferred expenses and other working 
capital needs, improvements, repairs, contingent liabilities, taxes and purchases. 
* Significant Sale" shall have the meaning set forth in Section 11.4. 
"Transfer" shall mean any transfer, assignment, disposition, pledge, mortgage, hypothecation or encumbrance of 
any Interest. 
ARTICLE 4 
CAPITAL CONTRIBUTIONS AND ACCOUNTS 
4.1 Capital Accounts, Individual capital accounts for each Member ("Capital Accounts") shall be maintained 
and adjusted in the manner provided in Regulations Section 1.704-l(b)(2)(iv) or, if the Managing Member so elects, in 
accordance with any amended or successor regulations or authoritative interpretations issued thereunder. 
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4.2 Initial Capital Contributions. Upon the execution hereof, the Members shall contribute the sums tb the 
capital of the Company set forth beside such Member's name on Schedule I attached hereto. 
4.3 Additional Capital Contributions, Loans and Guarantees. 
4.3.1 Additional Capital Contributions. Except as provided in Article 4 hereof, no Member shall be 
required to make any additional Capital Contributions to the Company. 
4.3.2 Operating Loans, Leases and Other Obligations. 
4.3.2.1 The Members agree and anticipate that additional funds, in addition to the initial Capital 
Contributions set forth on Schedule I, will be required by the Company for the development and construction of the 
Facility, the furnishing of the Facility, the commencement of operations of the Facility and the ongoing operation of the 
Facility and the Company thereafter. Each Member hereby covenants and agrees to loan the Company, in accordance 
with his or its pro rata Interest, (i) the amounts set forth on Schedule II beside such Member's name and (ii) the amounts 
that may necessary or required by the Company to carry out the business of the Company and to operate the Facility as 
set forth in the Approved Budget (collectively, "Member Loans"). 
4.3.2.2 Prior to requesting any Member to make a Member Loan, the Managing Member shall 
cause the Company to borrow the amount contemplated by the Approved Budget from a lending institution, bank or bther 
party (including, without limitation, any Member) selected by the Managing Member pursuant to a line of credit,;term 
loan, lease financing or other financing arrangement (collectively, a "Financing") and each Member (i) shall personally 
guaiantee his or its pro rata portion of such Financing and shall execute and deliver any and all guaranty documents and 
other documents required by such lender in connection with such Financing and (ii) shall pledge such Member's Interest 
in the Company as collateral to such personal guaranty of such Financing pursuant to documentation acceptable toisuch 
lender. 
4.3.2.3 In addition to the Financing described in Section 4.3.2.2, if, at any time the Company 
doef net have sufficient cash on hand (or projected by the Managing Member to be on hand within the next ninetV (90) 
days) to pay operating costs and expenses of the Company incurred pursuant to the Approved Budget and due and 
payable as of such time or expected to be due and payable within the next ninety (90) days (the excess of the amount 
needed, if any, to pay such operating costs and expenses of the Company over the cash currently on hand or projected to 
be on hand, the "Operating Deficit") or in the event the Managing Member desires, from time to time, to refinance kll or 
any portion of any prior Financing or other indebtedness of the Company upon terms acceptable to the Managing 
Member, then, in each case, the Managing Member shall cause the Company to borrow an amount equal to the Opeijating 
Deficit or such existing Financing or indebtedness to be refinanced from a lending institution, bank or other party 
(including, without limitation, any Member), selected by the Managing Member, as additional Financing (or J as a 
refinancing of existing Financing or indebtedness). In connection with such additional Financing described herein,! each 
Member (i) shall personally guarantee his or its pro rata portion of such Financing and shall execute and deliver any and 
all guaranty documents required by such lender in connection with such Financing and (ii) shall pledge such Member's 
Interest in the Company as collateral to such personal guaranty of such Financing pursuant to documentation acceptable 
to such lender. The terms, provisions of the documentation evidencing the Financing shall be on commercially 
reasonable terms and approved by the Managing Member. Each Member shall be provided a copy of any arid all 
Financing documentation. 
4.3.2.4 In the event the Managing Member is unable to obtain Financing for the Companylfrom 
any lender acceptable to the Managing Member after the exercise of commercially reasonable efforts, then, each Mejmber 
shall loan to the Company an amount equal to such Member's pro rata portion of the amount required by the Company 
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on or before thirty (30) days after written notice to such Member. Such loan shall be evidenced by a promissory note 
executed by the Company and shall be guaranteed by the personal guaranty of each of the other Members, pursuant to 
documentation acceptable to the Managing Member. The terms and conditions of such Member Loans shall be 
consistent with then current market interest rates and shall be otherwise reasonably determined by the Managing 
Member. 
4.3.2.5 In the event the Required Members approve any additional loans or expenditures in 
excess of the loans and expenditures described in Section 4.3.2., then, the provision of Section 4.4 below shall also apply 
to such Members who shall be deemed a "Defaulting Member". 
4.4 Failure To Provide Loans or Guarantees. If any Member (the "Defaulting Member") fails to provide the 
Member Loans or guaranties as provided in Section 4.3.2 hereof, then, the Members representing at least 51% of the 
Interest of the other Members (the "Majority Non-Defaulting Members") may pursue (but shall not be obligated to 
pursue) any of the following rights and remedies in the name of, and on behalf of, the Company: 
4.4.1 Make demand upon the Defaulting Member to immediately make or provide such loan or 
guarantee as provided in Section 4.3.2 hereof and seek damages and/or specific performance for such breach by Such 
Defaulting Member, with the Company withholding all distributions payable to such Defaulting Member until such 
Defaulting Member provides such loan or guarantee. 
4.4.2 Exercise a dilution remedy by increasing the Interest of the Non-Defaulting Members wjiich 
provided the Member Loan and/or the additional guarantees to the Financings as required by Sections 4.3.2 and by 
decreasing the Interest of the Defaulting Member on a pro rata basis, based upon the aggregate capital contributions, 
Member Loans and guarantees of Financings of the Members to or for the benefit of the Company as of such 'date 
(including in such calculation the Member Loans or guaranties provided as of the date in question). The Majority iffon-
Oefaulting Members shall exercise such remedy at any time during the term of this Agreement by giving written notice 
,o such Defaulting Member of such dilution. 
For illustration purposes only, suppose that $1,000,000, in the aggregate, had previously been contributed, 
loaned or guaranteed by the Members, and thereafter, $400,000 of Financings are approved, a Defaulting 
Member owning 20% fails to guarantee his pro rata portion of $400,000, then, if the dilution remedy is used the 
Defaulting Member's Interest would be reduced by 5.7% to equal 14.3% (i.e. $80,000 (i.e. pro rata portion = 
20% Interest times $400,000) divided by $1,400,000 (i.e. the total capital/loans/guaranties) and each of the Non-
Defaulting Members would be increased, pursuant to their respective Interests, by such 5.7%. 
4.4.3 Take such other action as the Majority Non-Defaulting Members are entitled, in their capacity as 
Members or on behalf of the Company or both, under the Act, at law, in equity, by statute or this Agreement against the 
Defaulting Member. The Defaulting Member shall be deemed in default of this Agreement and the Non-Defaulting 
Members shall be entitled to all remedies at law and in equity including but not limited to, the recovery of all attorney's 
fees and costs incurred in litigation at both trial and appellate levels. 
4.5 Limited Liability. The Members shall not have any personal liability for liabilities or obligations ojf the 
Company except to the extent of their obligations in this Article 4 or as otherwise provided in this Agreenbent. 
Notwithstanding the foregoing, (i) if any court of competent jurisdiction holds that distributions (or any part thereof 
received by a Member pursuant to the provisions hereof constitute a return of capital and directs that a Member pay jsuch 
amount (with or without interest thereon) to or for the account of the Company or any creditor thereof, such obligation 
sfiall bt the obligation of said Member and not of any other Member or the Company, and (ii) a Member shall indenpify 
and hold harmless the Company and each Member from any liability or loss incurred by virtue of the assessment of any 
fctx with respect to such Member's allocable share of the profits or gain of the Company. 
177374-5 7 
4.6 Interest on Capital Contributions or Right to Withdraw Capital Contributions. The Members shall not 
receive or be entitled to receive, interest on their contributions to the Company capital or resulting balance thereon. No 
Members shall be entitled to withdraw his/its capital contribution or to demand or receive a return of his/its contribution. 
4.7 Use of Capital Contributions. The aggregate of all the contributions to capital of the Company provided 
for herein will be available to the Company to carry out the purposes of the Company, including the organization and 
administration of the Company. 
ARTICLE 5 
PROFITS AND LOSSES 
Tne Company's net income, gains and net losses shall be allocated either debited or credited to the Member's 
capital account in accordance with the Member's respective Interest. "Net income" and "gain" means all items of 
Company income gained or credited, as determined for federal income tax purposes by the Company. "Net Iqsses" 
means all items of Company loss or deduction determined for federal income tax purposes by the Company. 
ARTICLE 6 
COMPANY FUNDS 
All funds received by the Company shall be utilized pursuant to the terms of the Approved Budget for Conipany 
purposes or as otherwise determined by the Required Members in the best interests of the Company. Until required for 
the Company's business, all Company funds shall be deposited and maintained in such accounts in such banks or jother 
financial institutions as shall be selected by the Managing Member or shall be invested in securities of the United States 
government, certificates of deposit or money market funds designated by the Managing Member. The Managing 
Member and the Manager shall have the right to draw checks payable in such funds and make, deliver, accepit and 
endorse negotiable instruments in connection with the Company's business. Company funds shall not be commingled 
with tV funds of any other person. The Managing Member and the Manager shall be designated an authorized signatory 
in all bank accounts of the Company. 
ARTICLE 7 
DISTRIBUTIONS 
7.1 Distribution of Available Cash From Operations. Available Cash From Operations shall be distripuied 
on a calendar quarter basis, unless otherwise agreed by the Required Members, as follows: 
7.1.1 Tax Distribution. First, to each Member, in an aggregate amount equal to the product off (A) 
forty-five percent (45%) and (B) the aggregate distributive shares of each Member of the net taxable income of the 
Company for the taxable year or other period to which such distribution relates; 
7.1.2 Loans. Second, to any Member, the amount then due on any Member Loans, payable toj each 
Member in the same ratio as the amount of the Member Loans (including interest thereon) bears to the aggregate amount 
of unpaid loans outstanding to all of the Members (including interest thereon), at the time of such distributions. 
7.1.3 Interests. Third, to the Members pro rata in accordance with their Interests, 
177374-5 8 
7.2 Distribution of Available Cash From Sale or Financing. Available Cash from Sale or Financing sh4ll be 
distributed on or before thirty (30) days after the closing of such sale or financing, unless otherwise agreed by the 
.Required Members, as follows: 
7.2.1 Tax Distribution. First, in the manner set forth in Section 7.1.1 hereof. 
7.2.2 Loans. Second, in the manner set forth in Section 7.1.2 hereof. 
7.2.3 Capital Contribution. Third, to the Members, to the extent of and in accordance with 'their 
respective Capital Contributions. 
7.2.4 Interests. Fourth, to the Members pro rata in accordance with their Interests. 
7.3 Priority and Distributions of Property. Except as otherwise provided herein, no Member shall ihave 
priority over any other Member either as to the return of capital or as to profits, losses or distributions. 
ARTICLE 8 
MANAGEMENT 
8.1 Management and Control in General. 
8.1.1 The Required Members shall have fiill power to manage and control the business and affairs of 
the Company as specifically set forth in this Agreement. Each of the Members hereby approve the executioii and 
delivery by the Company of the Management Services Agreement and delegate the day-to-day management! and 
operation of the Company and the Facility to the Manager pursuant to the terms of the Management Services Agreement. 
Unless specifically delegated to the Manager in the Management Services Agreement, the Required Members shall'have 
the power and authority to make such decision or to take such action. In no event shall the Members have any right to act 
on behalf of, or legally bind, the Company. The Managing Member shall have all the rights, powers and obligation^ of a 
managing member to implement the decisions of the Required Members or to take the actions required to be perfohned 
by t'*e Managing Member which are expressly set forth in this Agreement. 
8.1.2 Limitation of Authority. Notwithstanding the provisions of this Agreement, no Member 'shall 
have the power or authority to confess a judgment against the Company or execute or deliver any general assignment for 
the benefit of creditors of the Company or to take any act in contravention of the Act. 
8.1.3. Extraordinary Transactions, Notwithstanding anything to the contrary in this Agreement, the 
Managing Member shall not undertake any of the following extraordinary actions without the approval of the Reqjuired 
Members: 
8.1.3.1 The location and design of the Facility; provided however that the Manager shall (have 
the authority to approve non-material development matters with respect to the Facility which comply with the 
terms of the Approved Budget. 
8.1.3.2 The approval of each Approved Budget and any amendments thereto. 
8.1.3.3 Any Capital Transaction or Financing (including the terms and documentation rdlated 
thereto) for any amount, in each case, in excess of the aggregate operating expenses budjgeted for the Company in 
any Approved Budget for the current year in question. 
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8.1.3.4 Entering into any lease (and the terms of such lease) with annual rental obligations in 
excess of the amounts contemplated by the Approved Budget. 
8.1.3.5 Except as set forth in Section 7.2 and 7.3, any distributions by the Company t© ihe 
Members. 
8.1.3.6. Any expenditure in excess of $10,000.00 of the Company's monies on any one occasion, 
unless approved pursuant to the Approved Budget. 
8.1.3.7 The amount and frequency of any voluntary prepayments of any Financing (other, than 
Member Loans). 
8.1.3.8 The purchase of one or more key man life insurance policies covering the life of any 
Member which is an individual for the benefit of the Company, the amount of such key man insurance coverage and the 
identification of the Member(s) to be covered by such key man insurance coverage. 
8.1.3.9 The admission of additional Members to the Company. 
8.1.3.10 Engaging in business in any jurisdiction which does not provide for the registration lof 
limited liability companies. 
8.1.3.11 The filing of a petition under the United States Bankruptcy Code or an assignment for 
the benefit of creditors. 
8.2 Number and Appointment of Managing Member. There shall be one managing member of the 
Company, who shall be the Managing Member. Unless disallowed in order to maintain the taxability of the Company as 
a partnership for tax purposes based upon an independent opinion of tax counsel selected by the Managing Membej* and 
upon thirty (30) days notice to the Members, the Managing Member may freely assign all or any portion of its 
obligations without the consent or the vote of the remaining Members to one or more of its affiliates or to an entity in 
which one or more of the former beneficial owners own at least fifty-one (51%) percent of the new entity. 
8.2.1 The Managing Member may resign at any time upon ninety (90) days prior written notice tjo the 
Company or such notice as agreed upon by the Required Members. In the event of a vacancy in the position of 
Managing Member by reason of resignation, removal, death or Bankruptcy, a successor shall be appointed by the 
Required Members. In the event the Members fail to select a substitute Managing Member within sixty (60) lays 
thereafter, the Company shall dissolve and liquidate. 
8.2.2 If any one or more of the following events occurs, the Members may remove the Managing 
Member, and elect a new Managing Member: (i) the Managing Member's willful or intentional violation or reckless 
disregard of the Managing Member's duties to the Company, and the continuation of such conduct following the 
expiration of thirty (30) days written notice to the Managing Member; or (ii) the Managing Member's involuntary 
withdrawal from the Company by written notice. The determination of whether one or more of such events exist stall be 
made by the Required Members and shall be final, binding, and not reviewable unless the decision was based ion a 
material mistake of fact or law or was arbitrary and capricious. 
8.2.3 Except as otherwise provided in Section 8.2, a Managing Member shall be required to!be a 
Member of the Company. 
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8.3 Employment of Others, Including Affiliates. The Managing Member shall not be required to devofe its 
full time to the affairs of the Company and shall devote such time to Company affairs as it, in its sole and unrestricted 
liscretion, deems necessary to manage and supervise the operations and business of the Company. Nothing contained in 
this Agreement shall preclude the employment by the Managing Member, on behalf of and at the expense of the 
Company, of themselves or any agent or third party to operate and manage all or any portion of the Company or to 
provide any service relating to the business. The Managing Member may, on behalf of the Company, engage orie or 
more Affiliates of the Managing Member to render services to the Company, including, without limitation, the Manager 
and KRU Medical Ventures LLC. Neither the Company nor any of the Members shall have, as a consequence of the 
relationship created hereby, any right in or to any income or profits derived by the Managing Member or an Affiliate of 
any of the Managing Member from any business arrangements with the Company which are consistent with this Section. 
8.4 Other Activities and Right of First Opportunity. 
a. Subject to Article 15, Associates and any Affiliate of Associates may engage in or possess an interest in 
oth^r business ventures or investments of any kind, independently or with others, including but not limited to ventures 
engaged in owning, operating or managing businesses or properties similar to those businesses or properties owne'd or 
operated by the Company. Subject to Article 15, the fact that Associates or any Affiliate of Associates may avail itsejlf of 
such opportunities, either by itself or with other persons, including persons in which it has an interest, and not offer such 
opportunities to the Company or to a Member, shall not subject the Managing Member or such Affiliate to liability to the 
Company or to any other Member on account of lost opportunity or otherwise. Subject to Article 15, neitheij the 
Company nor any Member shall have any right by virtue of this Agreement or the relationship created hereby in or to 
such opportunities, or to the income or profits derived therefrom, and the pursuit of such opportunities, even though 
competitive with the business of the Company, shall not be deemed wrongful or improper or in violation of this 
Agreement. 
b. For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, each 
Non-Managing Member, on behalf of itself and each of its Affiliates (collectively, the "Non-Managing Member Group"), 
hereby grants to Associates and Associates hereby grants to the Non-Managing Member Group, a continuing and 
absolute right of first opportunity and right of refusal (collectively, the "Right of First Opportunity") to participate asia 
member in one or more limited liability companies or other legal entities with Associates and one or more Non-
Managing Member Group, as the case may be, in connection with the acquisition, formation, development, leasing, 
operation and/or management (whether directly or indirectly) of any clinic or other facility (whether one or more) in the 
State of Utah which provides or which is to provide any Dialysis Services or any other services similar to the medical 
services provided by the Facility in the State of Utah (each such clinic or facility transaction, a <rUtah Dialysis Services 
Transaction"). The percentage ownership in the legal entity which is to own and consummate the Utah Dialysis Services 
Transaction which is available for ownership by the Offering Party (hereinafter defined) is hereinafter called the 
"Available Interest." 
c. Before any Non-Managing Member Affiliate or Associates, as the case may be, executes any binding 
commitment or agreement with respect to any Utah Dialysis Services Transaction, each of the Non-Managing Member 
Group or Associates, as the case may be (the "Offering Party") covenants and agrees to offer to Associates or to the 
Managing Member Group, as the case may be (the "Other Party") the first opportunity to participate in the Available! 
Interest of the Utah Dialysis Services Transaction on the same business terms and conditions as such Offering Party shall 
represent and warrant to the Other Party was offered or is available to such Offering Party; provided however, that in; 
each Utah Dialysis Services Transaction (i) an Affiliate of Associates shall be entitled to own fifty-one percent (51%) of 
the Available Interest, (ii) the Non-Managing Member Group shall be entitled to own forty-nine percent (49%) of the 
Available Interest, and (iii) Associates or an Affiliate of Associates shall have the exclusive management contract to j 
manage and operate such clinic or facility which is the subject of such Utah Dialysis Services Transaction for at least? a 
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ten (10) year period for a fair market value management fee to be determined at such time by the parties (collectively, the 
"Offered Terms"). 
d. If the Other Party elects to participate in such Utah Dialysis Services Transaction on or before 30 days 
after receiving such Offered Terms, then the Offering Party and the Other Party shall form a new limited liability 
company with respect to the Available Interest (for each tranaction, "New LLC") and shall execute and deliver an 
operating agreement substantially similar to the form and substance of this Agreement on or before 30 days after the1 
written election by such Other Party to participate in such transaction, except that (a) the Offered Terms shall be 
incorporated into such agreement and (b) the parties shall make such other modifications as are reasonably necessary or 
reasonably appropriate to accommodate the particular transaction in question. In the event other parties (which are not 
Affiliates of any Member) shall also own any ownership interest in such Utah Dialysis Services Transaction, then, New 
LLC shall negotiate with such other parties and shall execute such other documents acceptable to New LLC with respect 
to the terms of the Utah Dialysis Services Transaction. The Offering Party shall deliver with each of the Offered Tertns, 
the specific proposed location of each clinic and facility and any and all background information reasonably requested by 
the other party in order that the other party may prudently evaluate such Offered Terms and the proposed Utah Dialysis 
Services Transaction. In the event the Other Party elects not to particiate in a particular Utah Dialysis Services 
Transaction, such decision shall not waive the Other Party's Right of First Opportunity with respect to any other Utah 
Dialysis Services Transaction which may be available during the ten year period set forth below. 
e. In the event the proposed clinic or facility contemplated in an Utah Dialysis Services Transaction is not 
opened for business within one year after the date the Other Party elects not to participate in such clinic or facility, .then, 
the Right of First Opportunity shall cover and apply to such clinic or facility after the expiration of such one year time 
period and the Offering Party shall be required to comply with the terms of this Section 8.4 with respect to such clinic 
and facility. The written consent or action of a majority of the Interests of the Non-Managing Members shall be sufficient 
to legally bind the entire Non-Managing Member Group under this Section 8.4. Effective on the date any Non-Managing 
Memoer is no longer a Member of the Company, such Non-Managing Member shall have no right to participate to the 
Non-Managing Member Group with respect to any Right of First Opportunity or any Utah Dialysis Services Transaction. 
f. The Right of First Opportunity and the covenants and agreements of the Non-Managing Member Group 
and Associates set forth in this Section 8.4 shall survive the termination of this Agreement and the dissolution of the; 
Company, for all purposes, for a period often (10) years after the later to occur of (i) the date of this Agreement andl(ii) 
the dissolution of the Company. 
g. Each of the Non-Managing Members agrees that (i) the Right of First Opportunity shall not apply to! the 
proposed establishment and operation of a dialysis clinic to provide Dialysis Services by affiliates of the Managing 
Member and Manager to be located to the west of Interstate 15 in Salt Lake County, Utah and (ii) such Non-Managing 
Members have elected not to participate in such proposed Utah Dialysis Services Transaction. 
8.5 Administrator. An employee of the Company, acceptable to the Required Members and the Medical 
Director, shall serve as Administrator of the Facility (the "Administrator") and shall have the authority and responsibility 
for making all of the day-to-day decisions of the Company with respect to all financial, staffing and business matters 
concerning the Facility. The Administrator shall take direction from the Managing Member. 
8.6 Meetings of Members and Voting. The Required Members shall hold regular meetings at times aind at 
places agreeable to the Required Members and at least one (1) meeting on an annual basis. Such meetings may be called 
and held telephonically or in person, and with no less than ten (10) days notice, or upon such notice as required b>f law. 
Any Member shall also have the right to call a meeting of the Members. Such notice shall set forth the time and plajce of 
the meeting. If no place for the meeting is designated, the place of meeting shall be the principal office of the Company. 
Members holding at least eighty percent (80%) of all Member Interests shall constitute a quorum at any meeting of 
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Members, whether present in person or by proxy. If a quorum is present at a meeting, the affirmative vote of Merribers 
holding at least a eighty percent (80%) of all Member Interests shall be the act of all of the Members, unless the vote'of a 
greater or lesser proportion or number is otherwise required by the Act, by the Articles of Organization or bys this 
Agreement. Any action required or permitted to be taken at a meeting of Members may be taken without a meeting if the 
action is evidenced by a written consent describing the action taken, executed by each Member required by this 
Agreement or the Act for the matter in question and delivered to the Managing Member(s) for inclusion in the Company 
records. Any action taken pursuant to this section shall be effective when such Members which are required to exdcute 
such consent have executed the consent, unless the consent specifies a different effective date. When any notice is 
required to be given to any Members, a waiver thereof in writing executed by the person entitled to such notice, whether 
before, at or after the time stated therein, shall be equivalent to the giving of such notice. 
8.7 Real Property Affiliate. Each of the Members acknowledge that certain Affiliates of certain Members of 
the company may acquire certain real property and improvements and lease such property and improvements to the 
Company as the location of the Facility. The terms and provisions of such lease arrangement by and between suchjreal 
property company (such company, the "Real Property Affiliate") and the Company shall be subject to the approval of the 
Required Members. 
8.8 Approval of Approved Budget. Each of the Members hereby approved the initial budget fori the 
development, construction (whether as a free standing structure or as tenant finish out in an existing structure), stai|t-up 
and operation of the Facility and the Company set forth on Exhibit A attached hereto (the "Approved Budgfct"). 
Commencing in December 2001, on or before December 15 of each calendar year and thereafter, the Managing Meijiber 
shall cause the Manager to present a proposed budget for the next calendar year (such proposed budget, the "Proposed 
Budget") to the Members. The Required Members shall review the Proposed Budget, provide comments to such budget, 
confer with the Manager and approve a new "Approved Budget" as soon as possible after January 1st of the calehdar 
year in question. Until a new "Approved Budget" is approved by the Required Members, the existing Approved Budget 
shall constitute the "Approved Budget" for the purposes of this Agreement. During the time period in which the prior 
ipproved Budget continues to constitute the "Approved Budget", the Required Members hereby authorize the Manjager 
to exceed the costs set forth in the Approved Budget with respect to (i) those budgeted items that have increased in icost 
iue to an automatic escaltor or other increase required by contract, (including, without limitation and by way of example, 
lease payments, medical director fees, management fees, and utilities), (ii) supply, maintenance and labor cost increjases 
due to the increase of patients and/or treatments at the Facility from the prior period, (iii) cost of living increase^ for 
salaiies and wages and increases in the cost of fringe benefits for employees of the Facility, (iv) increases in paymjents 
due to government entities (including, without limitation, and by way of example, ad valorem and personal property 
taxes, license fees and other governmental fees), (v) any amount payable to the Company's lender pursuant to the t^rms 
of the documentation evidencing the Financing or (vi) any specific line item of the Approved Budget specifically 
approved for increase by the Required Members for each calendar year such Approved Budget is used by the Company 
until a new Approved Budget is approved by the Required Members. 
ARTICLE 9 
REIMBURSEMENT OF EXPENSES 
9.1 Expenses.The Managing Member shall not be required to incur any costs or expenses for the benefit ojf, or 
en behalf of, the Company. All expenses related to the Company shall be incurred by the Manager and the Company 
sliall reimburse the Manager pursuant to the terms of the Management Services Agreement. The Company shallj not 
reimburse the Managing Member or its Affiliates for their general office and administrative expenses orj for 
compensation to its officers and employees.The Company shall bear the expenses incidental to its formation, ijiach 
Member shall bear his/its personal expenses incurred in connection with the acquisition of his Interest, excepjt as 
otherwise expressly provided herein. 
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9.2 Other Services. The Company may employ the Managing Member or its Affiliates and the Managing 
Member or its Affiliates shall be entitled to receive reasonable compensation for their services rendered in such capacity 
to the extent approved by the Required Members. 
ARTICLE 10 
ACCOUNTING MATTERS 
10.1 Books of Account. The Required Members shall cause the Manager to keep the books of and proper 
entries therein of all sales, purchases, receipts, payments, engagements, transactions and property of the Company, 
consistent with the provisions contained in the Management Services Agreement approved by the Required Members. 
The Required Members shall cause the Manager to provide to the Members, on an quarterly basis, the reports set forth in 
the Management Services Agreement. 
10.2 Place of Records. The Company's books of accounts and all securities, papers, records and writings of 
the Company shall be kept at offices of the Manager or in such other place where the business may be carried on |or as 
may be decided upon by the Required Members. Each Member shall have free access at all times to examine andicopy 
the b^oks, papers, and other writings of the Company. 
10.3 Fiscal Year. The fiscal year of the Company shall be the calendar year. 
10.4 Tax Returns/Cash Basis. The Required Members shall cause the Manager to retain tax professionals to 
prepare, at the Company's expense, income tax returns and appropriate state income tax returns, and cause to be 
furnished to each person who was a Member during the fiscal year a schedule of each such Member's share of profitjs and 
losses on the form then prescribed by the Internal Revenue Service. All elections and options available to the Conjpany 
for federal or state income tax purposes shall be taken or rejected by the Company in the discretion of the Reqjuired 
Members. The Required Members shall have the right to prepare, or supervise and control the preparation of, all income 
tax returns of the Company. To the extent permitted by applicable law, the Company's books, for tax purposes, shall be 
maintained on a cash basis. 
10.5 Tax Matters Member. Each of the Members hereby consent and appoint the Managing Member as the 
"Tax Matters Member" of the Company, as that term is used in Sections 6221-6231 of the Code, and the Managing 
Member hereby agrees to act as such Tax Matters Member. The Company shall reimburse the Tax Matters Member for 
any and all reasonable out-of-pocket costs and expenses (including reasonable attorneys' and other professional I fees) 
incurred by it in its capacity as Tax Matters Member of the Company. The Company shall indemnify, defend and! hold 
the Tax Matters Partner harmless from and against any loss, liability, damage, cost or expense (including reasonable 
attorneys' fees) sustained or incurred as a result of any act or decision concerning Company tax matters and withjn the 
scope of the Managing Member's responsibilities as Tax Matters Member, except for gross negligence or willful 
misconduct. 
ARTICLE 11 
TRANSFER OF MEMBER'S INTEREST 
11.1 General Limitation on Transfers. Notwithstanding anything to the contrary set forth in this Agreement, 
no Member shall Transfer any Interest to any Person unless such Transfer is permitted by the express terms of this 
Agreement. 
11.2 Transfer by Associates- Da Vita, Inc. Right of First Refusal. 
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11.2.1 Subject to Section 11.2.2, Associates may Transfer some or all of its Interest in the Company to any 
Person, including but not limited to, a charitable remainder trust or any other Person that Associates may choose in the 
vercise of its sole discretion, and none of Associates's Interest shall be subject to the restrictions upon Transfer set forth 
m this Article II. 
11.2.2 Due to the serious concerns expressed by the initial Non-Managing Members with respect to the Existing 
Facilities as described in the Preliminary Statements, in the event Associates desires to Transfer any Interest iii the 
Company to (i) Da Vita, Inc., (ii) Da Vita, Inc.'s Affiliate or (iii) any legal entity which is at least 51% owned or 
controlled by the existing chief executive officer of DaVita, Inc. or the existing chief operating officer of DaVita, Inc. 
(the entities described in clauses (i), (ii) and (iii), collectively, the "DaVita Affiliates" or individually, a "DaVita 
Affiliate"), then, the Non-Managing Members shall have the right of first refusal to purchase Associates's Interest in the 
Company upon the same terms and conditions offered by the DaVita Affiliate to Associates as set forth in this Section 
11.2.2. In the event Associates receives a purchase offer from DaVita Affiliate and Associates desires to Transfer ai^ y of 
Associates's Interest in the Company to DaVita Affiliate upon such offered terms, then, Associates shall send wrlitten 
notice to the Non-Managing Members setting forth the terms of such proposed transaction. The Non-Mandging 
Members have sixty (60) days after the receipt of such notice to notify Associates of whether the Non-Managing 
Members desire to purchase all, but not less than all, of Associates's Interest in the Company. In the event such Non-
Managing Members desire to purchase Associates's Interest in the Company, then, the closing shall occur on or before 
sixty (60) days after the date of such acceptance upon the terms set forth in such notice, provided however, thai the 
purchase price payable by the Non-Managing Members shall be "all cash" payable in full at the closing. In the event the 
Non-Managing Members fail to closing within such 60-day period, for any reason, then, any future rights of the Non-
Managing Members set forth in Section 11.2.2 shall be null and void and the Non-Managing Members shall reimburse 
Associates for any damages incurred by Associates arising from such breach by the Non-Managing Members, including 
Associates's reasonable attorney fees and costs. 
11.3 Transfer by Non-Managing Members. 
11.3.1. No Non-Managing Member shall Transfer any Interest in the Company unless such Member Transfers 
such Interest to a Qualified Party in accordance with this Article 11. In the event any Non-Managing Member desirps to 
Transfer all or any portion of such Member's Interest to a Qualified Party, such Member (the "Transferor") shall jgive 
written notice (the "Transferors Notice") to the other Members, excluding Associates (collectively, the "Other ljfon-
Managing Members") that it has received a bona fide offer to purchase any or all of such Member's Interest and that kuch 
Member desires to transfer any or all of such Interests. The Transferor's Notice shall specify the proposed transferee 
thereof (which must be a Qualified Party), the Interest to be transferred and the amount and type of consideration to be 
received therefor. In no event shall any Non-Managing Member Transfer any Interest to any Person, other thhn a 
Qualified Party, without the prior written consent of Required Members. 
11.3.2 In the event a majority of the Interests of the Non-Managing Members vote to permit a Qualified Party to 
become a Member of the Company and vote regarding the applicable percentage Interest to be Transferred to such inew 
member by the Non-Managing Members, then, all of the Non-Managing Members shall be required to sell a prorata 
portion of their respective Interests in the Company to the new proposed Member and each Non-Managing Member's 
Interest shall be diluted by a pro rata percentage in the same proportion as then existing among the Non-Managing 
Members; provided however that, without the consent of the Required Members, such Transfers shall not beciome 
effective until two (2) years after the date such Qualified Party requested consideration, by written notice to} the 
Managing Membei-, to be admitted as a "member" of the Company. Upon the closing of such transaction, such (new 
Qualified Party shall execute and deliver an agreement, acceptable to the Required Members, assuming all covenants! and 
obligations of a ''Member" under this Agreement. In no event shall the Interest of Associates be affected or diluted bv 
such Transfer to such Qualified Party. 
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11.4 Drag Along Rights of Associates. In connection with any proposed Transfer (to any Person other thab an 
Affilfate of Associates) by Associates of (i) all of Associates's Interest or (ii) any portion of Associates's Interest to a 
°erson in connection with, and as a condition precedent to, such Person's or such Person's Affiliate's commitment to 
provide one or more equity investments into the Company or to provide one or more loans to the Company or (iii) any 
portion of Associates's Interest in connection with an initial public offering transaction of, or involving, the Company or 
the Company's Affiliate (such Transfer, a "Significant Sale"), then, Associates shall have the right to require each non-
selling Member (each, a "Co-Seller") to sell all or a portion of its Interest which represents the same percentage of such 
Co-Seller's Interest as the Interest being disposed of by Associates. (For example, if Associates is selling 60% of its [ 
Interests, each Co-Seller shall be required to sell 60% of its Interest. Or, for example, if Associates is selling 100% of its 
Interests, then each Co-Seller shall be required to sell 100% of its Interest.) All Interests sold or transferred by Members 
pursuant to this Section 11.4 shall be sold at the same price and otherwise treated identically with the Interest being sold 
by Associates in all respects; provided, that the Co-Seller shall not be required to make any representations or warranties 
in coitnection with such sale or transfer other than representations and warranties as to (i) such Co-Seller's ownership of 
his or Interest Transferred free and clear of all liens, claims and encumbrances, (ii) such Co-Seller's power and authority 
to effect such Transfer and (iii) such other reasonable representations and warranties with respect to the assets, liabilities 
and operation of the Facility and the Company. Associates shall give each Co-Seller at least 30 days1 prior written nojtice 
of any Significant Sale as to which Associates intends to exercise its rights under this Section 11.4. If Associates elects 
to exercise its rights under this Section 11.4, the Co-Sellers shall take such actions as may be reasonably required and 
otherwise cooperate in good faith with Associates in connection with consummating the Significant Sale (including, 
without limitation, the voting of any Interest to approve such Significant Sale). At the closing of such Significant Sale, 
each Co-Seller shall deliver assignment documents and such other transaction documents for all Interests to be sold by 
such Co-Seller to the purchaser against payment of the appropriate purchase price. 
11.5 Tag Along Rights of Other Members. In the event Associates elects not to require 100% of all Other 
Members to sell 100% of their Interests in connection with a Significant Sale, then, Associates shall offer (the "Non-! 
Managing Tag Along Offer") to each Member to include in the proposed transfer a portion of the Interests designated by 
any of the Other Members, not to exceed in respect of any such Other Member, the percentage of ownership interest in 
the Company equal to the product of (a) the aggregate percentage ownership Interests to be transferred by Associates! to 
the proposed transferee and (b) a fraction, with a numerator equal to the percentage ownership in the Company of su<j;h 
Other Members desiring to participate in such sale and a denominator equal to 100%. The Non-Managing Tag Along 
Offer shall be conditioned upon Associates transferring Interests pursuant to the transactions contemplated in 
Associates's Notice with the transferee named therein. If any Other Member has accepted the Non-Managing Tag Along 
Offer, Associates shall reduce to the extent necessary its Interests which it would have sold in the proposed transfer s!o as 
to permit Other Members who have accepted the Non-Managing Tag Along Offer to sell the Interests that they are 
entitled to sell under this Section 11.5, and Associates and such Other Members shall transfer the Interests specified in 
the Non-Managing Tag Along Offer to the proposed transferee in accordance with the terms of such transfer set forth in 
Associates's Notice. 
11.6 Transfer of Substantially All of the Assets of the Company. At any time during the term of this 
Agreement, Associates shall have the right and power to cause the Company to Transfer all or substantially all of the 
assets of the Company to any Person (other than an Affiliate of Associates) upon terms acceptable to Associates; 
provided, that each Member shall not be required to make any representations or warranties in connection with such sale 
or transfer other than representations and warranties as to (i) such Member's ownership of his or Interest in the 
Company, (ii) such Member's power and authority to cause the Company to effect such Transfer and (iii) such other 
reasonable representations and warranties with respect to the assets, liabilities and operation of the Facility and the 
Company. Associates shall give each Member at least 30 days' prior written notice of such sale under this Section 11J6 
and each of the Members shall take such actions as may be reasonably required and otherwise cooperate in good faith 
with Associates in connection with consummating such sale (including, without limitation, the voting of any Interest ito 
approve such sale). 
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11.7 Right to Purchase Member's Interest Upon Occurrence of Special Event. In the event that a Non-
lanaging Member dies or in the event any Member's Interests are subject to Transfer by operation of law or are subject 
to an involuntary Transfer to any Person, including, but not limited to, to a Member's trustee in bankruptcy or state 
receivership, a Member's spouse incident to a divorce proceeding, a secured creditor, a judgment creditor, an attaching 
creditor, a garnishing creditor or a purchaser at any creditor or court sale or any assignee of any of the foregoing, theii, in 
each case, the remaining Members shall have the right to buy the pro rata portion of such Interest, consistent with the 
procedures set forth in Section 11.10 at the Appraised Value (hereinafter defined), provided however that the Other Non-
Managing Members shall have the first right to purchase such Interests within ninety (90) days of such event and if such 
Other Non-Managing Members fail to exercise such right to purchase all of such Interest within such 90-day period, then, 
Associates shall have the right to purchase such Interests for the Appraised Value within ninety (90) days thereafter. !In 
the event any key man insurance policy is payable due to the death of a Member covered thereby, then, the Company 
shall rlc eive the payment of such funds. 
11.8 Occurrence of Legal Prohibition Event — Reorganization Proposal. In the event of the legal effectivejness 
of any promulgated federal law after the date hereof which prohibits the Company (and its beneficial owners) (a) from 
operating the Facility, or (b) from receiving Medicare or Medicaid reimbursements for the basic dialysis services 
provided by the Company at or from the Facility (such event describedin clause (a) or (b), a "Legal Prohibition Event"), 
then, the Members shall cooperate in good faith to develop an ownership structure in order that the Members jmay 
continue to provide Dialysis Services and shall engage independent legal counsel, at the Company's expense, reasonably 
acceptable to the Required Members to advise the Company as to how to modify, alter or reorganize the structure and/or 
ownership of the Company in order to permit the beneficial owners of the Company to continue to provide Dialysis 
Services while maintaining, to the extent reasonably practicable, a material portion of the economic benefits to all oif the 
Members (or their beneficial owners) provided by the then existing structure of the Company. Upon receipt of the 
reorganization proposal(s) from such reorganization counsel, the Required Members shall cooperate in good faitli to 
^oprove and implement one of the reorganization proposal(s) or a modified reorganization proposal acceptable to such 
^organization counsel and the Required Members as soon as practicable. 
11.9 Purchase Option Following Legal Prohibition Event. In the event a Legal Prohibition Event occursi the 
Members are unable in good faith to develop and implement an acceptable reorganizational structure that complies With 
applicable law and such reorganization counsel is not able to provide a viable reorganization proposal to the Company 
within thirty (30) days after the date such counsel is engaged by the Company and the Required Members determine not 
to retain substitute legal counsel to explore other restructuring options for the Company, then, the Required Members 
shall, at the Required Member's sole option, either (A) cause the sale of all of the assets or Interests of the Company 
pursuant to Sections 11.4 or 11.6 or (B) require Associates to purchase the Interest of all of the Members for a purchase 
price equal to the Appraised Value calculated as of the effective date of the Legal Prohibition Event. The closing foi the 
transaction described in this Section 11.9 shall occur on or before ten (10) days prior to the date such closing is legally 
required, if any, by the applicable federal law giving rise to the Legal Prohibition Event. The terms of Section ill.10 
shall apply with respect to such transaction. 
11.10 Calculation of Purchase Price based upon Appraisal. 
11.10.1 The term "Appraised Value" means the aggregate appraised value of the equity of the Facility, 
the Company's other assets and the Company's business as a going concern as hereinafter provided. Within fifteen (15) 
days after demand by either one to the other, the Required Members (excluding such selling Member) and! the 
withdrawing or selling Member shall each appoint an appraiser to determine the value of the equity of the Company's 
assets. If the two appraisers agree upon the equity value of the Company's assets, they shall jointly render a sijigle 
written report stating that value. If the two appraisers cannot agree upon the equity value of the Company's assets, they 
*hall each render a separate written report and shall appoint a third appraiser, who shall appraise the Company's assets 
177374-: 17 
and determine the value of the equity therein, and shall render a written report of his or her opinion thereon. Each party 
shall pay the fees and other costs of the appraiser appointed by that party, and the fees and other costs of the [third 
appraiser shall be shared equally by both parties. The equity value contained m the aforesaid joint written repdrt or 
written report of the third appraiser, as the case may be, shall be the Appraised Value; provided, however, that if the 
value of the equity contained in the appraisal report of the third appraiser is more than the higher of the first two 
appraisals, the higher of the first two appraisals shall govern; and provided, further, that if the value of the equity 
contained in the appraisal report of the third appraiser is less than the lower of the first two appraisals, the lower cff the 
first two appraisals shall govern. 
11.10.2 Upon the purchase of the selling Member's Interest by the purchasing party, as the case may be, 
under this Article 11, the purchasing party, as the case may be, shall be obligated to the extent permissible, to obtkin a 
releasp of the selling Member from any and all loans owing by such selling Member as to which the selling Member is 
obligated and to repay to the selling Member (on a pro rata basis) any loans made by him to the Company. Upon such 
inpayment, the purchasing party(s) shall become entitled to repayment from the Company on the existing terms and 
conditions of the selling Member's loan. In the event of a purchase under this Article 11 by the Company or by any 
Member, the purchase price shall be paid in "all cash" in immediately available funds at the closing. 
11.11 Required Sale by Sanctioned Person. 
11.11.1 The Members acknowledge that the Company may be excluded from the Medicaid and Medicare 
programs upon the happening of the events described in Sections 1 LI 1.2.1 and 11.11.2.2 below, and agrde to 
immediately notify the Company of the occurrence of any such events. Terms in quotations used herein shall have the 
meanings given them in the Social Security Act and the Medicare and Medicaid Patient and Program Protection Alct of 
1987. In addition, those Members which are not individuals agree to immediately notify the Company of any person or 
entity which becomes a "control person," officer, director agent or "managing employee" of a Member. The Members 
further agree to obtain from such persons or entities such representations regarding their participation in the Medicare 
and Medicaid programs as the Company or its counsel shall request. 
11.11.2 Upon the occurrence of any of the following events, the affected Member shall be deemed to 
have st>ld his/its Interest to the Company, and the Company shall purchase the affected Member's Interest at the purchase 
pnee and upon the terms and conditions set forth in Sections 11.11.3 and 11.11.4 below: 
11.11.2.1 If a Member becomes a "sanctioned person"; 
11.11.2.2 If any control person of a Member or any Person who is an officer, dirdctor, 
agent, or managing employee of a Member, becomes a sanctioned person, unless the affected Member's organizational 
documents, contractual provisions, or other documents or agreements governing its relationship with the sanctioned 
person, allows such Member to automatically terminate its relationship with the sanctioned person, and the relationship is 
so terminated within ten (10) days after such Member receives notification of or otherwise becomes aware of the 
occurrence of such event, such that the sanctioned person is no longer either a control person of the affected Member, or 
an officer, director, agent, or managing employee of the affected Member. 
11.11.3 Upon the occurrence of either of those events set forth in Section 1 LI 1.2 hereof, and payment by 
the Company of the purchase price for the Interest, determined in accordance with this Section 11.11.3, the affected 
Member's Interest in the Company shall become the absolute property of the person or entity purchasing such affected 
Member's Interest, and the affected Member shall from such date have no Interest in the Company. The purchase j>rice 
of the affected Member's Interest sold pursuant to Section 11.11.2 hereof shall be computed as follows: (a) an amount 
equal to the Capital Contributions made by the affected Member through the date of the closing of the sale of the affected 
Member's Interest; less (b) the sum of (i) all distributions made to the affected Member from the date of his qr its 
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admission to the Company through the date of the closing of the sale of the affected Member's Interest; (n) ail losses (on 
a dollar for dollar basis) allocated to the affected Member from the date of his or its admission to the Company through 
e^ date of the closing of the sale of the affected Member's Interest; and (iii) any amounts due and payable to the 
^ompany which remain unpaid as of the date of the closing of the sale of the affected Member's Interest. 
11.11.4 The purchase price of the affected Member's Interest purchased pursuant to Section 11. Si 1.2 
hereof shall be paid consistent with the provisions contained in Section 11.10. hereof except for the manner in which the 
purchase price is calculated which is set forth herein, with the closing to occur no later than ninety (90) days after the 
Company shall have been notified of the occurrence of either of the events set forth in Section 11.11,2 hereof. In| the 
event the Members fail to select a substitute Managing Member within sixty (60) days of the occurrence, as to4 the 
Managing Member, consistent with the provisions of Section 8.2 hereof, of either of those events listed in Section 
11.1 L2 hereof, the Company shall dissolve and liquidate. 
11.12 Interest Remains Subject to Agreement. Each Member agrees that notwithstanding the provisions; for 
Transfer of any Interest contained herein, the Interest, when and if transferred, shall remain subject to all of the termsland 
conditions of this Agreement. As a further condition for a substituted or transferee Member becoming a Member in the 
Cjrnpany, such substitute or transferee Member shall be required to execute a counterpart of this Agreement, thereby 
agreeing to be bound by all of the terms, conditions and provisions contained in this Agreement. 
11.13 Costs of Assignment The cost of processing and perfecting an admission or assignment contemplated 
by this section (including reasonable attorneys' fees incurred by the Company) shall be borne by the party seeljcing 
admission as a Member to the Company. 
11.14 No Dissolution or Termination. In the event of the death of a Member or the Transfer of a Menjiber 
Interest, the Company shall not be dissolved or terminated and shall continue under its current name, except as otherwise 
Provided in Article 11 hereof 
ARTICLE 12 
TERMINATION AND LIQUIDATING DISTRIBUTIONS 
12.1 Liquidation of Assets and Application of Proceeds. Upon the dissolution of the Company, the Managing 
Member shall liquidate and reduce to cash the assets of the Company as promptly as is consistent with obtaining the (fair 
value thereof and apply and distribute the proceeds of such liquidation in accordance with the provisions of Section! 7.3 
hereof, by the end of the fiscal year obtained (or, if later, within ninety (90) days after the date of such liquidation). 
12.2 Compliance with Timing Requirements of the Regulations. Upon liquidation of the Company (or jany 
Member's Interest), liquidating distributions shall, in all cases, be made in accordance with the positive capital account 
bafences of the Members, in compliance with Regulation Section 1.704-l(b)(2)(ii)(b)(2), as determined after taking £nto 
account all capital account adjustments for the taxable year during which such liquidation occurs by the end of such 
taxable year (or, if later, within 90 days after the date of such liquidation). 
12.3 Deficit Makeup Provision. If any Member has a deficit balance in his Capital Account after allocation of 
gain or loss among the Members as provided in this Agreement, and after the payments and liquidating distributions 
specified above in this Article 12 have been made, such Member shall pay to the Company an amount equal to the 
amount of such deficit balance in his Capital Account by the end of the taxable year in which such liquidation occurs H of, 
if later, within 90 days after the date of such liquidation), in compliance with Regulation Section 1.704-l(b)(2)(ii)(b)j(3), 
and the Company shall use such deficit Capital Account balance payment first to pay amounts, if any, still owe<3 to 
Company creditors and then to distribute the balance, if any, of such deficit Capital Account balance payment in 
repayment of any remaining positive balances in Members' Capital Accounts. 
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12.4 Liquidation Distributions to Trust. Notwithstanding the provisions of Article 13 hereof, in the event the 
Company is "liquidated" within the meaning of Regulation Section 1.704-l(b)(2)(ii)(g), in the discretion of the Managing 
Member, distributions that would otherwise be made to the Members pursuant to Sections 12.1 and 12.2 hereof, may!be: 
12.4.1 Distributed to a trust established for the benefit of the Members, for the purposes of liquidating 
Company Assets, collecting amounts owed to the Company, and paying any contingent or unforeseen liabilities or 
obligations of the Company or of the Members arising out of or in connection with the Company. The assets of any such 
trust shall be distributed to the Members from time to time, in the reasonable discretion of the Managing Member, ip the 
same proportions as the amount distributed to such trust by the Company would otherwise have been distributed to the 
Members pursuant to this Agreement; or 
12.4.2 Withheld to provide a reasonable reserve for Company liabilities (contingent or otherwise) and 
to reflect the unrealized portion of any installment obligations owed to the Company, provided that such wit&held 
amounts shall be distributed to the Members as soon as practicable. 
ARTICLE 13 
NAME AND GOODWILL 
Upon the complete termination and winding up of the affairs of the Company, the name of the Company and 
goodwill shall not be appraised, sold, or otherwise liquidated, without the approval of the Required Members. 
ARTICLE 14 
SUCCESSOR ENTITY 
Subject to Article 11, upon the approval of the Required Members, all or any part of the Company assets and 
liabilities of the Company may be transferred to a successor entity and the Managing Member may thereafter liquidate 
the Company and distribute shares of ownership in the successor entity to the Members as provided in Article 12 hereof. 
ARTICLE 15 
RESTRICTIVE COVENANTS 
As an important inducement to the Company, as well as from the Members one to another, the Members,[have 
further agreed as follows; 
15.1 Legitimate Business Interest. The parties agree, having discussed the matter fully and having hajd the 
benefit of counsel, that the Company has a legitimate business interest which must be protected by this Article 15. In 
part, this is based upon the Members1 exposure, to trade secrets, confidential business or professional information that 
otherwise does not qualify as trade secrets, substantial relationships with specific prospective or existing custodiers, 
patients, or clients, confidential business lists, names and addresses of clients, confidential records, information, 
customer goodwill, proprietary methods of doing business and extraordinary or specialized training. The parties also 
agree that no Members1 right to work and pursue his or its chosen profession is unreasonably restrained by this Alrticle 
15. 
15.2 Restrictions. During the time period set forth in Section 15.4 and within the geographical limitation set 
forth in Section 15.5, each of the Members, covenants and agrees with the Company and each of the other Members as 
follows: 
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15.2.1 Not to compete, directly or indirectly, with the Company in the Company's business. By waiy of 
illustration and not by way of limitation, no Member shall, directly or indirectly, whether as a partner, sole proprietor, 
associate, employee, consultant or officer, medical director, director or beneficial owner (other than a owner of j less 
than a 5% interest in a publicly traded company) enter into or participate, in any way whatsoever, in the supply of 
home, CAPD, CCPD, acute dialysis services or chronic dialysis services or other Dialysis Services in competition with 
the business of the Company; 
15.2.2 Except for those specified clinics, in each of their current locations, and with their current fegal 
and beneficial ownerships, as such clinics are described on Schedule 15.2.2, not to serve as a medical director or in j any 
other similar capacity for any entity which is engaged in the supply of home CAPD, acute dialysis services or chronic 
dialysis services or other Dialysis Services in competition with the business of the Company; 
15.2.3 Not to persuade or encourage, directly or indirectly, another person or entity to compete with the 
Company in the Company's business; 
15.2.4 Not to persuade or encourage, directly or indirectly, another person or entity to modify, to 
terminate, to cancel, to reduce the extent of or to revoke any business agreement or relationship with the Company; 
15.3 Confidential Information. The Members acknowledge that the Company's trade secrets, private or sejcret 
processes, methods and ideas, as they exist from time to time, customer lists and information concerning the Company's 
products, services, training methods, development, technical information, marketing activities and procedures, ciiedit 
and financial data concerning patients and medical information are valuable, special and unique assets of the Company, 
access to and knowledge of which are essential to the performance of the Company. In light of the highly competitive 
nature of the industry in which the Company's business is conducted, the Members agree that all such proprietary 
information, heretofore or in the future obtained by each Member as a result of a Member's association with • the 
Company, shall be considered confidential. 
15.3.1 In recognition of this fact, the Members agree that they will never use or disclose any such 
proprietary information for their own purposes or for the benefit of any person or other entity or organization (except as 
contemplated by this Agreement) under any circumstances unless such proprietary information has been publicly 
disclosed generally or, unless upon written advise of legal counsel reasonably satisfactory to the Company alleging j the 
right to the proprietary information, the Member is legally required to disclose such proprietary information. 
15.3.2 Additionally, the Members shall not disclose to anyone for any reason, or to use for his own 
purposes, his knowledge or information gained about the Company, its related entities, clients, vendors, or any entity 
with whom the Company does business. This information shall include, by way of illustration and not limitation, 
patient data, contractual information, pricing information, financial information, personnel data and general information 
concerning corporate strategies. 
15.3.3 Documents, as hereinafter defined, belonging to the Company that come into any Member's 
possession during a Member's association with the Company are and remain the property of the Company. 
15.3.4 Upon termination of this Agreement, each party shall, with sixty (60) days of termination!, it 
requested, return all writings that reflect or embody the confidential or proprietary information. 
15.3.5 The obligations with respect to use, disclosure, and access to the proprietary information, trkde 
secrets and confidential information of each party set forth in this Agreement are not applicable to the following: 
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15.3.5.1 Information that was or is lawfully made available to the public without 
restriction by the disclosing party or lawfully by a third party; 
15.3.5.2 Information that was lawfully previously known to the receiving party 
independent of any disclosure by disclosing party. 
15.3.6 For purposes of this Agreement, "Document" shall mean all original written, recorded, or graphic 
matters whatsoever, and any and all copies thereof, including, but not limited to papers; books; records; tangible thfings; 
correspondence; telex messages; memoranda; work-papers; reports; statements; summaries; analyses; evaluations; client 
records and information; agreements; agenda; advertisements; manuals; brochures; publications; directories; indjustry 
lists; schedules; price lists; client lists; statistical records; training manuals; computer printouts; books of accpunt, 
records and invoices reflecting business operations; all things similar to any of the foregoing however denominated. In 
all case where originals are not available, the term "Documents" shall also mean identical copies of original documents 
or non-identical copies thereof. 
15.4 Duration. 
15.4.1 During the time period in which such Member is a Member of the Company, Article 15 shall be 
\r fuW force and effect at all times during the time period in which any Company Indebtedness remains outstanding and 
unpaid to any third party or to any Member. 
15.4.2 Article 15 shall be in full force and effect for a period of five (5) years following the termination 
of such Member's status as a Member of the Company, whether through the sale, gifting, disposition or other Transfer of 
his or her Interest in the Company; provided however the purchaser/transferee of the Interest of the Member in question 
shall have the option to extend such initial time period for an additional five year time period if jsuch 
^urchaser/transferree pays to the Member in question a one-time extension fee equal to ten percent (10%) of the 
.pplicable purchase price paid to such Member for such Interest, which extension fee shall be paid on or before the/fifth 
anniversary of such Transfer. 
15.4.3 However, notwithstanding the foregoing, the provisions contained in this Article 15, pertaijning 
t*> the Member's obligations with regard to confidential information shall be in full force and effect at all times during the 
duration of this Agreement and also, with regard to each Member, for all periods following the termination of puch 
Member's status as a Member of the Company, whether through the sale, gifting, disposition or other transfer of his/its 
Interest in same. The periods described above shall not include periods of time during which the restrictive covenants 
contained in this Article 15 are violated. Said periods of time during which a Member is in violation of the restrictive 
covenants specified herein shall be in addition to the period set forth above. 
15.5 Geographical Limitation - Special Exceptions. The provisions contained in Section 15.2 hereof shall be 
in full force and effect for the geographical area which is a twenty-five (25) mile radius of the Facility. Notwithstanding 
the geographical limitation set forth above, the provisions contained in Section 15.2 hereof shall not apply to Associates, 
any of its members, its beneficial owners, and any Affiliates of the foregoing, with regard to any similar facility which 
any of the foregoing individuals and/or entities may establish. Notwithstanding anything to the contrary set forth in fliis 
Article 15 or otherwise, each of the Non-Managing Members agrees that affiliates of the Managing Member and 
Manager shall be entitled to establish, own, operate, manage and dispose of, a dialysis facility providing Dialysis 
Services to be located to the west of Interstate 15 in Salt Lake County, Utah, even though such facility may be located 
within twenty-five miles of the Facility. 
15.6 Reasonableness. The Members agree, having discussed the matter and having had the benefit of counsel, 
that the duration and geographical limitation of Article 15 are reasonable. The Members also agree that they shall not 
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seek to avoid the obligations hereunder by claiming "unreasonableness" in either duration or geographical limitation. If, 
however, the reasonableness of the duration or geographical limitation does become an issue, apart from being raised by 
he parties to this Agreement, then the Members agree that a court shall interpret this provision for the longest duration 
^nd largest geographical area possible without voiding this Article 15 entirely. It is understood by and between the 
Members that the foregoing covenants by the Members contained in this Article 15 shall be construed to be Agreements 
independent of any other provision of this Agreement. The existence of any other claim or cause of action, whether 
predicated on any other provision in this Agreement, or otherwise, as a result of the relationship between the Members 
shall not constitute a defense to the enforcement of the covenants contained in this Article 15 against a Member. 
15.7 Remedies for Breach. The remedies for breach of Article 15 shall include, but not be limited to, 
injunctive relief. For this purpose, the Members agree that the Company will have no adequate remedy at law for sijch a 
breach and that such a breach will result in irreparable damage to the Company. Each Member, therefore, agrees that the 
Company and the injured Member or Members, without posting any bond, in seeking equitable relief in the fonji of 
specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy 
which may then be available to the injured Member and Members or Company, enjoining any further breach of Article 
15. The Company shall not be required to show anything further in order to obtain the injunction as it relates to the 
legitimate business interests of the Company and the reasonableness of the duration and geographical limitation a^  the 
Member's representations within this Agreement bear witness to the foregoing. In addition to, or in the alternative to, 
this injunctive relief, the Company shall be entitled to any and all other relief under the law as may be its right. IThe 
Members acknowledge that the granting of a temporary injunction, temporary restraining order or permanent injunction 
merely prohibiting the use of proprietary information would not be an adequate remedy upon breach or threatened breach 
of the provisions of Article 15 and consequently agree, upon proof of any such breach, to the granting of injunctive relief 
prohibiting any form of competitive business by the breaching Member. Nothing herein contained shall be construejd as 
prohibiting any injured Member or the Company from pursuing any other remedies available to it for such breach or 
threatened breach. 
15.8 Exceptions. Nothing in Article 15 shall be construed to detract from a physician's right and duty to t&ke, 
or omit to take, such action as the physician may, in his professional judgment, determine to be necessary for the medical 
care and treatment of a patient. Similarly, nothing in Article 15 shall be construed to be contrary to state or federal laws 
prohibiting patient referrals. By way of illustration and not of limitation of the foregoing, the Members whoj are 
physicians shall refer their patients only to such medical facilities as they determine appropriate in their professional 
judgment. Nothing herein shall be construed to restrict Members who are physicians from engaging in the priyate 
practice of medicine. Nothing in Article 15, shall, in any manner, limit any action by Associates or its Affiliates, it Wing 
specifically understood and agreed Associates or its Affiliates will, in fact, utilize all information gained by it from /this 
Company in the course of its other businesses. 
ARTICLE 16 
DISSOLUTION AND TERMINATION 
16.1 Dissolution and Termination. Consistent with the provisions of Article 12 hereof, and in the event of jany 
inconsistency herein, Article 12 shall control, the Company shall dissolve and be terminated on August 31, 2050, or upon 
the earlier happening of any one of the following: 
16.1.1 Upon written agreement by the Required Members; 
16.1.2 Upon the sale of substantially all of the property or other conversion of substantially all [the 
Company's assets to cash; or 
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16.1.3 Upon the occurrence of any other event other than one specified in this section which, under 
the Act or as otherwise provided by law, causes or requires a dissolution and termination of the Company. 
16.2 Liquidator. 
16.2.1 Upon dissolution of the company, the Managing Member(s), or if there is no Managing 
Member, such person as the Members holding a majority of the Members' Interests may designate, shall act as 
Liquidator of the Company (in either case, the "Liquidator"). The Liquidator shall, with reasonable speed, wind up the 
affairs of the Company and liquidate the Property. The Liquidator shall have unlimited discretion to determine the time, 
manner and terms of any sale of Property having due regard to the activity and condition of the relevant market and 
general financial and economic conditions. The Liquidator shall distribute any proceeds received from the disposition of 
the property and any other assets of the Company in accordance with the provisions of this Agreement. 
16.2.2 If any Member shall be indebted to the Company, then until payment of such amount by ihim, 
thf* Liquidator shall retain such Member's distributive share of property and apply the same to the liquidation of such 
indebtedness. 
16.2.3 The Liquidator shall comply with all requirements of the Act and other applicable! law 
pertaining to the winding up of a limited liability company, following which the Company shall stand liquidated and 
terminated, including the filing of a Certificate of Cancellation in the manner provided by the Act. 
16.3 Source of Distributions. Each Member shall look solely to the assets of the Company for all 
distributions with respect to the Company, the return of his capital contribution thereto and his share of profits or losses 




17.1 Notices. All notices ("Notices"), including service of notices to arbitrate, consents and reports provided 
f,. in this Agreement shall be in writing and shall be deemed given on hand-delivery or on mailing by United States 
certified mail, return receipt requested, whether or not accepted by any party, at the addresses set forth below or at such 
other address as the Company or any of the parties hereto may hereafter provide by notice given in the manner Member 
provided in Schedule II attached hereto. A copy of any notice, demand, consent or report to the Company by \ any 
Member shall be delivered to the other Members and the Managing Member in the same manner as provided in! this 
Section for the giving of notices. 
17.2 Additional Documents and Acts. Each Member agrees to execute and deliver such additional documjents 
and instruments, and to perform such additional acts as may be necessary or appropriate in the opinion of the Managing 
Member to effectuate, carry out, and perform all of the terms, provisions, and conditions of this Agreement, and all 
transactions contemplated hereby, including use of fictitious nature. 
17.3 No Conflicts With Other Agreements. Each of the Members covenants and agrees that the execution 
and delivery of this Agreement by each of the Members, the formation of the Company, the establishment (and 
operation of the Facility as contemplated by this Agreement and the performance by each of the Members ofj the 
covenants and provisions of this Agreement will not conflict with, constitute a default under or violate any of the terins, 
conditions or provisions of any document, agreement or other instrument to which any Member is a party or by which 
any Member is bound. 
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17.4 Construction. It shall be irrebuttably presumed that this Agreement was codrafied by all signatories 
hereof and therefor this Agreement shall be construed without regard to any presumption or other rule requiring 
construction against the party causing this Agreement to be drafted. 
17.5 Governing Law and Venue. This Agreement and the rights and obligations of the respective parties 
hereto shall be governed and interpreted in accordance with the Act and with the laws of the State of Delaware. Exclusive 
verue for all lawsuits or other proceedings related to this Agreement or transactions therein described shall be 
commenced in a court of competent jurisdiction in Broward County, Florida. 
17.6 Waiver of Jury Trial. TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE PARTIES 
HEREBY WAIVE ANY RIGHT THAT THEY MAY HAVE TO A TRIAL BY JURY OF ANY DISPUTE 
(WHETHER A CLAIM IN TORT, CONTRACT, EQUITY, OR OTHERWISE) ARISING UNDER >OR 
RELATING TO THIS AGREEMENT, AND AGREES THAT ANY SUCH DISPUTE SHALL BE TRIED 
SEFORE A JUDGE SITTING WITHOUT A JURY. 
17.7 Pronouns. All pronouns shall be deemed to refer to the masculine, feminine or neuter, singular or plural, 
?<? the identity of the entity or entities, or the person or persons may require. 
17.8 Headings. All headings herein are inserted only for convenience and ease of reference and are not to be 
considered in the construction or interpretation of any provision of this Agreement. Numbered or lettered articles, 
paragraph and subparagraphs herein contained refer to articles, paragraphs and subparagraphs of this Agreement unless 
otherwise expressly stated. 
17.9 Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Members and their 
respective heirs, personal representatives, successors and assigns, including the provisions set forth in Article 18 hereof. 
17.10 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be 
;emed an original and all of which shall constitute one and the same Agreement. 
17.11 Readjustment of Agreement on Invalidity. If any provision of this Agreement is declared invalid by jany 
tribunal exercising competent jurisdiction, such provision shall be deemed automatically adjusted to conform to; the 
requirements for validity, as declared at such time and, as so adjusted, shall be deemed a provision of this Agreemerit as 
though originally included herein. 
17.12 Litigation Costs. In the event of any litigation arising by virtue of this Agreement, each party shall bear 
its/his own court costs, litigation expenses, and attorneys' fees at both trial and appellate levels. 
17.13 Amendments to this Agreement. This Agreement, except with respect to vested rights of a Member, may 
be amended at any time by the Required Members. 
17.14 Entire Agreement. This instrument contains all of the understandings and agreements of whatsoever 
kind and nature existing between the parties hereto with respect to this Agreement and the rights, interests, 
understandings, agreements and obligations of the respective parties hereto pertaining to the Company. 
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IN WITNESS WHEREOF, the parties hereto have executed this Operating Agreement for East Valley Artificial 
Kidney Center LLC, as of the day and year first above written. 
MANAGING MEMBER: 
EAST VALLEY ASSOCIATES, INC., 
a Delaware corporation 
:^T' By 
Name: Robert T. Santelli 
Title: President 
OTHER MEMBERS 
Elisabet Atkin-Thor, M.D. 
rYf\*U^U (V WYXQ f^e> VYVT) 
Melinda J. McAxmltyAji^. V^J 
Gary M. feSetoy, M.D. 
Christy Prioe^abetoy, M.S.N. <r" i 
^ S k ) , hdf 
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SCHEDULEI 
LIST OF MEMBERS, INITIAL CAPITAL CONTRIBUTIONS AND PERCENTAGE INTERESTS 
Name of Members 
East VaHey Associates Inc. 
James B. Stmson, M.D. 
Richard G Lambert, M.D. 
Richard C Cline, M.D. 
Ehsabet Atkin-Thor, M.D. 
Melinda J. McAnulty, M.D. 
Gary M. Rabetoy, M.D. 
Christy Price-Rabetoy, M.S.N. 
TOTAL: 






















LIST OF NOTICE ADDRESSES 
East Valley Associates, Inc. 
c/o KRU Medical Ventures LLC 
70o 1 C/piess Road, Suite 104 
Plantation, Florida 33317 
Attention: Manager 
James B. Stinson, M.D. 
2466 Shadow Wood Circle 
Salt Lake City, Utah 84117 
I 
Richard G. Lambert, M.D. 
900 Terrace Hills Drive 
Salt Lake City, Utah 84103 
Rxhard C. Cline, M.D. 
1482 E. Show Cir. 
Sandy, Utah 84092 
Elisabet Atkin-Thor, M.D. 
2237 Lincoln Ct. 
Salt Lake City, Utah 84124 
Melinda J. McAnulty, M.D. 
687 R Dormer Hill Cir. 
Salt Lake City, Utah 84108 
Gary M. Rabetoy, M.D. 
2768 Commonwealth Ave. 
Salt Lake City, Utah 84109 
Christy Price-Rabetoy 
2768 Commonwealth Ave. 
Salt Lake City, Utah 84109 
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SCHEDULE 15.&2 
Central Valley Dialysis Center (IHC) 
880 East 3900 South 
SaltLaVe City,\7T B41D? 
Utah Dialysis (IHC) 
633 E. South Temple 
Salt Lake City, UT 84102 
South Valley Dialysis Center (University of Utah) 
8750 South Sandy Parkway 
Sandy, UT 84070 
BHS Dialysis (DaVita) 
1255 E 3900 South 
Salt Lake City, UT 84124 
Mid-Valley Dialysis Center (DaVita) 
^578 South 1900 West 
Tay!oiSviIle,UT84118 
West Bountiful Dialysis Center (DaVita) 
724 West 500 South 
Suite 300 
Bountiful, UT 84087 






FORM OF MANAGEMENT SERVICES AGREEMENT 
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AMENDED AND RESTATED 
LIMITED LIABILITY COMPANY AGREEMENT 
OF 
SUMMIT DIALYSIS, LLC 
Dated as of July 1,2003 
THE MEMBERSHIP INTERESTS REPRESENTED BY THIS AGREEMENT HAVE NOT 
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE 
"ACT") OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD OR 
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT 
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAW OR AN EXEMPTCON 
FROM REGISTRATION THEREUNDER. 
THE MEMBERSHIP INTERESTS REPRESENTED BY THIS INSTRUMENT ARE ALSO 
SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFERABILITY AS SET FORTH 
IN THIS AGREEMENT. 
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SECOND 
AMENDED AND RESTATED 
LIMITED LIABILITY COMPANY AGREEMENT 
OF 
SUMMIT DIALYSIS, LLC 
This SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY 
AGREEMENT (this "Agreement") of SUMMIT DIALYSIS, LLC, a Delaware limited liability 
company (the "Company"), is made as of July 1,2003, by and among Nephrology Associates, LLC, 
a Utah limited liability company ("Nephrology Associates"), Summit Dialysis II, Inc. ("Summit 
II")> a Delaware corporation, Mercer Utah, LLC, a Delaware limited liability company ("Mercer"). 
Mr. Robert Santelli, an individual ("Santelli"). Focus Enterprise LLC, a Utah LLC majori ty owned 
and controlled by Mr. Bill Jensen ("hereinafter Focus Enterprise is referred to as Jensen"), and 
James B. Stinson, M.D., Richard Lambert, MIX, Richard Cline, MIX, Elisabeth Atkin-Thor, M.D., 
Melinda McAnulty, M.D., Gary Rabetoy, M.D., Christy Price-Rabetoy, David Tien, MIX, and Jeff 
Barklow, M.D. Each of Nephrology Associates, Santelli, Summit II, Mercer and Jensen, shall 
individually be referred to as a "Member" and collectively as the "Members." Each of Drs. Stinson, 
Lambert, Cline, Atkin-Thor, McAnulty, Rabetoy, Tien and Barlow, and Ms. Price-Rabetoy, shall be 
referred to as the "Nephrology Members" or "Physicians"). 
WHEREAS, the Company was formed as a limited liability company pursuant to the 
Delaware Limited Liability Company Act, Delaware Code, Title 6, Sections 18-101, et seq., as 
amended (the "Delaware Act"), by having a Certificate of Formation of the Company (the 
"Certificate") filed with the Secretary of State of the State of Delaware on February 6,2002; and 
WHEREAS, the Members wish to amend and restate the Agreement as provided herein to 
set out their respective rights, obligations and duties regarding the Company and its assets; 
NOW, THEREFORE, in consideration of the mutual covenants and agreements herein made 
and other good and valuable consideration, the Members hereby agree as follows: 
ARTICLE 1 
ORGANIZATION 
1.1 In General, The name of the limited liability company constituted by this Agreement 
is Summit Dialysis, LLC or such other name or names as the Board may from time to time 
designate; provided* that the name shall always contain the words "Limited Liability Compainy" or 
the terms "LLC" or "L.L.C." The rights, powers, duties, obligations and liabilities of the Members 
shall be determined pursuant to the Delaware Apt and this Agreement To the extent that the rights, 
powers, duties, obligations and liabilities of any Meiqber are different by reason of any provision of 
this Agreement than they would be in the absence of such provision, this Agreement shall, to the 
extent permitted by the Delaware Act, control. 
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1.2 Registered Office: Agent. The Company shall maintain a registered office in the 
State of Delaware at c/o Corporation Service Company, Suite 400,2711 Centerville Road, 
Wilmington, New Castle County, Delaware 19808 or at such other place within Delaware as the 
Board may designate. The name and address of the Conjpan/s registered agent for service of 
process on the Company in the State of Delaware is Corporation Service Company, Suite 400,2711 
Centerville Road, Wilmington, New Castle County, Delaware 19808 or such other agent as the 
Board may from time to time designate. 
1.3 Term. The term of the Company shall continue perpetually unless terminated in 
accordance with the provisions of this Agreement. 
1A Purpose; Powers. The purposes and character of the business of the Compiiny shall 
be to transact any or all lawful business for which limited liability companies may be organized 
under the Delaware Act, including the development, ownership and operation of one or more 
kidney dialysis facilities. As of the date hereof, the Company operates two licensed dialysis clinics 
through subsidiary limited companies known as Wasatch Artificial Kidney Center LLC and Oquirrh 
Artificial Kidney Center LLC- The Company owns 100% of the equity of East Valley Associates 
LLC which in turn owns 100% of the equity of Wasatch Artificial Kidney Center LLC, The 
Company owns 100% of the equity of West Valley Associates LLC which in turn owns 100% of the 
equity of Oquirrh Artificial Kidney Center LLC. 
ARTICLE 2 
MEMBERSHIP 
2.1 Membership and Capital Contributions. The Company has only one class of 
Members. The Members of the Company who h^ve made contributions to the capital of the 
Company, the cash contributed by each such Member and the capital account for each such member 
as of the date hereof are as sot forth on the Members Schedule attached as Exhibit 2.1. The 
Company shall maintain the Members Schedule which shall reflect the Members of the Company 
and their capital contributions from time to time. No Member shall have any obligations to make 
any additional contributions of cash or other assets to the Company. 
2.2 Issuance of Additional Membership Interests. The Company shall not issue any 
additional voting or economic interests in the Company except pursuant to an amendment to this 
Agreement which is approved by the Board. Furthermore, except as approved by the Board, the 
Company shall not admit any other Person as a new Member accept pursuant to Section 6.2 in 
connection with a transfer of any membership interest. 
2.3 Loans. As of the date hereof, Bain Capital Venture Fund, L.P. and certain affiliates 
have lent the Company the aggregate principal sum of $760,000. Prior to the date hereof Mztrk 
Caputo ("Caputo"). the controlling member of Mercer, has lent the Company the aggregate 
principal sum $480,000. The foregoing loans are referred to herein as the Members Loans". The 
Members Loans shall bear interest and be payable as sot forth in the notes applicable thereto and 
shall not be considered capital contributions of such Members to the Company. In addition, DVI 
Financial Services has lent the Company $1,800,000 and the Company and its subsidiaries owe 
DaVita, Inc. the sum of $3,450,000. Each Nephrology Member and Jensen hereby agrees to 
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guarantee up to $70,000 of the debt owed to DVI Financial Services (on a several basis and not a 
joint and several basis). 
2.4 Representations and Warranties of Members, Each Member hereby represents and 
warrants to the Company and acknowledges that: (i) such Member is capable of evaluating the 
merits and risks of an investment in the Company and making an informed investment decision with 
respect thereto; (ii) such Member has a pre-existing personal or business relationship with Caputo; 
(iii) such Member is able to bear the economic and financial risk of an investment in the Company 
for an indefinite period of time; and (iv) such Member is acquiring interests in the Company for 
investment only and not with a view to, or for resale in connection with, any distribution to the 
public or public offering thereof. 
2.5 No Liability of Members. 
(a) No Liability. Except as otherwise required by applicable law and as 
expressly set forth in this Agreement, no Member shall have any personal liability 
whatsoever in such Member's capacity as a Member, whether to the Company, to any of the 
other Members, to the creditors of the Company or to any other third party, for the debts, 
liabilities, commitments or any other obligations of the Company or for any losses of the 
Company. 
(b) No Management or ControL No Member shall take part in or interfere in any 
manner with the management of the business or affairs of the Company or have any right or 
authority to act for or bind the Company, notwithstanding Section 18-402 of the Delaware 
Act The business of the Company shall be managed by the Board as provided in Section 
4.2 and except for the rights of Members to appoint members of the Board as provided in 
Exhibit 4.1, the Members shall not have the right to vote or consent on any matter. 
(c) Specific Limitations. No Member shall have the right or power to: (a) 
withdraw or reduce such Member's capital contribution except as otherwise provided by law 
or in this Agreement, (b) make voluntary capital contributions or to contribute any property 
to the Company other than cash, (c) bring an action for partition against the Company or any 
Company assets (which right each Member hereby waives and agrees not to assert), (d) 
cause the termination and dissolution of the Company, or (e) require that distributions be 
made in property other than cash. 
ARTICLE 3 
DISTRIBUTIONS 
3.1 In General. The profits and losses of the Company from and after the date hereof, 
and each item entering into the computation thereof, as well as each distribution made by the 
Company to a Member, whether of cash, property or securities (each such distribution, a 
"Distribution"), shall be shared by and allocated among the Members as follows: 
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Nephrology Associates 45.0% 




The foregoing Members are the only Members entitled to receive Distributions from the Company 
and no other Member shall have any interest in the Company, its assets or its profits or losses by 
virtue of being a Member or a Nephrology Member. 
32 General Tax Distributions. The Board shall determine the amount and timing of any 
Distributions to be made to the Members listed in Section 3.1; provided, however, that to the 
maximum extent permitted by law and subject to the provisions of any agreement to which the 
Company is a party, the Company shall mak$ Distributions in cash to the Members listed in Section 
3.1 on a quarterly basis in an amount determined by the Board to be sufficient to cover the 
Members' combined federal and state income tax liabilities incurred by virtue of the Member's 
ownership interest in the Company, taking into account both profits and losses allocated to the 
Members after the date hereof. All such Distributions shall be made in accordance with the» 
percentage interests set forth in Section 3.1. 
3.3 Certain Tax Distributions. Notwithstanding the provisions of Section 3.1 and 32 
above, in the event that the Board elects to sell substantially all of the assets of the Company (or 
substantial assets of any of its subsidiaries), the Company shall first make a cash distribution 
sufficient to cover each Members' tax liability resulting from such asset sale (as calculated for each 
Member and its owners based upon the Member's and owners' highest marginal tax rate), and then 
distribute the remaining proceeds (after repayment of all Members Loans and other debts) in 
accordance with Section 3.1. 
3i4 No Violation. Notwithstanding any provision to the contrary contained in this 
Agreement, the Company shall not make a distribution to any Member on account of such 
Member's Interest if such distribution would violate Section 18-607 of the Act or other applicable 
law. 
ARTICLE 4 
MANAGEMENT OF THE COMPANY 
4.1 v Board of Managers. The business of the Company shall be managed by a Board of 
Managers (the "Board"), and the Persons constituting the Board shall be the "managers" of the 
Company for all purposes under the Delaware Act The Board shall initially be set at six and the 
individuals set forth in Exhibit 4.1 shall constitute the initial Board. Thereafter, the individuals 
constituting the Board shall be determined in accordance with the provisions of Exhibit 4.1. 
Exhibit 4.1 sets forth the procedures for the conduct of the affairs of the Board and decisions of the 
Board shall be set forth in a resolution adopted in accordance with the procedures set forth in 
Exhibit 4.1. Such decisions shall be decisions of the Company's "manager" for all purposes of the 
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Delaware Act and shall be carried out by officers or agents of the Company designated by the Board 
in the resolution in question or in one or more standing resolutions or with the power and authority 
to do so under Section 4.4. A decision of the Board may be amended, modified or repealed in the 
same manner in which it was adopted or in accordance with the procedures set forth in Exhibit 4.1 
as then in effect, but no such amendment, modification or repeal shall affect any person or entity 
who has been furnished a copy of the original resolution, certified by a duly authorized officer of 
the Company, until such person or entity has been notified in writing of such amendment, 
modification or repeal. 
4.2 Authority of Board of Managers. The Board shall have the exclusive power and 
authority to manage the business and affairs of the Company and to make all decisions with respect 
thereto. The Board or persons or entities designated by the Board, including officers and agents 
appointed by the Board, shall be the only persons or entities authorized to execute documents which 
shall be binding on the Company. To the fullest extent permitted by Delaware law, the Board shall 
have the power to perform any acts, statutory or otherwise, with respect to the Company or this 
Agreement, which would otherwise be possessed by the Members under Delaware law. 
4.3 Officers: Agents. The Board by vote or resolution shall have the power to appoint 
officers and agents to act for the Company with such titles, if any, as the Board deems appropriate 
and to delegate to such officers or agents such power and authority to act on behalf of the Company, 
including the power to execute documents on behalf of the Company, as the Board may in its sole 
discretion determine; provided, however, that no such delegation by the Board shall cause the 
Persons constituting the Board to cease to be the "managers" of the Company within the meaning of 
the Delaware Act. Unless the authority of the officer in question is limited in the document 
appointing such officer or is otherwise specified by the Board, any officer so appointed shall have 
the same authority to act for the Company and shall have the same responsibilities as a 
corresponding officer of a Delaware corporation would have in the absence of a specific delegation 
of authority or responsibility. The Board, iij its sole discretion, may by vote or resolution of the 
Board ratify any act previously taken by an officer or agent acting on behalf of the Company. Any 
officer or agent shall serve at the pleasure of the Board and may be removed by the Board at any 
time with or without cause. 
4.4 Appointment of Officers. The Board shall initially appoint one or more Nephrology 
Members to serve as Medical Director of its Oquirrh and Wasatch dialysis clinics. As 
compensation during its initial year as Medical Director, Oquirrh and Wasatch shall collectively pay 
$120,000 for such Medical Director services. The Board shall initially appoint Bill Jensen as Chief 
Operating Officer, with an annual compensation of $60,000. The Board shall initially appoint 
Caputo as Chief Executive Officer (with compensation of $30,000 annually) and Santelli as 
President (with compensation of $30,000 annually). 
4:5 Indemnity, etc. To the fullest extent permitted by applicable law, the Company shall 
indemnify, defend and hold harmless the Board and each member of the Board, each Member, 
including the Tax Matters Partner in such Member's capacity as such, each such person's or entity's 
officers, directors, partners, members, shareholders, employees, accountants, counsel and agents, 
and the employees, officers, accountants, counsel and agents of the Company (each person or entity 
entitled to indemnification under this Section 4.6 being referred to as an "Indemnified Person" for 
purposes of this Agreement), from any liability, loss or damage incurred by the Indemnified Person 
by reason of any act performed or omitted to be performed by the Indemnified Person in connection 
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with the business of the Company and from liabilities or obligations of the Company imposed on 
such person or entity by virtue of such person's or entity's position with the Company, including 
reasonable attorneys' fees and costs and any amounts expended in the settlement of any such claims 
of liability, loss or damage; provided however, that if the liability, loss, damage or claim arises out 
of any action or inaction of an Indemnified Person, indemnification under this Section 4.6 shall be 
available only if (a) either (i) the Indemnified Person, at the time of such action or inaction, 
determined in good faith that its, his or her course of conduct was in, or not opposed to, the best 
interests of the Company or (ii) in the case of inaction by the Indemnified Person, the Indemnified 
Person did not intend its, his or her inaction to be harmful or opposed to the best interests of the 
Company, and (b) the action or inaction did not constitute fraud or willful misconduct by the 
Indemnified Person; provided, farther, however, that indemnification under this Section 4.6 shall be 
recoverable only from the assets of the Company and not from any assets of the Members. No 
Indemnified Person shall be liable, in damages or otherwise, to the Company or to any Member for 
any loss that arises out of any act performed or omitted to be performed by it, him or her pursuant to 
the authority granted by this Agreement if (a) either (i) the Indemnified Person, at the time of such 
action or inaction, determined in good faith that such Indemnified Person's course of conduct was 
in, or not opposed to, the best interests of the Company, or (ii) in the case of inaction by the 
Indemnified Person, the Indemnified Person did not intend such Indemnified Person's inaction to be 
harmful or opposed to the best interests of the Company, and (b) the conduct of the Indemnified 
Person did not constitute fraud or willful misconduct by such Indemnified Person. 
ARTICLE 5 
CAPITAL ACCOUNTS AND TAX MATTERS 
5.1 Partnership Taxation. At any time when the Company has more than one Member, 
the Company shall be treated as a partnership for federal, foreign, state and local income tax 
purposes, as applicable, and each Member and the Company shall file all tax returns and shall 
otherwise take all tax and financial reporting positions in a manner consistent with such treatment. 
The Company shall not be deemed a partnership or joint venture for any other purpose. 
5.2 Capital Accounts. 
(a) The Company shall maintain for each Member a separate capital account. 
Each such capital account shall be increased by the cash amount or fair market value of any 
property contributed by such Member to the Company pursuant to this Agreement and such 
Member's allocable share of profits and shall be decreased by the cash amount or fair 
market value of any property distributed to such Member pursuant to this Agreement and 
such Member's allocable share of losses. 
(b) The foregoing provisions relating to the maintenance of capital accounts (and 
the allocation of profits and losses or items thereof) are intended to comply with the 
provisions of 704(b) of the Internal Revenue Code of 1986, as amended (the "Code") and 
with Section 1.704-1 (b) of the regulations of the Department of the Treasury under the Code 
(such regulations, the "Treasury Regulations") and shall be interpreted and applied in a 
manner consistent with the Code and such Treasury Regulations. In furtherance of the 
foregoing, the Board is hereby directed to resolve any ambiguity in the provisions of this 
Agreement in a manner that will preserve, protect and further the intention of the Members 
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to cause this Agreement to comply with the aforesaid provisions for federal income tax 
purposes and to adopt such amendments and curative provisions to this Agreement as the 
Board may deem necessary to achieve the desired results. In accordance with Section 
704(c) of the Code, income, gain, loss and deduction with respect to any property 
contributed to the Company with an adjusted basis for federal income tax purposes different 
than the initial asset value at which such property was accepted by the Company shall, 
solely for tax purposes, be allocated among the Members so as to take into account such 
difference in the manner required by Section 704(c) and the applicable Treasury 
Regulations. 
5.3 No Withdrawal, etc.. No Member shall be entitled to withdraw any part of its capital 
contribution or capital account or to receive any distribution from the Company, except as expressly 
provided herein. If any Member has a deficit balance in its capital account, such Member shall have 
no obligation to restore such negative balance or to make any capital contributions to the Company 
by reason thereof. No Member shall receive any interest, salary or drawing with respect to its 
capital contributions or its capital account Members shall be entitled to look solely to the assets of 
the Company for the return of Member's capital. 
5.4 Regulatory Allocations. There are hereby included in this Agreement such 
additional provisions governing the allocation of income, gain, loss, deduction and credit (and items 
thereof) as may be necessary to provide that the Company's allocation provisipns contain a so-
called "Qualified Income Offset" and comply with all provisions relating to the allocation of so-
called Nonrecourse Deductions" and "Member Nonrecourse Deductions" and the chargeback 
thereof as set forth in the Treasury Regulations under Section 704(b) of the Code ("Regulatory 
Allocations"): provided, however, that, to the extent possible, all Regulatory Allocations that may 
be required shall be offset by other Regulatory Allocations or special allocations of tax items such 
that each Member's share of the profits, losses and capital of the Company will be the same as it 
would have been had the events requiring the Regulatory Allocations not oceuiTed. 
5.5 Tax Matters Partner, Mercer shall be the ' tax matters partner" of the Company 
pursuant to Section 6231(a)(7) of the Code (the "Tax Matters Partner") and shall not receive any 
compensation for acting as such. 
5.6 No Effect on Distributions. The provisions of this Article 5 are included solely for 
the purpose of allocating profits and losses and maintaining capital accounts for tax purposes and 
shall not affect the Distributions (other than tax distributions) required to be made as provided in 
Article 3. 
ARTICLE 6 
TRANSFER OF MEMBERSHIP INTERESTS; WITHDRAWAL 
6.1 Restrictions, Each Member acknowledges and agrees that such Member shall not 
transfer any membership interest except with the prior consent of the Board. Any Member who 
transfers all of his or its membership interests (i) shall cease to be a Member upon such Transfer, 




62 Procedure for Transfers. No transferee of any Membership Interest may be newly 
admitted as a Member without the approval of the Board. No transfer of a Membership Interest 
may be completed until the prospective transferee executes and delivers to the Company a written 
undertaking to be bound by the terms and conditions of this Agreement in form and substance 
reasonably satisfactory to the Board. Upon the amendment of the Members Schedule and the 
approval of the Board, such transferee shall be admitted as a Member and deemed listed as such on 
the books and records of the Company. 
6.3 Withdrawal. A Member shall not cease to be a Member as a result of the bankruptcy 
of sucfrMember. So long as a Member continues to own or hold any membership interests, such 
Member shall not have the ability to resign as a Member prior to the dissolution and winding up of 
the Company and any such resignation or attempted resignation by a Member prior to the 
dissolution or winding up of the Company shall be null and void. 
ARTICLE 7 
OPERATION OF THE COMPANY 
7.1 Conduct of Business. Each Member and each Nephrology Member will use its 
reasonable efforts to establish, grow and preserve the business of the kidney dialysis facilities 
operated by the Company. 
7.2 Right of First Opportunity. Each Member and each Nephrology Member hereby 
grants to each other Member a continuing and absolute right of first opportunity and right of first 
refusal to participate as a member or equity owner (on terms substantially similar to the terms 
contained in this Agreement) in one or more limited liability companies or other legal entities in 
connection with any such Member's or Nephrology Member's, as the case may be, acquisition, 
formation, development, leasing, operation and/or management (whether directly or indirectly) of 
any dialysis clinic or other dialysis-related facility (one or more) in Salt Lake County, Utah. 
7.3 Non-Compete upon Sale. In the event that the Members or Board decide to sell or 
transfer substantially all of the assets of the Company, or sell the membership interest in the 
Company, then each Member and each Nephrology Member shall not compete directly or indirectly 
with the Company by owning, managing, operating, controlling, joining, assisting, advising, or 
consulting to, any business engaged in the provision of out-patient dialysis, home dialysis or acute 
dialysis within a 5 mile radius of any of the facilities then operated by the Company. This covenant 
shall have a duration of three years from the date of sale. 
7.4 Joinder Agreement. Nephrology Associates shall have each new associate or partner 
that joins Nephrology Associates join in this Agreement as a Nephrology Member by signing a 
joinder agreement in form and substance reasonably satisfactory to the Board. 
7.5 Accounting. Accurate books, records and accounts shall be maintained by the 
Company showing its assets, liabilities, operations, transactions and financial condition. The Board 
shall designate the methods of accounting available to the Company. The Company's books shall 
be maintained at the principal office of the Company and each Member shall, at all reasonable times 
have the right to inspect and copy the same. The Company shall have an annual audit conducted of 
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its financial records by an outside accounting firm and shall provide each member a copy of its 
audited financial statements within 150 days after the end of each fiscal yt?ar. The Company's tax 
returns shall be prepared by an outside accounting firm designated by the Tax Matters Member. 
7.6 Tax Year. The tax year of the Company shall commence on January 1 and end on 
December 31. 
7.7 Disclosure, Each Member and each Nephrology Member shall have the right during 
business hours on reasonable notice to examine the books and records of the Company. 
7.8 Professional Liability Insurance. Each Member and each Nephrology Member who 
is a licensed physician shall be insured, at such physician's own expense, against professional 
liability, with coverage limits of no less than $1,000,000, issued by a company or companies 
approved to do business in the state in which the Company operates its dialysis clinic. In addition, 
each Nephrology Member described in the preceding sentence that is required to purchase 
professional liability insurance shall also purchase appropriate tail insurance coverage or continuing 
coverage in the event of withdrawal from the Company or a dissolution of the Company. 
7.9 Professional Liability Insurance. The Company shall bind professional liability 
insurance for the Company in an amount of no less than $1 million, at the Company's expense. 
ARTICLE 8 
DISSOLUTION AND LIQUIDATION 
8.1 Dissolution. The Company shall be dissolved and its affairs wound up only upon the 
happening of any of the following events: 
(a) the disposition of all or substantially all of the Company's assets determined 
on a consolidated basis; 
(b) determination of the Board; 
(c) the entry of a decree of judicial dissolution under Section 18-802 of the 
Delaware Act 
No withdrawal of any Member shall cause a dissolution of the Company and the Company shall 
continue in existence subject to the terms and conditions of this Agreement Dissolution of the 
Company shall be effective on the day on which the event occurs giving rise to the dissolution, b\ 
the Company shall not terminate until the winding up of the Company has been completed, the 
assets of the Company have been distributed as provided in Section 9.2 and the Certificate shall 
have been canceled. 
8.2 Distribution of Assets. Upon the dissolution of the Company, the net proceeds fra 
liquidation of Company assets shall be applied and distributed as follows: 
(a) To the payment of all debts and liabilities of the Company (including all 
debts described in Section 2.3 of this Agreement) and the expenses of liquidation of the 
Company; 
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(b) To the establishment of such reserves as may be deemed advisable by the 
Board for any contingent liabilities or obligation of the Company; 
(c) To the Members in accordance with the provisions of Article 3. 
ARTICLE 9 
GE^^ERAL/MISCELLANEOUS PROVISIONS 
9.1 Notices. Whenever any notice is required to be given by law or this Agreement, a 
written waiver thereof, signed by the Person entitled to notice, whether before or after the time 
stated therein, shall be deemed equivalent to the giving of such notice. Any notice to be given 
hereunder will be given in writing and may be given personally or by mail. If given by mail, the 
notice will be deemed given when deposited in the United States mail, postage prepaid, certified or 
registered mail, return receipt requested, addressed to the recipient at its address on the books and 
records of the Company (which may be changed at any time by sending to the Company a notice of 
change of address satisfying the requirements of this paragraph). Whenever any notice is required 
to be given by law or this Agreement, a written waiver thereof, signed by the Person entitled to 
notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of 
such notice. 
92 Governing Law. This Agreement and the rights of the parties hereunder shall be 
interpreted in accordance with the internal laws of the State of Delaware, and all rights and 
remedies shall be governed by such laws without regard to principles of conflicts of laws. 
9.3 Entire Agreement. This Agreement constitutes the entire agreement of the parties 
thereto relating to the Company and supersedes all prior contracts or agreements with respect to the 
Company, whether oral or written. 
9.4 Amendment or Modification. This Agreement and any provision hereof may be 
amended, modified or waived from time to time only by the prior approval of the Board and of 
Members holding not less than 60% of the percentages listed in Section 3.1. Any amendment, 
modification or waiver of this Agreement approved as contemplated by the immediately preceding 
sentence shall be binding on all Members and Nephrology Members. 
9.5 Binding Effect Subject to the restrictions on transfers of Membership Interests set 
forth in this Agreement, this Agreement is binding on and shall inure to the benefit of the Members 
and their respective heirs, legal representatives, successors and permitted assigns. 
9.6 Counterparts. This Agreement may be signed in any number of counterparts, each of 
which shall be an original for all purposes, but all of which taken together shall constitute only one 
agreement. 
9.7 Severability. Each provision of this Agreement shall be considered severable and if 
for any reason any provision or provisions herein (a) are determined to be invalid or contrary to any 
existing or future law, such invalidity shall not impair the operation of or affect those portions of 
this Agreement which are valid or (b) would cause any Member to be bound by the obligations of 
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the Company under the laws of any state or locale as the same may now or hereafter exist, such 
provision or provisions shall be deemed void and of no effect 
9.8 Headings. All section headings or captions contained in this Agreement are for 
convenience only and shall not be deemed part of the text of this Agreement. 
9.9 Parties in Interest Except as provided in Section 4.3, nothing herein shall be 
construed to be to the benefit of or enforceable by any third party including, but not limited to, any 
creditor of the Company. 
9.10 Further Assurances. The Members will execute and deliver such further instruments 
and do such further acts and things as may be required to carry out the intent and purposes of this 
Agreement 
9.11 No Strict Construction. The parties to this Agreement have participated jointly in the 
negotiation and drafting of this Agreement hi the event an ambigiihy or question of intent or 
interpretation arises, this Agreement shall be construed as if drafted jointly by the parties to this 
Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any party by 
virtue of the authorship of any of the provisions of this Agreement 
9.12 Construction. Whenever the context requires, the gender of all words used in this 
Agreement include the masculine, feminine and neuter and the singular number includes the plural 
number and vice versa. All references to Articles and Sections refer to articles and sections of this 
Agreement, and all references to Schedules and Exhibits are to schedules and exhibits attached 
hereto, each of which is made a part hereof for all purposes. 
[The remainder of this page has been intentionally left blank.] 
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IN WITNESS WHEREOF, this Limited Liability Company Agreement has been duly 
executed on the day and year first above written. 
MEMBERS: 
NEPHROLOGY ASSOCIATES, LLC 
By. James B. Stinson, M.D. 
SUMMIT DIALYSIS U, INC., 




MERCER UTAH, LLC, 




Mr. Robert Santelli 
Focus Enterprise LLC, a Utah limited liability company 
By: Bill Jensen, its Managing Partner 
NEPHROLOGY MEMBERS 
James B. Stinson, M.D. 
Richard Lambert, M.D. 
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Richard Cline, M.D. 
Elisabeth Atkin-Thor, M.D. 
Melinda McAnulty, M.D. 
Gary Rabetoy, MIX 
Christy Price-Rabetoy, MJD. 
David Tien, M.D. 
Jeff Barklow, M.t>. 
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SCHEDULEA 
Summit Dialysis, LLC 
Members Schedule 
(as of June 1,2003) 
Name of 
Member 
Summit Dialysis II, 
Inc. 
Mercer Utah, LLC 
Robert Santelli 





















Summit Dialysis, LLC 
Members Schedule 
(as of June 1,2003) 
Names and Addresses of Members 
1. Summit Dialysis II, Inc. 
c/o Bain Capital Venture Fund, LJP. 
Two Copley Plaza 
Boston, Massachusetts 02116 
Attention: Mr. Michael Krupka 
2. Mercer Utah, LLC 
c/o Mark Caputo 
3820 East Mercer Way 
Mercer Island, WA 98040 
3. Robert Santelli 
II Centaurus 
Irvine, CA 92612 
4. Focus Enterprise LLC 
c/o Bill Jensen 
5691 ShadyTarm Lane 
Murray, UT 84107 
5. NEPHROLOGY ASSOCIATES LLC (and each Nephrology Member) 
Nephrology Associates LLC 
650 East 4500 South, Suite 210 
Salt Lake City UT 84107 
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Exhibit 4,1 
4.1.1 Number, Election of Board Members. The Board shall initially consist of six 
members (each member of the Board, a ''Board Member"); the Board Members shall be 
designated as follows: 
(a) one Board Member shall be designated by Mercer; 
(b) one Board Member shall be designated by Santelli; 
(c) one Board Member shall be designated by Summit II; 
(d) two board members shall be designated by Nephrology Associates; and 
(e) one Board Member shall be designated by Jensen. 
In the event any Board Member ceases to serve on the Board for any reason, the Member or 
Members that have the right to designate such Board Member at the time such Board Member 
ceases to serve shall have the right to designate an individual as a replacement on the Board. 
Each Member with the right to designate one or more Board Members may replace or remove its 
designee(s) at its sole discretion at any time by written notice to the other Members with a copy 
to the Company, which notice shall be filed with the minutes of meetings of the Board In the 
event that any Member or Members entitled to designate one or more individuals for the Board 
following the resignation or removal of a Board Member fails to so designate an individual 
following such resignation or removal, such position shall remain vacant; provided that any such 
failure shall not deprive the Member or Members so entitled to designate an individual for such 
opening of its right to designate individuals as Board Members in the future. 
4.1.2. Initial Board of Managers. The following individuals, as nominees of the Member 
indicated, will be the initial Board Members: 
Board Member Nominating Member 
Mark Caputo Mercer 
Robert Santelli Santelli 
Michael Krupka Summit II 
James Stinson, M.D. Nephrology Associates 
Richard Cline, MX). Nephrology Associates 
Bill Jensen Jensen 
4.1.3. Tenure. Each Board Member shall, unless otherwise provided by law, hold office 
until such individual is removed, resigns or dies. Any Board Member may be removed and 
replaced pursuant to Section 4.1.1 above at any time without giving any reason for such removal 
and replacement A Board Member may resign by written notice to the Company which 
resignation shall not require acceptance and, unless otherwise specified in the resignation notice, 
shall be effective upon receipt by the Company. Vacancies in the Board shall be filled as 
provided in Section 4.1.1 above. 
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4.1.4. Meetings, Meetings of the Board may be held at any time and at anyplace within 
or without the State of Delaware designated in the notice of the meeting, when called by the 
Chair of the Board, if any, the President, if any, or any two Board Members acting together, 
reasonable notice thereof being given to each Board Member. 
4.1.5. Notice. It shall be reasonable and sufficient notice to a Board Member to send 
notice by overnight delivery at least forty-eight hours or by facsimile at least twenty-four hours 
before the meeting addressed to such Board Member at such Board Member's usual or last 
known business or residence address or to give notice to such Board Member in person or by 
telephone at least twenty-four hours before the meeting. Notice of a meeting need not be given 
to any Board Member if a written waiver of notice, executed by such Board Member before or 
after the meeting, is filed with the records of the meeting, or to any Board Member who attends 
the meeting without protesting prior thereto or at its commencement the lack of notice to such 
Board Member. Neither notice of a meeting nor a waiver of a notice need specify the purposes 
of the meeting. 
4.1.6. Quorum. Except as may be otherwise provided by law, at any meeting of the 
Board a majority of the Board Members then in office shall constitute a quorum, provided that 
the Board Members designated by Mercer and Summit II shall be present at such meeting. Any 
meeting may be adjourned from time to time by a majority of the votes cast upon the question, 
whether or not a quorum is present, and the meeting may be held as adjourned without further 
notice. 
4.1.7. Action by Vote. Except as may be otherwise provided by law, when a quorum is 
present at any meeting the vote of a majority of the Board Members present shall be the act of 
the Board. Provided however, that any vote with respect to a sale of the Company or 
substantially all of its assets, or the dissolution or Iiquidiation of the Company shall require a 
vote of at least four Board Members. Provided further, that any vote that would impact the 
Company's ability to repay the Member's Loans, shall require the consent of Mercer and 
Summit H. 
4.1.8. Action Without a Meeting. Any action required or pennitted to be taken at any 
meeting of the Board may be taken without a meeting if all the Board Members consent thereto 
in writing, and such writing or writings are filed with the records of the meetings of the Board 
Such consent shall be treated for all purposes as the act of the Board. 
4.1.9. Participation in Meetings by Conference Telephone. Board Members may 
participate in a meeting of the Board by means of conference telephone or similar 
communications equipment by means of which all persons participating in the meeting can hear 
each other or by any other means pennitted by law. Such participation shall constitute presence 
in person at such meeting. 
4.1.10. Compensation. Each Board Member shall be reimbursed for such Board 
Member's reasonable expenses incurred in connection with attending meetings of the Board or 
otherwise in connection with the performance of such Board Member's duties as Board Member. 
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4.1J1 Board Observation. Each Member and each Nephrology Member who so 
requests shall be permitted observation rights to the Board, whereby the Company shall permit a 
Member or Nephrology Member who is an individual or a representative of a Member which is 
an entity (the "Observer") to attend, as an observer without voting rights, all meetings of the 
Board. The Observer shall be entitled to receive a copy of all written materials and other 
infonnation given to the Board in connection with such meetings at the same time as such 
materials and infonnation are given to the Board. If the Company proposes to take any action by 
written consent in lieu of a meeting of the Board, the Company shall give notice thereof to the 
Observer at the same time notice is given to the Board. The Observer shall be reimbursed for 





AMENDED AND RESTATED 
LIMITED LIABILITY COMPANY AGREEMENT 
OF 
SUMMIT DIALYSIS, LUC 
Dated us of July I,2003r 
THE MEMBERSHIP INTERESTS REPRESENTED BY IHE AJSREEMENT HAVE NOT 
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (1HE 
"ACT') OR ANY STATE SECURITIES LAW, AND MAYNOT HE SOLD OR 
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE :RBCHSTRATION STATEMENT 
UNDER THE ACT AND APPLICABLE STATE SECURITIES LAW OR AN EXEMPTION 
FROM REGJSraAITON THEREUNDER. 
THE MEMBERSHIP INTERESTS REPRESENTED BY W S mSXRUMENT ARE ALSO 
SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFERABILITY AS SET PORTH 
IN THIS AGREEMENT. 
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SECOND 
AMENDED AND RESTATED 
LIMITED LIABILITY COMPANY AGREEMENT 
OF 
SUMMTT DIALYSIS, LLC 
This SECOND AMENDED AND RESTATED UMTEED LIABILTTY COMPANY 
AGREEMENT (Urn "AgreemenTl of SUMMIT DIALYSIS, LLC, a Delaware limited liability 
company (the "Company*)? it made as of July 1,2003, by aad'among Nephrology Associates, IXC, 
a Utah limited liability company ("hfapjuology AsacxJates"! Summit Dialysis U, Inc. l^ Sumroit 
IT), a Delaware corporation, Mercar Utah, LLC, a Delaware limited liability company ("MSEQoTX 
Mr. Robert Santelll an individual CSflBMT). ««* James 3B, Stowo, MJ>„ Richard Lambert. MD.„ 
Richard Oinc, MD., EEsabcth Atkin-Thor, MJX, Melicda McAnuhy, M.DM Gary Rabetoy, MD., 
Christy Price-Rabetoy, David Tien, M.D^ and Jeff Baxldow, KLD. Bxcb of Nephrology Associates, 
Santeffi, Summit H; and Mercer, shall individually bereftoedtoasa TjiflxnhflT and collectively aa 
the T^embera." Each afDrs. Stinaon, Lambert, Cline, Atkin-Thor, McAnuhy, Rabetoy, Tien and 
Barlow, and Ms. Price-Rabetoy, shall be referred to as the ^eohn*k>OT Members" or 
ThysiriaAj"}-
WHEREAS, the Company was formed as a limited Hal^iryconn^any pursuant to tixs 
Delaware Limited liability Company Act, Delaware Code, Title 6, Sections 18-101, et acq., aa 
amended (me "Delaware AcTL by having a Cerfifieate of Formation of the Company ftfec 
^eriifip^fi^ ^ed with the Secrettry 
WHEREAS, the Members wish to amend and restate tfro Agreement as provided herein to 
set out their respective rigbta, obligations and dutiei regardingfthe Company and ks assets; 
NOW, THEREFORE, in conaideradoa of tbe mutual covenants and agreements herein made 
and other good and valuable consideration, the Members hereby agree is follows: 
ARTICLE.I 
ORGANIZATION 
1.1 In General 7nenanieoftb&linii1edBabilftycx>mpairy cxinsiraited by this Agreement 
is Summit Dialysis, IXC or such otiier name or names aa the Board inay iran tbne to time 
deaimiatc: prodded that ttenanre 
the terms U C T o r ^ L C , " The rights, powers; duties, obligations and HabUhies of the Members 
shall be determined pnrtuaifr to the Delaware Ad and this Agreement Tb the extort that the rights, 
powers, doners, c&iigatioris andKabjiiriaof an^ 
this Agreement than they woold be in the absence of sudb provision this Agreement 
cxkot peimitted by the Delaware Act, contiol 
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L2 Registered Office: Agent The Company shall maintain a registered office In the 
State of Delaware at c/o Corporation Service Company, Suite 400,2711 Centerville Road, 
Wilmington, New Castle County, Delaware 19808 or at such other place within Delaware as the 
Board may designate. The name and address of the Company's registered agent for service of 
process on the Company in the State of Delaware is Corporation Service Company, Suite 400,27 U 
Genterviffe jRoad, Wilmington, New Castfo County, Delaware 19808 or such other agent as the 
Board may from time to time designate. 
1.3 Term. The term of the Company shall contmue perpetuaMy unless terminated in 
accordance with the provisions of this Agreement. 
1.4 Purpose: Powers. The purposes and character of the business of the Company shall 
be to transact any or all lawful business for which limited liability companies may be oiganized 
under the Delaware Act, including the development, ownership and operation of one or more 
kidney dialysis ftcilities. As of the date hereof, the Company operates two licensed dialysis clinics 
through subsidiary limited companies lenown as Wasatch Artificial Kidney Center LLC and Oquinh 
Artificial Kidney Center IXC. The Company owns 100% of the equity o f East Valley Associates 
IXC which in turn owns 100% of the equity of Wasatch Artificial Kidney Center LLC. The 
Company owns 100% of the equity of West Valley Associates? IXC which in turn owns 100% of the 
equity of Oquinh Artificial Kidney Center LLC 
ARTICLE 2 
MEMBERSHIP 
2.1 Membership and Capital Contributions. The Company has oohr one class of 
Members. The Members of the Company who have made contributions to the capital of the 
Company, the cash contributed by each such Member and the capital account for each such member 
as ofthe date heroofare as set forth on the Members Schedulcfcttacfced as Schedule A. The 
Company shall maintain the Members Schedule which shall rc&ect the Members ofthe Company 
and thzir capital contributions G-om time to time. NoM&nbersh&ll have eny obligations to mite 
any additional contributions of cash or other assets to the Company. 
2.2 Issuance of ALdditional Membership Interests. The Company shall not issue any 
additional voting or economic interests in the Company except pursuant to an amendment to this 
Agreement which is approved by the Board. Furthermore* except as approved by the Board, the 
Company 6hall not admit any other Person as a new Member except pursuant to Section 6.2 in 
connection with a transfer of any membership interest 
Z3 Loans. As of the date hereof Bain Capital Venfure Fund, LJP. and certain affiliates 
have lent the Company the aggregate principal sum of $760,00CL Prior to the date hereof Mark 
Caputo Ct£8£u&''), the controlling member of Mercer, has lent the Company the aggregate 
principal aum $480,000. The fnrrefminfr lnans are referrgd to ht*t*n as the <,rRfemlw& \xvm$n The 
Members Loans shall bear interest and be payable as set forth in the notes applicable thereto and 
shall not be considered capital contributions of such Members to the Company. In addition, DVI 
Financial Services has lent the Company 51,800,000 and the Company and its subsidiaries owe 
DaVita, Jtac the sum of $3,450,000. Each member of Nephrology Associates hereby agrees to 
guarantee up to $70,000 ofthe debt owed to DVI Financial Services. 
SummitL2X>/an3om 
2.4 Representations and Warranties of Members. Each Member hereby represents and 
warrants to tbe Company and acknowledges that: (i) such Member is capable of evaluating the 
merits and risks of an investment in the Company and making;an infbnned investment decision with 
respect thereto; (11) such Member has a pre-existing personal or business relationship with Ceputo; 
(iii) such Member is aWe to bear tbe -economic and financial risk of an investment in the Company 
for an indefinite period of time; and Qv) such Member is acquiring interests in the Company for 
investment only and not with a view to, or for resale in connedSon with, any distribution to the 
public or public offering thereof 
2.5 No liability of Members. 
(a) No liability;. Except as otherwise required by applicable law and as 
expressly set forth in this Agreement, no Member shall have any personal liability 
whatsoever in such Member's capacity as a Member, whether to the Company, to any of the 
other Members, to the creditors of the Conaparry or to any other third party, for the debts, 
liabilities, commitments or any other obligations of the. Company or for any losses of the 
Company. 
(b) No Management or Control No Member shall take part in or interfere in any 
manner with the management of tbe business or affaire of the Company or hay© any right or 
authority to act for or bind the Company, notwithstanding Section 18-402 of the Delaware 
Act. The business of the Company shall be managed fcy the Board as provided in Section 
4 ^ and except fin* the rights of Members to appoint members of the Board as provided in 
Exhibit 4.1, tbe Members shall not ba*e the right to yote or consent on any matter. 
(c) Specific limitations. No Member shall have the right or power to: (a) 
withdraw Or reduce such Member* s capital contribution; except as otherwise provided by} aw 
or in this Agreement, (b) make voluntary caphal contributions or to contribute any property 
to the Company other than cash, (c) bring an action JGbr partition against the Company or any 
Company assets (which right each Member hereby waives and agrees not to assert), (d) 
cause the teraomation and dissolution of the Company, sir (c) require that distributions be 
made in property other than cash. 
ARTICLE 3 
DISTRIBUIXOKS 
3.1 In General The profits and losses of the Compknyfixim and after tbe date hereof 
and each hem entering into the computation thereof) as well as each distribution made by tbe 
Company to a Member, whether of cash, property or securities (each such distribution, a 
*I>isfaTbutipif,V shall be shared by and allocated among the Members as follows' 
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Nephrology Associates 45.0% 
Summit n 11.0% 
Santclli 22.0% 
Mercer 22.0% 
The foregoing Members are the only Members entitled to receive Distributions from the Company 
and no other Member shall have any interest in the Company, its assets or its profits or losses by 
virtue of being a Member or a Nephrology Member. 
3.2 General Tax Distributions. The Board shall determine the amount and timing of any 
Distributions to be made to the Members listed in Section 3.1; provided hQWgvqi; that to the 
maximum extent permitted by law and subject to the provisions of airy agreement to which the 
Company is a party, the Company shall make Distributions in cash to the Members listed in Section 
3.1 on a quarterly basis in an amount determined by the Board to be sufficient to cover the 
Members' combined federal and state income tax liabilities inclined by virtue of the Member's 
ownership interest in the Company, taking into account both profits and losses allocated to the 
Members after the date hereof Afl such Distributions shall bet mad* in accordance with the 
percentage interests set forth in Section 3.1. 
3.3 Certain Tax Distribntiohs. Notwithstanding the-provisions of Section 3.1 and 32 
above, iatha eveatthattha Board elects to sell substantially all of the assets of tha Company (or 
substantial assets of any of its subsidiaries), the Company shall first make a cash distribution 
sufficient to cover each Members* tax liability resulting fiom audi asset sale (as calculated for each 
Member and its owners based upon the Member's and owners! highest marginal tax rate), and then 
distribute the remaining proceeds (after repayment of all Membera Loans and otber debts) in 
accordance with Section 3.1. 
3.4 No Violation. Notwithstanding any provision to the cxmtrary contained in this 
Agreement, the Company shall not make a distribution to my Member on account of such 
Member's Interest if such distribution would violate Section 1$-607 of the Act or other applicable 
law. 
ARTICLE 4 
MANAGEMENT OF THE COMPANY 
4.1 Board of Mi»"ff gyr* The business of the Company shall be managed by a Board of 
Managers (the "BoanT), and thePcrsons constituting the Boarxl shall be the "managers* of the 
Company for all purposes under the Delaware Act, The Board shall initially be set at six and the 
individuals set forth in Exhibit 4,1 shall constitute the initial Bbard. Thereafter, the individuals 
constituting the Board shall be determined in accordance with ifce provisions of Exhibit 4.1. 
Exhibit 4.1 sets forth the procedures for the conduct of the flffijjre of the Board and decisions of the 
Board shall be set forth in a resolution adopted in accordance with the procedures set forth in 
Exhibit 4.1.. Such decisions shall be decisions of the Company's "manager" for all purposes of the 
Delaware Act and shall bo carried out by officers or agents of the Company designated by the Board 
in the resolution in question or in one or more standing resolutions or -with the power and authority 
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to do so under Section 4.4. A decision of the Boaid inay be amended, modified or repealed in the 
same manner in which it was adopted or in accordance with the procedures set forth in Exhibit 4.1 
as then in effect, but no such amendment, modification or repeal shall affect any person or entity 
who has been furnished a copy of the original resolution, certified by a duly authorized officer of 
the Company, until such person or entity has been notified in writing of such amendment, 
modification or repeal. 
4.2 Authority of Board of Managers. The Board shall have the exclusive power and 
authority to manage the business and affairs of the Company and to make all decisions with respect 
thereto. The Board or persons or entities designated by the Board, including officers and agents 
appointed by the Board, shall be the only persons or entities authorized to execute documents which 
shall be binding on the Company. To the fullest extent peranittcd by Delaware law, the Board shall 
have the power to perform any acts> statutory or otherwise, with respect to the Company orthis 
Agreement, which would otherwise be possessed by the Members under Delaware law. 
4.3 Officers: Agents. The Board by vote or resolution shall have the power to appoint 
officers and agents to act for the Company with such titles^ if any, as the Board deems appropriate 
and to delegate to such officers or agents such power and authority to act on behalf of the Company, 
including the power to execute documents on behalf of the Company, as the Beard may in its sole 
discretion determine; provided, however, that no such delegation by the Board shall cause the 
Persons constituting the Board to cease to be the "raanagerc" of the Company within the meaning of 
the Delaware Act Unless fee authority of the officer in question is limited in the document 
appointing such officer or is otherwise specified by the Board, any officer so appointed shall have 
the same authority to act for the Company and shall have the same responsibilities as a 
corresponding officer of a Delaware corporation would have in the absence of a specific delegation 
of authority or responsibility. The Board, in its sole discretion, may by vote or resolution of the 
Board ratify any act previously taken by an officer or agent acting on behalf of the Company, Any 
officer or agent shall serve at the pleasure oftfae Board and may be removed by the Board at $ny 
time with or without cauae. 
4.4 Appointment oFOfficers. The Board shall initially appoint one or more Nephrology 
Members to serve as Medical Director of its Oqukrh and Wasatch dialysis clinks. As 
compensation during its initial year as Medical Director, Oquirrh and Wasatch shall collectively pay 
$120,000 for such Medical Director services. The Board shall initially appoint Bill Jensen as Chief 
Operating Officer, with an annual compensation of $60,000. The Board shall initially appoint 
Caputo as Chief Executive Officer (with compensation of 530,000 annually) and SantelK as 
President (with compensation of $30,000 annually). 
4.5 Indemnity, etc. To the fullest extent permitted by applicable law, the Company shall 
indemnify, defend and hold harmless the Board and each member of the Board, each Member, 
including the Tax: Matters Partner in sudi Member** capacity as such, eadh such person's or entity's 
officers, directors, partners, members, shareholders, employees, accountants, counsel and agents, 
and the employees, officers, accountants, counsel and agents ofthe Company (each person or entity 
entitled to indemnification under this Section 4.6 being referred to as an "ftidcmnifiod Person" for 
purposes of this Agreement), from any liability, loss or damage incurred by the Indemnified Person 
by reason of any act performed or omitted to be performed by the Indemnified Person in connection 
with the business of the Company and ftora liabilities or obligations of the Company imposed on 
such person or entity by virtue of such person's or entity's position with the Company, including 
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reasonable attorneys* fees and costs and any amounts expended in the settlement of any such claims 
of liability, loss or damage; provided, however, that if the liability, Joss, damage or claim arises out 
of any action or inaction of an Indemnified Person, indemnification under this Section 4.6 shall be 
available only if (a) either (i) the Indemnified Person, at the time of such action or inaction, 
determined in good faith that its, his or her course of conduct was in, or not opposed to, the best 
interests of the Company or (u) in the case of inaction by the Indemnified Person, the Indemnified 
Person did not intend its, his or her inaction to be harmful or opposed to the best interests of the 
Company, and (b) the action or inaction did not constitute fraud or willful misconduct by the 
Indemnified Person; provided, further, however, that indemnification under this Section 4.6 shall be 
recoverable only from the assets of the Company and not from any assets of the Members. No 
Indemnified Person shall be liable, in damages or odicrwise, to.the Company or to any Member for 
any loss that arises out of any act performed or omitted to be performed by h, him or her pursuant to 
the authority granted by this Agreement if (a) either (3) the Indemnified Person, at the time of such 
action or inaction, determined in good faith that such Indemnified Person's course of conduct was 
in, or not opposed to, the best interests of the Company, or (ii) An the case of inaction by the 
Indemnified Person, the Indemnified Person did not intend such Indemnified Person's inaction to be 
harmful or opposed to the best interests of the Company, and (h) the conduct of the Indemnified 
Person did not constitute fraud or willful misconduct by such Indemnified Person. 
ARTICLE 5 
CAPITAL ACCOUNTS AND TAX MATTERS 
5.1 Partnership Taxation. At any time when the Company has more than one Member, 
the Company shall be treated as a partnership for federal, foreign, state and local income tax 
purposes, as applicable, and each Member and die Company shall file all tax: returns and shall 
otherwise take all tax and financial reporting positions in a manner consistent with such treatment. 
The Company shall not be deemed a partnership or joint venture for any other purpose. 
5.2 Capital Accounts. 
(a) The Company shall maintain for each Member a separate capital account. 
Each such capital account shall be increased by the cask amount or fair market value of any 
property contributed by such Member to the Company pursuant to this Agreement and such 
Member's allocable share of profits and shall be decreased by the cash amount or fair 
market value of any property distributed to such Member pursuant to this Agreement and 
such Member's allocable share of losses. 
(b) The foregoing provisions relating to the.maintenance of capital accounts (and 
the allocation of profits and losses or items thereof) are intended to comply with the 
provisions of 704(b) of the Internal Revenue Code of 1986, as amended (the ''Code") and 
with Section L 704-1(b) of the regulations of the Deportment of the Treasury under the Code 
(such regulations, the 'Treasury Regulations") and shall be interpreted and applied in a 
manner consistent with the Code and such IVeasury Regulations. In furtherance of the 
foregoing, the Board is hereby directed to resolve any ambiguity in the provisions of this 
Agreement in a manner that will preserve, protect and jfbrther the intention of the Members 
to cause this Agreement to comply with the aforesaid provisions for federal income tax 
purposes and to adopt such amendments and curative provisions to this Agreement as the 
Board may deem necessary to achiervc the desired results. In accordance "with Section 
704(c) of the Code, income, gain, lo JS and deduction with respect to any property 
contributed to the Company with an adjusted basis for federal income tax purposes different 
than the initial asset value at which such property was accepted by the Company sbal^ 
solely for tax purposes, be allocated among the Members so as to take into account such 
difference in the manner required by Section 704(c) and the applicable Treasury 
Regulations. 
5.3 No Withdrawal, etc.- No Member shall be entitled to withdraw any part of its capital 
contribution or capital account or to recdve any distribution from the Company, except as expressly 
provided herein. If any Member has a defidt balance in its capital account, such Member shall have 
no obligation to restore such negative balance or to mike any capita] contributions to the Company 
by reason thereof. No Member shall receive any interest, salary or drawing with respect to its 
capital contributions or its capital account Members shall be entitled to look solely to the assets of 
the Company for the return of Members capital. 
5 A Regulatory Allocations- There arc hereby included in this Agreement such 
additional provisions governing the allocation of income, gam, loss, deduction and credit (and items 
thereof) as may be necessary to provide that the Company's allocation provisions contain a so-
called "Qualified Income OffeeT and comply with all provisions relating to the allocation of so-
called "Nonrecourse Deductions'" and "Member Nonrecourse Deductions* and the chargebafck 
thereof as set forth in the Treasury Regulations under Section 704(b) of the Code ("Regulatory 
Allocations"); provided, however, that, to the extent possible, all Regulatory Allocations that may 
be required shall be of&et by other Regulatory Allocations or special allocations of tax items such 
that each Member's share of the profftSj losses and capital of die Company will be the same as h 
would have been had the events requiring the Regulatory Allocations not occurred. 
5.5 Tax Matters Partner. Mercer shall be the "tax matters partner" of the Company 
pursuant to Section 6231(a)(7) of the Code (the "Tax Matters Partner*') and Aall not receive any 
compensation for acting as such. 
5.6 No pffftrr on Distributions. The provisions of this Article 5 are included solely for 
the purpose of allocating profits and losses and maintaining capital accounts for tax purposes and 
shall not affect the Distributions (other than tax distributions) required to be made as provided in 
Article 3. 
AMICLE 6 
TRANSFER OP MEMBERSHIP INTERESTS; WITHDRAWAL 
6.1 Restrictions. Each Member acknowledges and agrees that such Member shall not 
transfer any membership interest except with the prior consent of the Board, Any Member who 
transfers all of his or ha membership interests (i) shall cease td be a Member upon such Transfer, 
and (ii) shall no longer possess or have the power to exercise any rights or powers of aMember of 
the Company. 
6.2 Procedure for Transfers. No transferee of any Membership Interest may be newly 
admitted as a Member without the approval of tbc Board, No transfer of a Membership Interest 
SumniitLLC-Jun30[l] -*. 
maybe completed until the prospective transferee executes and delivers to Ac Company a written 
undertaking to be bound by the terms and conditions of this Agreement in form and substance 
reasonably satisfactory to the Board. Upon the amendment of the Members Schedule and the 
approval of the Board, such transferee shall be admitted as a Member and deemed listed is such on 
the books and records of the Company. 
63 Withdrawal. A Member shall not cease to be a Member as a result of the bankruptcy 
of such Member. So k>ng as a Meniber continues to own or bold any membership interests, such 
Member shall not have the ability to resign as a Member priorto the dissolution and winding up of 
the Company and any such resignation or attempted resignation by a Member prior to the 
dissolution or winding up of the Company shall be null and void. 
ARTICLE 7 
OPERATION OF THE COMPANY 
7.1 Conduct of Business. Each Member and each Nephrology Member will use its 
reasonable efforts to establish, grow and preserve the business of the kidney dialysis ikcOities 
operated by the Company. 
7.2 Right ofFirst Opportunity. Bach Member and each Nephrology Member hereby 
grants to each other Member a continuing and absolute right of first opportunity and right of first 
refusal to participate as a member or equity owner (on terms substantially similar to the teems 
contained in this Agreement) in one or more limited liability companies or other legal entities in 
connection with any such Member's or Nephrology Member's* as the case may be, acquisition; 
formation, development, leasing, operation and/or management (whether directly or indirectly) of 
any dialysis clinic or other dialysis-related fecility (one or more) in Salt Lake County, Utah. 
7.3 Non-Compete upon Safe. In the event that the Members or Board decide to sell or 
transfer substantially all of the assets of the Company, or sell the membership interest in the 
Company, then each Member and each Nephrology Member shall not compete directly or indirectly 
with the Company by owning, managing, operating; controlling, joining, assisting, advisirg, or 
consulting to, any business engaged in the provision of out-patient dialysis, home dialysis or acute 
dialysis within a 5 mile radius of any of the facilities then operated !>y the Company. This covenant 
shall have a duration of three years from the date of sale. Notwithstanding the foregoing, 
Nephrology Associates shall in all cases be permitted to continue to serve Ms medical director (and 
in no other capacity) of Central Valley Dialysis (owned by IHCiX Utah Dialysis Lab (owned by 
IHC), Tooele Dialysis (owned by IHC), and South Valley Dialysis (owned by the University of 
Utah). This clause shall not be construed as to restrict patient referrals. 
7.4 Joinder Agreement- Nephrology Associates shall have each new associate or partner 
that joins Nephrology Associates join in this Agreement as a Nephrology Member by signing a 
joinder agreement in form and substance reasonably satisfactory to the Board. 
7.5 Apcotmtmg- Accurate books, records and accounts shall be maintained by the 
Company showing Irs assets, liabilities, operations, transactions and financial condition. Hie Board 
shall designate the methods of accounting available to the Company. The Company's books shall 
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be maintained at the prindpal office of the Company and each Member Bhall, at all reasonable times 
have the right to inspect anid copy the same. The Company shall have an annual audit conducted of 
its financial records by an outside accounting firm and shall provide each member a copy of its 
audited financial statements within 150 days after the end of each fiscal year. The Company1 s tax 
returns shall be prepared by an outside accounting firm designated by the Tax Matters Member. 
7-6 Tax Year. The tax year of the Company ghall commence on January 1 and end on 
December 31. 
7.7 Disclosure. Each Member and each Nephrology Member shall have the right dining 
business hours on reasonable notice to examine the books and records of the Company. 
7& Professional Liability Insurance. Each Memberand each Nephrology Member who 
is a licensed physician shall be insured, at such physician's own expense, against professional 
liability, with coverage limits of no less than $1,000,000, issued by a compairy or companies 
approved to do business in the state in which the Company operates its dialysis clinic. In addition, 
each Nephrology Member described in the preceding sentence that is required to purchase 
professional liability insurance shall also purchase appropriatetail insurance coverage or continuing 
coverage in the event of withdrawal from the Company or a dissolution of the Coirpany. 
7
-9 Professional liability Insurance. The Company shall bind professional liability 
insurance for the Company in an amount of no less than SI million, at the Company's expense. 
ARTICLE » 
MSSOLUTTOPT AND OQUIDATION 
8.1 Dissolution. The Company shall be dissolved and its afeirsivcjund up only upon tfte 
happening of any of the following events: 
(a) the disposition of all or substantially all of the Company's assets determined 
on a consolidated basis; 
(b) detennination of the Board; 
(c) the entry of a decree? ofjudicial dissolution under Section 18-802 of the 
I>elawareAct 
No withdrawal of any Member shall cause a dissolution of the Company and the Company shall 
continue in existence subject to the terms and conditions of £hi$ Agreement Dissolution of the 
Company shall be effective on the day on which the event occurs jgiving rise to the dissolution, but 
the Company shall not terminate until the windmg up of the Con^ 
assets of the Compauy have been distributed as provided in Section 9.2 and the Certificate shall 
have been canceled. 
f-2 Distribution of Assets. Upon the dissolution of the Company, the net proceeds from 
liquidation of Company assets shall be applied and distributed as follows: 
SummitLLC-Jun30[ij -10-
(a) To the payment of all debts and liabilities of the Company (including all 
debts described in Section 2-3 of this Agreement) and the expenses of liquidation of the 
Company; 
(b) To the establishment of such reserves as may be deemed advisable by the 
Board for any contingent liabilities or obligation of the Company; 
(c) To the Members in accordance with the provisions of Article 3. 
ARTICLE 9 
GJENERAI^MKCT^ PROVISIONS 
9.1 Notices. Whenever any notice is required to be-fijven by law or this Agreement, a 
written waiver thereof; signed by the Person entitled to notice, whether before or after the time 
stated therein, shall be deemed equivalent to the giving of such notice. Any notice to be given 
hereunder will be given in writing and may be given personally or by rnaiL If given by mail, the 
notice will be deemed given when deposited in the United States mail, postage prepaid, certified or 
registered mail, return receipt requested, addressed to the recipient at its address on the books and 
reoords of the Company (which may be changed at any time bjr sending to the Company a noti ce of 
change of address satisfying the requirements of this paragraph). Whenever any notice is required 
to be given by law orttds Agreement, a written waiver thereof signed by the Person entitled to 
notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of 
such notice, 
9.2 Governing Law. This Agreement and the rights of the parties hereunder shall he 
interpreted in accordance with the internal laws of the State of Delaware, and all rights and 
remedies shall be governed by such laws without regard ta principles of conflicts of laws. 
9.3 Entire Agreement- This Agreement constitutes the entire agreement of the parties 
thereto relating to the Company and supersedes all prior contracts or agreements with respect to the 
Company, whether oral or written. 
9 A Amendment or Modification. This Agreement and any provision hereof may be 
amended, modified or waived from time to time only by the p£*or approval of the Board and of 
Members holding not less than 60% of the percentages listed in Section 3.1. Any amendment, 
modification or waiver of this Agreement approved as contemplated by the immediately preceding 
sentence shall be binding on all Members and Nephrology Members. 
9.5 Binding Effect Subject to the restrictions on transfers of Membership Interests set 
forth in this Agreement, this Agreement is binding on and shall inure to the benefit of the Members 
and their respective heirs, legal representatives, successor and permitted assigns. 
9.6 Counterparts. This Agreement may be signed in any number of counterparts, each of 
which shall be an original for all purposes, but all of which taken together shall constitute paly one 
agreement 
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9/7 Severability. Each provision of this Agreement shall be considered severable and if 
for any reason any provision or provisions herein (a) are determined to be invalid or contrary 1o any 
existing or fixture law, such invalidity shall not impair the operation of or affect those portions of 
this Agreement which are valid or (b) would cause any Member to be bound by the obligations of 
the Company under the laws of any state or locale as the same may now or hereafter exist, such 
provision or provisions shall be deemed void and of no effect. 
9.8 Headings. All section headings or captions contained in this Agreement are for 
convenience only and shall not be deemed part of the text of this Agreement. 
9.9 Parties in Interest. Except as provided in Section 4.3, nothing herein shall be 
construed to be to the benefit of or enforceable by any third party including, but not limited to, any 
creditor of the Company. 
9.10 Further Assurances. The Members will execute and deliver such Anther instruments 
and do such further acts and things as may be required to carry out the intent and purposes of this 
Agreement. 
9.11 No Strict Constractioix The parties to this Agreement have participated jointly in the 
negotiation and drafting of this Agreement. Lithe event an ambiguity or question of intent or 
interpretation arises, this Agreement shall be construed as if drifted jointly by the parties to this 
Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any party by 
virtue of the authorship of any of the provisions of this Agreement. 
9.12 Construction. Wheneverthe context requires, the gender of all words used in this 
Agreement include the masculine, feminine and neuter and the singular number includes the plural 
number and vice vensa. All references to Articles and SectkmSrefer to articles and sections of this 
Agreement, and all references to Schedules and Exhibits are to schedules and exhibits attached 
hereto, each of which is made a part hereof for all purposes. 
[The remainder of this page has been intentionally left blank.] 
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IN WITNESS WHEREOF, this Limited liability Company Agreement has been duly 
executed on the day and year first above written. 
MEMBERS: 
NEPHROLOGY ASSOCIATES, LLC 
By: James B. Stinson^MD. 
SUMMIT DIALYSIS H, INC. 




MERCER UTAH, LLC, 
a Delaware limited liability company 
By: i^t/u* */*fl*~i> 
"Name; /* . < T 
Title:
 T S-* ~ / U / ^ ^ J ? S <SEf& 
Mr. Robert SanteUi 
NEPHROLOGY MEMBERS 
James B. Stinsgn, M.1 James t*. Sfrnsgn, N 
MZx 
Richard Lambert, MX). 
£4*3 
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Elisabeth Atidn-Thor, MD. 
Melinda Mc Anility, M.D. 
Gary Rabetoy, MJ>. 
Christy Price-Rabetoy, Afc^T V) * 
—3 
Baridow, M B . /L-L.C. 
SumnritLLC-2 -14-
SCHEDULE A 
Summit Dialysis, LLC 
Members Schedule 
(as of July 1,2003) 
Nameof Contributed Capital 
Mem3)er Capital Account 
SmnmitDialrsis U, $40,000 $40,000 
Inc. 
Maccr Utah, LLC $80*000 $80,000 
Robert Santelli $80,000 $80,000 
Nephrology Associates 5164,000 $164,000 
Total; S364,000 $364,000 
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SCHEDULE A 
Summit Dialysis, LLC 
Members Schedule 
(as of June 1,2003) 
Names and Addresses ofMembers 
1. Summit Dialysis H, Inc. 
c/o Bain Capital Venture Fund, LJP. 
Two Copley Plaza 
Boston, Massachusetts 02116 
Attention; Mr. Michael Krupka 
2. Mercer Utah, LLC 
c/o Mark Capufco 
3820 East Mercer Way 
Mercer Island, WA 98040 
3. Robert Santefli 
11 Centaums 
Irvine, CA 92612 
4. NEPHROLOCFY ASSOCIATES LLC (and each Nephrology Member) 
Nephrology Associates LLC 
650 East 4500 South, Suite 210 
Salt Lake City UT 84107 
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Exhibit 4.1 
4.1.1 Number Election ofBoard Members. The Board shall initially consist of six 
members (each member of the Board, a "Board Member3'): the Board Members shall be 
designated as follows: 
(a) one Board Member shall be designated by Mercer; 
(b) one Board Member shall be designated by Santelli; 
(c) one Board Member shall be designated by Summit H; 
(d) two board members shall be designated by Nephrology Associates; and 
(e) one Board Member shall be designated by vote of all board members 
described in (a) thru (d) above. 
In the event any Board Member ceases to serve on the Board For any reason, the Member or 
Members that have the right to designate such Board Member at the time such Board Member 
ceases to serve shall have the right to designate an individual as a replacement on the Board. 
Each Member with the right to designate one or more Board Members may replace or remove its 
designee($) at its sole discretion at any time by written notice to the other Members with a copy 
to the Company, which notice shall be filed with the minutes of meetings of the Board. In the 
event that any Member or Members entitled to designate one. or more individuals for the Board 
following the resignation or removal of a Board Member fails to so designate an individual 
following such resignation or removal, such position shall remain vacant; provided that any such 
failure shall pot deprive the Member or Members so entitled to designate an individual lor such 
opening of its right to designate individuals as Board Members in (he future. 
4.1.2. Initial Board of Managers. The following individuals, as nominees of the Member 
indicated, will be the initial Board Members: 
Board Member Nominating Member 
Mark Caputo Mercer 
Robert Santeflj Santelli 
Michael Krupka Summit II 
James Stinson, MD. Nephrology Associates 
Melinda McAnulty, MD. Efephrology Associates 
Bill Jensen \fote of all other Board Members 
4.1.3. Tenure* Each Board Member shall, unless otherwise provided by law, bold office 
until such individual is removed, resigns or dies- Any Board Member may be removed and 
replaced pursuant to Section 4.1.1 above at anytime without giving any reason for such removal 
and replacement A Board Member may resign by written notice to the Company which 
resignation shall not require acceptance and, unless otherwise^ specified in the resignation notice, 
shall be effective upon receipt by the Company. Vacancies m the Board shall be filled as 
provided in Section 4.1.1 above. 
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4_1A Meetings. Meetings of the Board may be held at any time and at any place within 
or without the State of Delaware designated in the notice of the meeting, when called by the 
Chair of the Board, if any, the President, if any, or any two Board Member* acting together, 
reasonable notice thereof being given to each Board Member. 
4.1.5. Notice. It shaU be reasonable and suffid^ 
notice by overnight delivery at least forty-eight hours or by facsimile at least twenty-four hour* 
before the meeting addressed to such Board Member at such Board Member's usual or last 
known business or residence address or to give notice to such Boaid Member in person or by 
telephone at least twenty-four hours before the meeting. Notice of a meeting need not be given 
to any Board Member if a written waiver of notice, executed.by such Board Member before or 
after the meeting, is filed with the records of the meeting, or to any Board Member who attends 
the meeting without protesting prior thereto or at its commencement the lack of notice to such 
Board Member. Neither notice of a meeting nor a waiver of a notice need specify the purposes 
of the meeting. 
4.1.6. Oipppn Except as may be otherwise provided by law, at any meeting of the 
Board a majority of the Board Members then in office shall constitute it quorum, provided that 
the Board Members designated by Mercer and Summit H shall be present at such meeting, and at 
least one Board Member designated by Nephrology Associates shall be present at such meeting. 
Any meeting may be adjourned from time to time by a majority of the votes cast upon the 
question, whether or not a quorum is present, and the meeting may be hdd as adjourned without 
further notice. Except in the event of emergency or crisis; the Board shall use its reasonable 
efforts to have all Board Members (or their designees) present for meetings. 
4.1.7. Action by Vote. Except as may be otherwise provided by law, when a quorum is 
present at any meeting the vote of a supermajority of the Board Members (or their designees) 
present shall be the a?t of the Board. Supermajority shall be defined as at least S0% of the 
Board Members present Provided however, that any vote with reapectto a sal© of the Company 
or substantially all of its assets, or the dissolution or Hquidiflrian of the Company shall require a 
vote of at least four Board Members, and provided furiberthat at least one Board Member 
designated by Nephrology Associates shall have voted in fevor of such sale, dissolution or 
Uquidatioa Provided further, that any vote that would impact the Company's ability to repay the 
Member's Loans, shall require the consent of Mercer and Summit EL 
4:1.8, Action Without a Meeting. Any action required or permitted to be taken at any 
meeting of the Board may be taken without a meeting if all the Board Members consent thereto 
in writing, and such writing or writings are filed with the records of the meetings of the Boaid 
Such consent shall be treated for all purposes as the act of the Board 
4.1.9. Participation inMeetmgs bv Conference Telephone. Board Members may 
participate in a meeting of the Board by means of conference telephone or similar 
communications equipment by means of which all persons participating in the meeting can hear 
each other or by any other means pennhted by kw. Such participation shall constitute presence 
in person at such meeting. 
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4.1.10. Compensation Each Board Member shall be .reimbursed for suchBoard 
Member's reasonable expenses incurred in connection with attending meetings of the Board or 
otherwise in connection with the performance of such Board'Member's duties as Board Member. 
4.1.11 Board Observation. Each Member and each Nephrology Member who so 
requests shall be pcnnitted observation rights to the Board, whereby the Company shall permit a 
Member or Nephrology Member who is an individual or a representative of a Member which is 
an entity (the "Observer") to attend, as an observer without voting rights, all meetings of the 
Board. The Observer shall be entitled to receive a copiy of all written materials and other 
information given to the Board in connection with such meetings at the same time as such 
materials and information are given to the Board. If the Company proposes to take any action by 
written consent in lieu of a meeting of the Board, the Company shall give notice thereof to the 
Observer at the same time notice is given to the Board. The Observer shall be reimbursed for 
costs and expenses incurred in attending meetings of the Board. 
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RICHARD S. NEMELKA #2396 
STEPHEN R. NEMELKA #9239 
NEMELKA & NEMELKA 
6806 South 1300 East 
Salt Lake City, Utah 84121 
Telephone: (801)568-9191 
Fax: (801)568-9196 
Attorneys for Plaintiff 
IN THE THIRD JUDICIAL DISTRICT COURT OF SALT LAKE COUNTY 
STATE OF UTAH 
SONJA M. JENSEN, FOCUS ENTERPRISE 
L.L.C., a Utah Limited Liability Company, 




JAMES B. STINSON, M.D.; et al 
Defendant's, 
AFFIDAVIT OF SONJA JENSEN 
Case No. 050902765 
Judge: Lindberg 
STATE OF UTAH ) 
: ss 
County of Salt Lake ) 
Sonja Mann Jensen, being firstly sworn upon her oath hereby deposes and states as follows: 
1. That she is the Plaintiff in the above-entitled matter and has personal knowledge of the 
facts alleged herein and is competent to testify to the same. 
2. That the statement contained in the Defendant's Memorandum in Support of a Motion for 
Summary Judgment under paragraph 15 taken from her deposition, is a misrepresentation of her 
position and her deposition. Specifically, she has always asserted and claimed that there was an oral 
agreement between the Plaintiffs and the Defendants, wherein the Defendants agreed to convey to the 
Plaintiffs an interest in the Defendant, Summit Dialysis. Attached hereto as Exhibit "A" and 
incorporated herein by reference are additional statements from her deposition supporting her position 
of an oral agreement. Further, the Complaint in this matter is specific in alleging an oral agreement 
between the parties. 
3. The statements in paragraph 15 taken out of her deposition were taken out of context and 
Affiant's answer of "no" referred to no other written agreements other than what she had already 
stated and testified to in her deposition. Apparently, Affiant misunderstood the question, however, 
her answer indicated she had already talked about Pasadena and Austin which were in fact other 
dialysis centers, but she was not asserting in this litigation that there was any oral agreements in 
regard to receiving an ownership interest in those dialysis centers, although Affiant believes that in 
fact there were. However she is asserting that there are unwritten agreements in regard to the 
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dialysis centers involved with Summit Dialvsis and the Defendants listed in Affiant's Complaint. 
4. In Affiant's deposition on page 57 and 59 she discussed again the ownership interest. Her 
testimony specifically indicates that she believes as of the date of the deposition that Mr. Jensen had 
an 8% ownership interest in Summit Dialysis based upon the fact that she had found the $8,000.00 
cash disbursement. Further, she said in her opinion she believed that he had some interest since May 
of 2001, and that it was being hidden due to the fact that Mr. Jensen could not legally have an interest 
in Summit Dialysis LLC, based upon his covenant not to compete with DaVita, his former employer. 
The Defendants are well aware of Plaintiffs position that the parties began in 2001, as alleged in the 
complaint, to conspire between themselves to take the dialysis business in Utah from DaVita, and that 
pursuant to the oral agreements between the parties at that time, Mr. Jensen would have an 8% 
interest in Summit Dialysis. However, as stated in Affiant's deposition, as indicated in her Exhibit 
"A", there were numerous conversations after 2001 wherein the Defendant specifically agreed that 
Mr. Jensen would be given his 8% interest in Summit Dialysis after the DaVita lawsuit was settled, 
which was in fact settled in the spring of 2003. It was immediately thereafter that the June 2003 
agreement was drafted to solidify the agreement that the parties had entered into prior to said date. 
Again, the interest that Bill Jensen was to receive through Focus Enterprises of 8% in Summit 
Dialysis was agreed upon between the Defendant's and Bill Jensen, and the Plaintiff, Sonja Jensen, 
through the numerous conversations that took place in Plaintiffs home with Mr. Santelii, the 
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President of Summit Dialysis, as was stated in Affiant's deposition on pages 57 - 59 as well as other 
places. 
5. Affiant had various conversations with the Defendant, Bill Jensen, specifically from the 
time period of February 2003, through May of 2003 wherein Bill Jensen specifically indicated that 
in his conversations with Mr. Santelli and the other Defendants that his 8% interest in Summit 
Dialysis would be finalized and completed after the DaVita lawsuit was settled, which again is 
evidenced by the June 19, 2003 draft. 
6. There was a meeting of the minds in regard to the terms of the contract which is 
substantiated by the documents attached hereto as Exhibit "B" and incorporated herein by reference, 
specifically the fax dated March 21,2001 from James B. Stinson to Bill Jensen. The other documents 
in Exhibit B support the agreement between the parties that Bill Jensen would own an 8% interest in 
Summit Dialysis once the DaVita lawsuit was settled. 
7. Also attached hereto as Exhibit "C" is a letter from Affiant to James Stinson again 
indicating the verbal agreements between Mr. Stinson and the Plaintiffs through Bill Jensen in regard 
to Bill Jensen's ownership interest. 
8. In summary the specific terms of the contract were as follows: 
a. Bill Jensen would own an 8% interest in Summit Dialysis and Summit Dialysis 
would own 100% interest in the East Valley Dialysis Center and the West Valley Dialysis Center. 
4 
b. Bill Jensen's ownership interest would be conveyed to him once the DaVita 
lawsuit was settled. 
c. Bill Jensen's consideration for his interest in the DaVita lawsuit, was all of the 
work that Bill Jensen and Sonja Jensen did to secure the locations and to organize and establish the 
dialysis centers in Utah. Further, the capital contribution was waived pursuant to an agreement with 
James Stinson and Robert Santelli in consideration for Bill Jensen leaving the State of Utah and 
hiding out for over three months to prevent DaVita from taking his deposition. 
These terms were reduced to writing as indicated in the Amended and Restated Limited 
Liability Company Agreement of Summit Dialysis LLC, dated July 1, 2003, which is attached as 
Exhibit 7 to Defendant's Memorandum. The reason that said agreement was not signed by the 
Defendants was based upon the fact that Sonja Jensen and Bill Jensen had separated, and Bill Jensen 
and the other Defendants agreed to not sign said agreement to prevent Sonja Jensen from asserting 
any claim for her share of the ownership interest in Summit Dialysis LLC. 
9. Further, between the settlement of the DaVita case in the spring of 2003 and June 19, 
2003, William Jensen had numerous conversations with Robert Santelli, wherein Mr. Santelli as 
President of Summit Dialysis Inc., acknowledged the oral agreement that William Jensen would 
receive his 8% interest in Summit Dialysis Inc., and that the written agreement to memorialize the 
oral agreement would be prepared and sent to Mr. Jensen, which in fact it was. 
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Mr. Santelli specifically #&&&& &at B*& Jensen would have an 8% ownership interest in Summit 
Dialysis once the Da Vita j&wsuft w a s settled. La fact, for the period of two years prior to June, 2003
 > 
there were never any distf1^*0315 o r indications that there were any conditions upon Bill Jensen's 
receiving the 8% ov^nersltip of Snrntnit Dialysis other than waiting until the DaVita lawsuit was 
settled so that he would n0& ^ s^ed for violating his non-compete agreement with DaVita. 
DATED this iff " day of November, 2006. 
"^TMA Mmm Mm^ 
SONJA N1ANM JENSEN^' 
SUBSCRIBED &$& SWORN TO before wt this , & day of November, 2006. 
^ J i d m R Y PUBLIC 
Janet GWefeen 
Notary Public Seal Stale of irrtfcara 
LaKeCoomy 
CERlTtFlCATE OF MAILING 
< r ^ i l I 
CERTIFICATE OF MAILING 
4 I hereby certify that I mailed a true copy of the foregoing Affidavit this <> day of 
December, 2006, postage prepaid and addressed as follows: 
Bart J. Johnsen 
Attorney at Law 
50 South Main Street, Suite 1600 
Salt Lake City, Utah 84144 
Byron Benevento 
Tyler Murray 
SNELL & WILMER 
15 West South Temple #1200 




RICHARD S. NEMELKA #2396 
STEPHEN R. NEMELKA #9239 
NEMELKA & NEMELKA 
6806 South 1300 East 
Salt Lake City, Utah 84121 
Telephone: (801)568-9191 
Fax- (801)568-9196 
Attorneys for the Respondent 
IN THE THIRD JUDICIAL DISTRICT COURT OF SALT LAKE COUNTY 
STATE OF UTAH 
SONJA M. JENSEN, et ah, 
Plaintiffs, 
vs. 
JAMES B. STINSON, M.D.; et al 
Defendant's. 
PLAINTIFF'S ANSWERS TO 
DEFENDANT'S FIRST SET OF 
REQUEST FOR PRODUCTION 
AND INTERROGATORIES 
Civil No. 050902765 
Judge: Adkins 
Commissioner: 
Plaintiffs, by and through their attorney Richard S. Neraelka respectfully submit the 
following answers to Defendant's First Set of Requests for Production and Interrogatories. 
Answer to First Set of Interrogatories 
1. Attached hereto as Exhibit "A" and incorporated herein by reference is Plaintiffs 
response to Defendant's First Set of Interrogatories 1-10. 
Answers to First Set of Requests for Production 
1. All documents requested in request number 1 -12 are available for inspection at the office 
of Plaintiffs counsel, Richard S. Nemelka, 6806 South 1300 East, Salt Lake City, Utah, upon 
reasonable arrangements made to inspect said documents. 
DATED this fj day of January, 2006. 
NEMELKA & NEMELKA 
Richard S. Nemelka 
Attorney for the Plaintiff 
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VERIFICATION 
State of Utah ) 
:ss 
County of Salt Lake ) 
Sonja Jensen, Being first duly sworn upon her oath, deposes and states that she is the Plaintiff 
in the above-entitled matter and that she has read the foregoing Plaintiffs Answers to Defendant's 
First Set of Request for Production and Interrogatories, that she knows the contents thereof and 
acknowledge the contents therein and that they are true and correct to the best of her knowledge and 
belief 
DATED this [y_ day of J ^ , 2006. 
Sonja Jensen 
SUBSCRIBED AND SWORN to befere-me this / (day of J N / ^ J _ , 2006. 
Residing in the State of Utah 
r>i?l 
CERTIFICATE OF MAILING 
I hereby certify that I mailed a true and correct copy of the foregoing Plaintiffs Answers to 
Defendant's First Set of Request for Production and Interrogatories this JT) day of January, 
2006, postage prepaid and addressed as follows: 
Bart J. Johnsen 
50 South Main Street, Suite 1600 
Salt Lake City, Utah 84144 L ^ — — — 
4 
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PLAINTIFFS ' RESPONSE TO DEFENDANTS' 
FIRST SET OF INTERROGATORIES 
1. Identify all persons involved in any discussions or negotiations regarding any 
alleged contract to convey to Plaintiffs any ownership interest in Summit Dialysis, L.L.C. 
or any other business entity involved in kidney dialysis. 
Response 
William A. Jensen, James B. Stinson, MIX, Richard G. Lambert, M.D., Richard 
C. Cline, M.D., Elisabeth Atkin-Thor, MIX, Melinda J. McAnulty, M.D., Gary 
Rabetoy, M.D., Christy Price-Rabetoy, M.D., David Tien, M.D., Jeff Barklow, 
M.D.? Robert Santelli, Mark Caputo, Michael Krupka, Gerald B. Stephanz, M.D.. 
Nancy Ahlstrom, MJD., Terry Hammond, M.D., Lawrence R. Spira, M.D.. Vicky 
Burner, Steven Hard, Esq. 
2. Describe in detail the terms of any contract to convey to Plaintiffs any ownership 
interest in Summit Dialysis, L.L.C., or any other business entity involved in kidney 
dialysis that you claim defendants' breached. Your answer should include the following 
information: 
(a) The identity of all parties to the alleged agreement(s); 
(b) When the alleged agreement(s) were made: 
(c) What Plaintiffs promised to do or pay to obtain an ownership interest in 
Summit Dialysis, L.L.C. or any other business entity involved in kidney 
dialysis; 
(d) The percentage of ownership interest Plaintiffs were to receive; 
(e) When Plaintiffs were supposed to have received this interest and what rights 
they were to have in Summit Dialysis, L.L.C. or any other business entity 
involved in kidney dialysis, as a result of this interest; 
(f) All other terms of the alleged agreement(s). 
Response 
First Agreement: The following two items were located in a manila file folder 
titled, "Ownership" written in Bill Jensen's handwriting: The James B. Stinson 
letter was attached to the Operating Agreement. The signatures on the Operating 
Agreement are the original signatures. 
1. Operating Agreement for East Valley Artificial Kidney Center LLC dated and 
signed 5-01-0 L (See Plaintiffs Exhibit List dated 12-26-05, Item #8). This 
operating agreement is owned by East Valley Associates, LLC, which is owned 
by the Summit Dialysis, LLC pursuant to the "Sale of Membership Interests 
Agreement" (Plaintiff's Exhibit List Item #14) dated 3-06-02, wherein Dr. 
Gi*Q 
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Lawrence R. Spira, M.D., sold all membership interests to Robert Santelli and 
Mark Caputo. 
2. James B. Stinson letter (on Nephrology Associates letterhead) dated 
3-21-01, (See Plaintiffs Exhibit List dated 12-26-05, Item #7). 
(a) The identity of all parties to the alleged agreement(s); 
James B. Stinson, M.D., Richard G. Lambert, M.D., Elisabeth Atkin-Thor, 
Richard C. Cline, M.D., Melinda J. McAnuIty, M.D., Gary Rabetoy, M.D., 
Christy Price-Rabetoy, M.D., Bill Jensen, Robert Santelli (East Valley 
Associates), Lawrence R. Spira replaced by Mark Caputo, 
(b) When the alleged agreement(s) were made; 
This Operating Agreement for East Valley Artificial Kidney Center, LLC 
was the operating agreement set up to operate Wasatch Artificial Kidney 
Center. The agreement was signed on 5-01-0]. 
(c) What Plaintiffs promised to do or pay to obtain an ownership interest in 
Summit Dialysis, LLC or any other business entity involved in kidney 
dialysis; 
See copies of each Nephrology Partner's personal check to purchase an 
ownership percentage in the Operating Agreement for East Valley 
Artificial Kidney Center, LLC, dated 5-01-01 (PlaintifFs Exhibit List Item 
#8). Each check was made out to Wasatch Artificial Kidney Center at the 
end of March, 2001, (PlaintifTs Exhibit List Item #13). The amount of 
each Partner's check is detailed as follows: 
James B. Stinson, M.D.: $2051.10, (Check #0617, dated 3-30-01) 
Richard G. Lambert, M.D. $1139.55, (Check #1786, dated 4-01-01) 
Elisabeth Atkin-Thor, M.D. $1139.55, (Check #5256, dated 3-29-01) 
Richard C. Cline, M.D. $1139.55, (Check #1712, dated 4-03-01) 
Melinda J. McAnuIty, M.D. $797.70, (Check #2217, dated 3-30-01) 
Gary Rabetoy, M.D. $683.70, (Check #1268, dated 3-31-01) 
Christy Price-Rabetoy $398.83, (Check #1278, dated 3-31-01) 
Bill Jensen $797.70* (Jensen paid Stinson cash so the 
transaction would be hidden) 
*This amount was paid by James B. Stinson for Bill Jensen, Check 
#0617, in the amount of $2051.10, as listed above, because Bill Jensen 
was in violation of an Employee Noncompetition Agreement with Davita 
and his name could not appear on the contract. Bill Jensen was still 
employed with Davita at this point in time, therefore. Dr. Stinson held Bill 
Jensen's membership interest share in his name until such time as 
2 
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Nephrology Associates and Bill Jensen could force Davita out of the 
Utah dialysis market by moving their dialysis patients from Davita centers 
to their own dialysis centers. 
The percentage of ownership interest Plaintiffs were to receive; 
Member ownership percentages are listed below as detailed in the James 
B. Stinson letter dated March 21, 2001, (Plaintiffs' Exhibit List Item 
#7): 
_%_ 
James B. Stinson, M.D. 8.33 
Richard G. Lambert, MJD. 7.59 
Elisabeth Atkin-Thor, M.D. 7.59 
Richard C. Cline, M.D. 7.59 
Meiinda J. McAnulty, M.D. 5.29 
Gary Rabetoy, M.D. 4.55 
Christy Price-Rabetoy 2.64 
Bill Jensen 5.29 
When Plaintiffs were supposed to have received this interest and what 
rights they were to have in Summit Dialysis, LLC or any other business 
entity involved in kidney dialysis, as a result of this interest; 
Plaintiffs received an ownership interest when the Operating Agreement 
for East Valley Artificial Kidney Center, LLC, was signed on 5-01-01, 
(PlaintifFs Exhibit List Item#8). The rights Plaintiffs received through the 
execution of this operating agreement are: 
Bill Jensen has a 5.29% ownership interest in the above mentioned 
operating agreement, meaning he would have a 5.29% ownership interest 
in all outpatient kidney dialysis centers that are owned and operated by 
East Valley Associates (Robert Santelli, President) that are located on the 
East side of the Salt Lake Valley. He is a full Partner with Nephrology 
Associates, he is holding ten (10) shares, and he has a length of service of 
four (4) years (onset service date 1995) based on the original Total Renal 
Care of Utah Contract dated 9-01-97, as detailed by James B. Stinson in 
his letter dated 3-21-01, (Plaintiffs' Exhibit List Item #7.) 
Schedule I, Page 27, of the Operating Agreement for East Valley Artificial 
Kidney Center, LLC, (Plaintiffs' Exhibit List Item M8) titled, "List of 
Members, Initial Capital Contributions and Percentage Interests", lists 
each Members' "Initial Capital Contribution" as well as each Members* 
"Percentage Interest". Since James B. Stinson is holding Bill Jensen's 
ownership percentages in his name, James B. Stinson's total capital 
3 
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contribution equals $2051.10, the amount of the personal check he wrote 
to Wasatch Artificial Kidney Center as stated above. 
As detailed in his letter dated 3-21-01, (Plaintiffs' Exhibit List ltem#7)? 
Dr. Stinson has an 8.33% ownership interest and Bill Jensen has a 5.29% 
ownership interest, the same ownership interest percentage as Melinda J. 
McAnulty, M.D. The amount of Dr. McAnulty's check (capital 
contribution) to Wasatch Artificial Kidney Center is $797.70, to purchase 
her 5.29% ownership interest. Therefore, Bill Jensen's 5.29% ownership 
interest would result in a capital contribution of $797.70, as well. 
Subtracting Bill Jensen's capital contribution of $797.70, from Dr. 
Stinson's capital contribution of $2051.10, leaves Dr. Stinson with an 
actual capita] contribution amount of $1253.40. 
Also, on Schedule I of the above mentioned operating agreement, James 
B. Stinson's "percentage interest" totals 13.674%, because he is holding 
his own "percentage interest" of 8.33%, plus Bill Jensen's "percentage 
interest" of 5.29%, as listed on the Nephrology Associates letter from 
James B. Stinson dated 3-21-01, (Plaintiffs' Exhibit List Item #7). 
(f) All other terms of the alleged agreement(s); 
All other terms and rights that are conveyed to Plaintiffs as "Members" 
of the Operating Agreement for East Valley Artificial Kidney Center, 
L L C (Plaintiffs' Exhibit List Item #8), are detailed throughout the body of 
the agreement itself. (This operating agreement is owned by East Valley 
Associates, LLC, which is owned by the Summit Dialysis, LLC through 
the Sales of Membership Interests Agreement dated 3-06-02, (Plaintiffs' 
Exhibit List Item #14). 
Second Agreement: Operating Agreement for West Valley Artificial Kidney 
Center, LLC. This operating agreement is owned by West Valley Associates, 
LLC, which is owned by Summit Dialysis, LLC pursuant to the "Sale of 
Membership Interests Agreement" (Plaintiffs Exhibit List Item #14) dated 3-06-
02, wherein Dr. Lawrence R. Spira, M.D., sold all membership interests to Robert 
Santelli and Mark Caputo. 
(a) The identity of all parties to the alleged agreements); 
James B. Stinson, M.D., Richard G. Lambert, M.D., Richard C. Cline, 
M.D., Melinda J. McAnulty M.D., Christy Price-Rabetoy, David Tien, 
M.D., Jeff Barklow, M,D., Bill Jensen, Robert Santelli, (West Valley 
Associates), Lawrence R. Spira replaced by Mark Caputo. 
(b) When the alleged agreements) were made; 
ans 
The West Valley Artificial Kidney Center, LLC, was the operating 
agreement set up to operate the Oquirrh Artificial Kidney Center. This 
agreement was made initially in the Spring of 2001, approximately 
the same time as the Operating Agreement for East Valley Artificial 
Kidney Center, LLC, dated 5-01 -01. At that time Dr. Lawrence R. Spira 
owned 100% of this LLC and Nephrology Associates had no interest in 
the LLC because their Noncompetition Agreement with Davita precluded 
them from having an ownership interest in any dialysis center within a 25 
mile radius of any Davita* s dialysis center. Davita's Midvalley Dialysis 
center was within 2 miles of the Oquirrh Artificial Kidney Center, 
therefore that would be a violation of the Nonecompetition Agreement 
Nephrology Associates had with Davita. 
Once the Total Renal Care and Total Renal Care of Utah LLC vs. 
Nephrology Associates, LLC, Lawsuit (Case Number 020906806) was 
settled on approximately 5-06-03, the Operating Agreement for West 
Valley Artificial Kidney Center was revised to allow Nephrology 
Associates Partners to have a membership interest 
What Plaintiffs promised to do or pay to obtain an ownership interest in 
Summit Dialysis, LLC or any other business entity involved in kidney 
dialysis; 
Once the Total Renal Care and Total Renal Care of Utah LLC vs. 
Nephrology Associates, LLC, lawsuit was settled, each Nephrology 
Associates Partner was allowed to have an ownership percentage 
interest. 
Plaintiffs' ownership percentage interest in the Operating Agreement for 
West Valley Artificial Kidney Center, LLC, through Bill Jensen, is 
2,71%, meaning he would have a 2.71% ownership interest in all 
outpatient kidney dialysis centers that are owned and operated by West 
Valley Associates (Robert Santelli, President) that are located on the 
West side of the Salt Lake Valley. 
Bill Jensen has a total ownership percentage interest of 8.0% in the 
Second Amended and Restated Limited Liability Company Agreement of 
Summit Dialysis, LLC, dated 6-19-03, (as stated below), and since he 
received a 5.29% ownership percentage interest in the Operating 
Agreement for East Valley Artificial Kidney Center, LLC dated 5-01-01, 
as stated above, his ownership percentage interest in the Operating 
Agreement for West Valley Artificial Kidney Center, LLC amounts to 
2.71% (8.0% minus 5.29% equals 2.71%). 
The percentage of ownership interest Plaintiffs were to receive; 
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Plaintiffs, through Bill Jensen were to receive 2.71% as noted in (c) above. 
Member ownership percentages for each Nephrology Partner can be 
calculated the same way as Bill Jensen^s ownership interest percentage 
was calculated in (c) above. 
(e) When Plaintiffs were supposed to have received this interest and what 
rights they were to have in Summit Dialysis, LLC or any other business 
entity involved in kidney dialysis, as a result of this interest 
Plaintiffs received this 2.71% ownership when the Operating Agreement 
for West Valley Artificial Kidney Center, LLC was signed in 
approximately June, 2003, after the Total Renal Care of Utah vs. 
Nephrology and Total Renal Care of Utah LLC vs. Nephrology 
Associates, LLC, Lawsuit (Case Number 020906806) was settled. 
(f) All other terms of the alleged agreement(s). 
All other terms and rights that are conveyed to Plaintiffs as "Members" 
of the Operating Agreement for West Valley Artificial Kidney Center, 
LLC, are detailed throughout the body of the agreement itself (This 
operating agreement is owned by West Valley Associates, LLC, which is 
owned by Summit Dialysis, LLC through the Sale of Membership 
Interests Agreement dated 3-06-02, (Plaintiffs' Exhibit List Item #14). 
Third Agreement: Second Amended and Restated Limited Liability Company 
Agreement of Summit Dialysis, LLC, dated 6-19-03, (William Jensen Deposition 
Exhibit #2). This LLC agreement showing Bill Jensen's 8.0% ownership 
percentage in the Summit Dialysis, LLC, was faxed to the Jensen residence on 
6-23-03, the day that William and Sonja Jensen separated. 
(a) The identity of all parties to the alleged agreement(s); 
Nephrology Associates (each Nephrology Member), Michael Krupka 
(Summit Dialysis II, Inc.), Mark Caputo, (Mercer Utah, LLC), Robert 
Santelli, Bill Jensen, (Focus Enterprise LLC), East Valley Associates, 
LLC, West Valley Associates, LLC, Wasatch Artificial Kidney Center 
LLC, Oquirrh Artificial Kidney Center LLC. 
(b) When the alleged agreements) were made; 
The Second Amended and Restated Limited Liability Company 
Agreement of Summit Dialysis, LLC, was made when the Total Renal 
Care and Total Renal Care of Utah LLC vs. Nephrology Associates, LLC, 
Lawsuit (Case Number 020906806) was settled on approximately 5-06-03. 
D-ntJ 
The settlement agreement that was reached between Total Renal Care and 
Nephrology Associates was very important because Nephrology 
Associates and Bill Jensen would no longer be violating their Noncompete 
Agreements with Total Renal Care (Davita), and more importantly, Bill 
Jensen could finally return to the State of Utah. {He left the state on 
2-07-03, to avoid deposition service in the Total Renal Care vs. 
Nephrology Associates lawsuit that is mentioned above). 
The Second Amended and Restated Limited Liability Company 
Agreement of Summit Dialysis, LLC is the LLC agreement that was the 
final step and entity set up to own all of the various operating 
agreements for any dialysis centers that Nephrology Associates and its 
partners build in the State of Utah. As stated above, this LLC 
agreement could not be executed until Total Renal Care (Davita) was out 
of the Utah market thereby releasing Nephrology Associates and Bill 
Jensen from their Noncompetition Agreements. 
What Plaintiffs promised to do or pay to obtain an ownership interest in 
Summit Dialysis, LLC or any other business entity involved in kidney 
dialysis; 
Bill Jensen's capital contribution was $34,043, for his ownership interest 
in the Summit Dialysis, LLC. This capital contribution was waived by 
Nephrology Associates because he had to leave the state of Utah from 
2-07-03, to 5-07-03, to avoid deposition service in the Total Renal Care 
vs. Nephrology Associates lawsuit as stated above. 
Bill Jensen told Sonja Jensen on two occasions that the $34,043, capital 
contribution would be waived. The first occasion was a conversation on 
4-30-03. Bill Jensen called Sonja Jensen from her brother's home in Las 
Vegas, Nevada, and told her that he spoke with James B. Stinson, and that 
Dr. Stinson said that Nephrology Associates would waive the $34,043, 
contribution. Also, on 6-22-03, the day before Bill and Sonja Jensen 
separated, Bill Jensen told Sonja Jensen, during an evening walk around 
their Murray neighborhood, that the Summit Dialysis, LLC Agreement 
was ready to be signed, and that the $34,043, capital contribution would 
be waived as compensation for all the hardships we had endured during 
2001 through 2003, as the Summit Dialysis, LLC was being formed. 
Additionally, Plaintiffs paid for their 8% ownership interest in the Summit 
Dialysis, LLC, by providing the following services: 
Bill Jensen's substantial period of unemployment. Bill Jensen resigned 
from Davita on 4-06-01, in order to work covertly with Robert Santelli to 
build the Oquirrh Artificial Kidney Center and the Wasatch Artificial 
Kidney Center. Robert Santelli had to rely on Bill Jensen to instruct and 
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direct him regarding all aspects of the construction and operation of the 
dialysis centers because he had no kidney dialysis center operational 
expertise. Bill Jensen was acquainted with Robert Santelli because both 
were employed with Davita. (Robert Santelli drafted the Amended and 
Restated Operating Agreement of Total Renal Care of Utah dated 9-01-97, 
between Nephrology Associates, William Jensen and Total Renal Care, 
Plaintiffs Exhibit List Item #51). Bill Jensen and Dr. Stinson brought in 
Robert Santelli and Dr. Lawrence R. Spira as investors to build the 
Oquirrh Artificial Kidney Center and the Wasatch Artificial Kidney 
Center. At this point in time Bill Jensen had an Employee Noncompete 
Agreement with Davita which is why he finally resigned his employement 
with them on 4-06-01. 
Sonia Jensen passed up acceptance to attend nursing school, Sonja Jensen 
was not able to start nursing school at the University of Utah in August, 
2001, because Bill Jensen was unemployed. Instead she became 
employed with Southwest Airlines in order to receive family insurance 
benefits because of Bill Jensen's unemployment. 
Accommodations made for Robert Santelli. Robert Santelli stayed in the 
Jensen family home three to four days a week for two years while the 
Oquirrh Artificial Kidney Center and the Wasatch Artificial Kidney 
Center were being constructed and brought into operation. Bill and Sonja 
Jensen agreed to provide lodging, food, and transportation for Robert 
Santelli in order to reduce Summit Dialysis, LLC overhead costs while the 
dialysis centers were being built and brought into operation. 
When Plaintiffs were supposed to have received this interest and what 
rights they were to have in Summit Dialysis, LLC or any other business 
entity involved in kidney dialysis, as a result of this interest; 
Plaintiffs were to receive their 8% ownership interest by signing the 
Second Amended and Restated Limited Liability Company Agreement of 
Summit Dialysis, LLC dated 6-19-03, (William Jensen Deposition Exhibit 
#2). On 6-23-03, the date of the Jensen marital separation, the above 
agreement was faxed to the Jensen home. On 6-23-03, Sonja Jensen 
informed Bill Jensen she was separating from him. Not knowing Sonja 
Jensen had received a faxed copy of the 6-19-03, draft Summit Dialysis 
LLC agreement, Bill Jensen immediately contacted the Summit Dialysis 
partners and asked that they remove his name and 8% ownership 
percentage from the 6-19-03, draft agreement and draft a new agreement. 
On 6-30-03, the Second Amended and Restated Limited Liability 
Company Agreement of Summit Dialysis, LLC (William Jensen Exhibit 
#3) was signed without Bill Jensen's name or 8% ownership percentage 
included on it 
8 
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Plaintiffs were to receive all rights as listed in the Second Amended and 
Restated Limited Liability Company Agreement of Summit Dialysis, LLC 
dated 6-19-03 (WiJIiam Jensen Deposition Exhibit #2) as well as a 
monthly cash disbursement of $8000. Bill Jensen told Sonja Jensen on 
many occasions that once the Summit Dialysis LLC agreement was signed 
they would begin receiving a monthly check for $8000. 
Plaintiffs believe Bill Jensen is receiving his hidden monthly cash 
distributions because Sonja Jensen found exactly $8000 in $100 dollar 
bills in Bill Jensen's briefcase in the marital residence on 11 -21-03. 
(f) All other terms of the alleged agreement(s). 
Plaintiffs would receive increased monthly cash disbursements once other 
Summit Dialysis, LLC dialysis centers were opened and operating and the 
operating agreements were signed. Currently the dialysis centers Plaintiffs 
are aware of that are open and operating are Oquirrh Artificial Kidney 
Center, Wasatch Artificial Kidney Center, and South Mountain 
Dialysis. 
3. Describe in detail what Plaintiffs actually did or paid (were supposed to have paid 
or done) to obtain an ownership interest in Summit Dialysis, L.L.C. or any other business 
entity involved in kidney dialysis, pursuant to any alleged contract referenced in 
Interrogatory No. 2. 
Response 
See all information included in the response to Interrogatory #2 above. 
4. Describe in detail the alleged assistance that Plaintiff Sonja M. Jensen provided 
"in the procurement of real estate upon which to build the dialysis centers as well as the 
development of the same," referenced in paragraph 42 of the Complaint. You answer 
should include the following information: 
(a) Everything that Ms. Jensen did; 
(b) When she did it; 
(c) Who else was involved; and 
(d) How her alleged work assisted in the procurement of real estate upon 
which to build the facilities and/or assisted in the development of the 
facilities. 
Response 
Sonja Jensen accompanied Bill Jensen on many occasions to find property 
because it was difficult to find dialysis center property in a suitable location for 
the right price per square foot. 
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1 Q. What do you mean by agreements 
2 grandfathered in? 
3 A. I assumed, and I'm not a lawyer, that the 
4 East and West Valley Operating Agreements that were 
5 signed were taken over and inherited, because in the 
6 agreement it says on page 4 that what Mr. Santelli 
7 and Mr. Caputo inherited when they took over 
8 Mr. Spira's position. 
9 Q. Right. That was the whole purpose of 
0 Summit buying the East Valley and West Valley 
11 facilities was so that Summit would own them rather 
12 thanSpira? 
13 A. Right, and you're saying today was I a ware 
14 that Nephrology - what was the word? 
15 Q. Well, they reassigned their ownership 
16 interests at the same time Summit purchased them from 
17 Spira. 
18 A. And who would they reassign them to? 
19 Q. Summit. 
20 A. Okay. 
21 Q. Do you know when the Oquirrh and Wasatch 
22 facilities became operational? 
23 A. Yes. Oquirrh became operational in June 
24 of '02 and Wasatch in about September of '02. 
25 Q. Let me have you take a look at Exhibit 2, 




3 MR. NEMELKA: No. 
4 THE WITNESS: No? Okay. That's right. 
5 Q. (BY MR. LALLI) So those Defendants 
6 mentioned, they had agreements with yourself, Focus 
7 Enterprise and the family limited partnership. 
8 Is that your testimony? 
9 A. Yes. 
10 Q. And I note there that the word 
11 "agreements" is plural; is that correct? 
12 A. Yes. 
13 Q. So is it your testimony that yourself, 
14 Focus and the family limited partnership had multiple 
15 agreements with Summit, Nephrology Associates, 
16 Nephrology members Santelli, Caputo, Krupka, Mercer 
17 and Summit Dialysis II? 
18 A. Yes. 
19 Q. How many agreements were there? 
20 A. Do you want verbal or written? 
21 Q. Well, let's start with written. 
22 How many written agreements are there 
23 between the Plaintiffs and those Defendants? 
24 A, Well, the first one was the one you 
25 already showed. I t was this agreement (indicating). 
1 if you would, please. 
2 Do you recognize this as the Complaint you 
3 filed in this lawsuit? 
4 A. Yes. 
5 Q. Did you provide the information to your 
6 attorney for purposes of preparing this Complaint? 
7 A. Some. 
8 Q. Did you review it before it was filed? 
9 A. I'm quite sure I did. 
10 Q. And did you verify the accuracy of the 
11 allegations made in here? 
12 A. Yes. 
13 Q. Turn to page - they're not numbered. Go 
14 to paragraph 50 of the Complaint, if you would, 
15 please. Actually, 51. 
16 Do you have that? 
17 A. Uh-huh. 
18 Q. That paragraph says, "Defendants Summit 
19 Nephrology Associates and Nephrology Members, 
20 Santelli, Caputo, Krupka, Mercer, and Summit Dialysis 
21 I I have breached their agreements with the 
22 Plaintiffs." 
23 By the Plaintiffs, do you mean Sonja 
24 Jensen, Focus Enterprise and the William A. Jensen 
25 Family Limited Partnership? 
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1 MR. NEMELKA: Which exhibit? 
2 THE WITNESS: I'm sorry. It's Exhibit 
3 Number 10. That was the first agreement. 
4 Q. (BY MR. LALLI) Okay. 
5 A. I don't have a copy of the second 
6 agreement, which was the West Valley Artificial 
7 Kidney Center - I'm sorry. West Valley Associates' 
8 agreement, which included the Oquirrh facility, but I 
9 know that my husband had a 2.71 percent ownership in 
10 that. 
11 Q. How do you know that? 
12 A. Because he ended up with eight percent, 
13 and he was always going to have eight percent, as 
14 reflected in the June 19th Summit Dialysis contract 
15 where his name was removed in June of f03. 
16 Q. You say he ended up with eight percent? 
17 A. That was what he was always planning to 
18 have. 
19 Q. I'm not interested in what he was planning 
20 to have. I'm interested in what he had. 
21 A. That's what he had, eight percent. 
22 Q. Eight percent of what? 
23 A. Eight percent of Summit Dialysis. 
24 Q. Okay. And you're saying that that's 
25 reflected where? 
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1 A. With the East Valley Operating Agreement 
2 and the West Valley Operating Agreement. The East 
3 Valley Operating Agreement included all centers built 
4 on the east side of the valley, the west included all 
5 centers built on the west side. 
6 Q. How could your husband have an eight 
7 percent interest in Summit by virtue of agreements 
8 that did not include Summit? 
9 A. These agreements that we're talking about 
10 that were signed in May of '01 were assigned over to 
11 Mr. Caputo and Mr. Santelli in March of '02 when they 
12 took over Spira's responsibilities and paid him for 
13 what he had. 
14 Q. Okay. So you're telling me that so far 
15 there are two written agreements that you're 
16 referring to in paragraph 51 of the Complaint; is 
17 that right? 
18 A. Right. 
19 Q. Are there more written agreements? 
20 A. There is the agreement that his name was 
21 taken off of of the 6-19 draft of the Summit 
22 Dialysis, LLC, which it finally got to show what he 
23 had. 
24 Q. You're referring to Exhibit 4? 
25 MR. NEMELKA: Yes, it's Exhibit 4. Do you 
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1 them. 
2 Q. And how are you sure of that? 
3 A. Because he was going to take over the 
4 whole State of Utah. 
5 Q, Well, I was going to be president of the 
6 United States, but that didn't happen. 
7 How do you know that your husband has 
8 ownership interests in these other Summit LLCs? 
9 A. I don't have the documents to show you, 
10 but I know that he does. 
11 Q. Hence my question: How do you know that? 
12 A. Because that's what this was set up. 
13 That's why it was west side and east side, and 
14 anything that they've done since we separated he has 
15 ownership in. 
16 Q. Have you seen any documents -
17 A. No. 
18 Q. - that suggests - okay. 
19 Has anyone told you that he has ownership 
20 interests in other Summit LLCs? 
21 A. I'm not sure about Pasadena and Austin. I 
22 don't know if they're included in Summit. I don't 
23 believe that they are. Those are other LLCs that he 
24 told me he had ownership in. 
25 Q. Okay. And when did he tell you that he 
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1 have it there? 
2 THE WITNESS: 1 don't know where it is. 
3 Probably in this pile. 
4 Q. (BY MR. LALLI) Yeah, it should be there. 
5 A. I t would be the Summit Dialysis, LLC, yes, 
6 right here (indicating). 
7 Q. Okay. Any other written agreements that 
8 you claim that the Plaintiffs in this lawsuit had 
9 with the Defendants identified in paragraph 51? 
10 A. I assume there are other agreements that 
11 my husband has with Summit Dialysis because I know 
12 that there's another facility built on South Mountain 
13 on 106th South in Sandy. 
14 Q> I'm not asking about agreements that your 
15 husband has with anyone. I'm asking about agreements 
16 that Sonja Jensen, Focus Enterprises and William H. 
17 Jensen Family Limited Partnership have with Summit, 
18 Nephrology Associates, Nephrology members Santelli, 
19 Caputo, Krupka, Mercer and Summit Dialysis I I . 
>0 A. There's just a Summit Dialysis agreement 
?1 that lists all of those parties you just said, but I 
!2 believe that Summit owns other LLCs besides Wasatch 
!3 and Oquirrh, one being South Mountain. 
!4 Q. So what if Summit owns other LLCs? 
!5 A. I'm sure my husband has an interest in 
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1 had ownership in those? 
2 A. In Pasadena he told me that in 2002. 
3 Mr. Santelli gave him a two and a half percent 
4 ownership interest in the Arroyo Dialysis Center, and 
5 then also the exhibit here, Exhibit Number 1, 
6 Mr. Jensen had a four percent ownership agreement 
7 here with Mr. Santelli, and those are the only other 
8 two that I know about. 
9 Q. Okay. We're talking about written 
10 agreements, and you've identified three. 
11 A. Right. 
12 Q. The East Valley and West Valley Operating 
13 Agreements from 2001 and the unsigned Second Amended 
14 Operating Agreement of Summit, which we've identified 
15 as Exhibit 4; is that correct? 
16 A. Yes. 
17 Q. Are there any other written agreements 
18 that you've actually seen -
19 A. No. 
20 Q. - and know of? Okay. Are there other 
21 unwritten agreements that you're referring to that 
22 were breached in paragraph 51? 
23 A. I just spoke of two, the Pasadena and the 
24 Austin, Texas, and those are two that Mr. Jensen told 
25 me he had ownership in through Mr. Santelli. 
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1 Q. Okay. Were the Nephrology Associates 
2 members of these agreements--
3 A. No. 
4 Q. - in Pasadena? 
5 A. Those were other physicians. 
6 Q. Which of the Defendants identified in 
7 paragraph 51 do you believe are party to agreements 
8 that you haven't seen regarding Pasadena and Austin, 
9 Texas? 
10 A. Santelli and Caputo. 
11 Q. And, again, your sole basis for the belief 
12 that such agreements exist is that your former 
13 husband told you that he had an ownership interest in 
14 those? 
15 A. Yes. Specifically in the Pasadena 
116 dialysis center Mr. Caputo did not want my husband 
17 having an ownership position, but since Mr. Santelli 
18 didn't feel that competent in running the day-to-day 
19 operations, he offered my husband two and a half 
20 percent. 
21 Q. Okay. Any reason to believe that that 
22 offer was accepted and an agreement was consummated? 
23 A. Yes, I believe it was accepted because my 
24 husband continually worked down there and continually 
25 talked about that he had a two percent interest. 
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1 Q. Did you ever see any manifestation of that 
2 two percent interest, like money? 
3 A. No, I didn't. 
4 Q. How about a written agreement? 
5 A. No, I didn't. He just told me that that's 
6 what he would have. 
7 Q. Well, again, I mean, I can tell you that 
8 I've got a Porsche out in the parking garage, but 
9 it's not true. 
10 What I'm interested in is evidence that 
11 there actually was an agreement? 
12 MR. NEMELKA: Well, let me make an 
13 objection and move to strike the editorializing of 
14 Counsel. 
15 Go ahead and answer the question. 
16 THE WITNESS: Mr. Santelli told my husband 
17 that, and my husband was traveling when he was 
18 employed with Santelli in the year of 2002. My 
19 husband was traveling to Pasadena quite frequently 
20 because he could go outside the state and work on 
21 other projects, like Austin and Pasadena, and that 
22 would be okay because it wasn't violating his 
23 noncompete in Utah. 
24 Q. (BY MR, LALLI) Are these purported 
25 agreements you're referring to regarding Pasadena and 
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1 Austin, Texas, are those agreements that you are 
2 suing for in this lawsuit? 
3 A. Actually, t h i s - I would have to refer to 
4 my attorney. 
5 Q. Well, do you think you're suing for the 
6 breach of those agreements? 
7 A. I was hoping that we would figure out if 
8 they were under Summit or where they were under 
9 because I wasn't sure how they've set up all of their 
10 entities. 
11 I assume that they're through Liberty 
12 Dialysis now that I see how they've set everything 
13 up. 
14 Q. Well, the answer to my question might be 
15 you don't know, but you need to answer my question, 
16 which is: Are you suing for breach of agreements 
17 concerning Pasadena and Austin, Texas, in this -
18 A. Not in this Complaint. 
19 Q. Okay. I'm only interested in the 
20 agreements that you're suing for that are referred to 
21 in paragraph 51. 
|22 Other than the three written documents 
23 that you've told me you believe are agreements that 
24 the Plaintiffs are party to, are there any other 
25 agreements that you're suing under in this lawsuit? 
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1 A. Can I answer? 
2 MR. NEMELKA: Oh, you betcha. Go ahead. 
3 He's talking whether they're verbal or written 
4 agreements; is that correct, Counsel? Either written 
5 or unwritten? 
6 MR. LALLI: You tell me. 
7 • THE WITNESS: Can you say the question 
8 again? 
9 MR. LALLI: Yeah. 
10 Q. (BY MR. LALQ) I want to know how many 
11 agreements you claim that the Plaintiffs had with the 
12 Defendants and that the Defendants breached. You've 
13 already told me about three. 
14 A. Right. 
15 Q. I want to know if there are any more, 
16 written or unwritten? 
17 A. I believe there are others that are 
18 verbal, like I just told you about. 
19 Q. Okay. That you're suing for in this 
20 lawsuit? 
21 A. Okay. No. 
22 Q. Okay. So just the three. So if those 
23 three documents establish a contract, then we can 
24 talk about a breach, but if it's not in those three 
25 agreements, there's no other agreement or contract 
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1 that you're suing for here; is that correct? 
2 A. I f they have established something called 
3 North Valley or South Valley, LLC, and there's a -
4 for instance, I know that they have -- they're 
5 planning to build these other centers around the 
6 State, then those would be included. I just don't 
7 know about them. 
8 Q. Okay. Let's just talk about the 
9 agreements that you're aware of --
10 A. Okay. 
11 Q. - okay? Are there any other agreements 
12 that you're aware of between the Plaintiffs and 
13 Defendants in this lawsuit that you're suing for? 
14 A. No. 
15 Q. Okay. No oral unwritten agreements you're 
16 suing for in this lawsuit? 
17 MR. NEMELKA: Well, objection. She 
18 already - asked and answered. She said there's 
19 agreements she's suing for. 
20 MR. LALLI: No. I think she just said the 
|21 opposite. 
|22 MR. NEMELKA: No. I think she previously 
'23 testified that there were agreements that she's suing 
24 for that were reduced to writing. 
25 THE WITNESS: Agreements reduced to 
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1 writing and others that were verbal. 
J 2 Q. (BY MR. LALLI) By verbal, do you mean 
I 3 unwritten? 
I 4 A. Right. 
5 Q. Okay. Tell me what the unwritten 
6 agreements were that you're suing for in this 
7 lawsuit. 
8 A. Well, I've already said Pasadena and 
9 Austin, and we've decided that they're not as part of 
10 this lawsuit, so that would be the end of the answer. 
I I Q. Okay. So there are no unwritten 
12 agreements that you're suing for -
13 A. No. 
14 Q. - in this lawsuit? Okay. 
15 Let me ask you this question: With 
16 respect to the three written documents that you claim 
17 are agreements you're suing under in this lawsuit, 
18 what are the agreements for? 
L9 A. What do you mean what are the agreements 
>0 for? 
11 Q. Well, you say that there are agreements. 
!2 What do the agreements provide to the 
!3 Plaintiffs in this lawsuit? 
!4 A. This East Valley Operating Agreement, 
:5 Exhibit Number 10, provides that my husband has a 
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1 5.29 percent interest in any centers that are built 
2 on the east side of the valley with Dr. Stinson and 
3 his partners that are listed, meaning Bain Capital. 
4 Q. Okay. Now, you've never seen the 
5 West Valley agreement; right? 
6 A. Right. 
7 Q. Okay. But despite not having seen it, do 
8 you have some understanding of what that's an 
9 agreement for? 
10 A. I t ' s for the Oquirrh. 
11 Q. Okay. And what about the Oquirrh? 
12 A. It 's the Operating Agreement for the 
13 Oquirrh facility, and it's also called the 
14 West Valley Operating Agreement, which would mean my 
15 husband would have a 2.71 percent ownership on all 
16 facilities that Nephrology and my husband and 
17 Santelli built and Caputo built on the west side of 
[l8 Utah. 
19 Q. Okay. So is it your testimony that the 
20 West Valley agreement that you've never seen provides 
21 your husband with a 2.71 percent ownership? 
22 A. Right. 
23 Q. In what? 
24 A. In all centers built on the west side of 
25 Salt Lake. 
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1 Q. Okay. Forever? 
2 A. I don't know how it's written. I don't 
3 know what the contract says. 
4 Q. Okay. And the third written document that 
5 you claim is an agreement; that is, the unsigned 
6 second amendment to the Limited Liability Company 
7 Agreement of Summit Dialysis--
8 A. Exhibit 4? 
9 Q. -Exh ib i t 4 -
10 A. Correct. 
11 Q. What agreement does that provide? 
12 A. That is actually the official instrument 
13 that holds these Operating Agreements of West Valley 
14 and East Valley Associates, and that was the 
15 formalized document that my husband could finally 
16 have his name on because he was back in the State and 
17 his noncompete was invalid. They settled with 
18 Davita, and he could officially have his name on the 
19 paper. 
20 Q. And what did it give him? 
21 A. Eight percent ownership in anything Summit 
122 did. 
'23 Q. Okay. What's the difference, if any, 
24 between the three documents you're saying are 
25 agreements? 
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